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CHAPTER I

INTRODUCTION

1

2

This investigation examines the effect of two antitumor drugs, all
trans retinoic acid (RA) and butyric acid (BA), on the metastatic
properties of murine Bl6a melanoma cells.

The Bl6a cell line is the

murine counterpart to human melanoma which is the most lethal form of
skin cancer.

Accepted forms of chemotherapy have been found to be

ineffective in controlling metastatic melanoma (McClay and Mastrangelo,
1988).
Vitamin A (retinal) and metabolites (such as retinoic acid) are
necessary for the visual system, normal development and tissue
differentiation of an organism.

Evidence is accumulating for retinoids

in chemoprevention and therapeutic control of cancer (Lippman et al.,
1988).

Butyric acid (and its sodium salt) is a natural four carbon

fatty acid normally present in lipids.

Much less is known about BA than

RA in the normal development of an organism.

However, a role for BA in

the control of neoplastic formation has been found (Kruh, 1982).
Retinoic acid and BA warrant investigation for two main reasons.
First, RA and BA can be less toxic and less mutagenic to the host than
conventional chemotherapeutic drugs when administered at cytostatic
concentrations, i.e. the concentration of a drug that inhibits cellular
proliferation without causing cell death.

Second, the effects of RA and

BA on the individual steps of the metastatic cascade are undefined.
Most of the deaths due to cancer are a result of the appearance of
neoplasms in parts of the body removed from the primary lesion.

The

metastatic cascade is a complex series of steps involving: (1) primary
growth and progression of the primary tumor, (2) intravasation, i.e. the

3
escape of tumor cells into the lymphatics and blood vessels, (3)
dissemination of cells through the lymphatics and blood vessels, (4)
arrest of cells within the walls of small vessels, (5) extravasation,
the escape of tumor cells from small vessels and into surrounding
tissues, and (5) cell proliferation at the new secondary site.
Important host tumor cell interactions can take place at any point of
the cascade.

Experimental evidence suggests that only a select few

tumor cells are capable of completing this sequence of events (Poste et
al., 1980).
A tumor cell must invade various tissue barriers, which include the
extracellular matrices and basement membranes, for metastasis to take
place.

Migration, defined here as the ability of a cell to locomote and

deform, is an important part of the invasion process.
The cytoskeleton is a network of proteineous filaments found
throughout the cytoplasm of all eukaryotic cells.

The cytoskeleton

includes microtubules (25 nm in diameter), intermediate filaments (10-15
nm in diameter) and microfilaments (5-7 nm in diameter).

The

cytoskeleton has many different functions essential for the normal
functioning of the cell including cellular migration.

However, the

importance of the cytoskeleton in the metastatic process is unclear.
Five parameters of the metastatic cascade that I am investigating
are:

(1) determination of the cytostatic and cytotoxic concentrations

of RA and BA for the Bl6a cell line, (2) quantification of in vitro
migration, (3) quantification of in vitro invasion, (4) quantification
of in vivo experimental metastasis, and (5) cytoskeletal morphology.
The experimental metastasis assay is the inoculation of tumor cells into
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the murine lateral tail vein followed by extravasation of tumor cells in
the lungs.

This project emphasizes the evaluation of in vitro

experiments in light of in vivo assays, and stresses the importance of
testing potential antitumor agents by multiple parameters.

This project

is novel in that it will lead to further understanding of the multistep
process of metastasis by in vitro methods following RA and BA treatment.
In this study, evidence for a role for RA and BA in the treatment of
metastasis was found.

In addition, both drugs present interesting model

systems for evaluating the mechanisms behind tumor cell migration and
invasion.

CHAPTER II

REVIEW OF LITERATURE

5
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Cancer and Metastasis
The second leading cause of death in the United States is cancer.
Most of these deaths are a consequence of metastasis or complications
as a result of the treatment of the metastasis.

Of the million new

cases of cancer each year, two thirds of the individuals will develop
and die of metastasis (American Cancer Society Facts and Figures,
1982).

Metastasis is defined as the appearance of neoplasms in parts

of the body remote from the primary tumor.

Metastasis is a complex

series of events starting with initiation, growth, and progression
(diversification) of a primary tumor.

Some tumor cells have the

inherant ability to invade local tissues and enter the venous and
lymphatic vessels (intravasation).

Single tumor cells or tumor emboli

may travel within these vessels to distant sites and then arrest in
capillaries.

Surviving tumor cells may exit the capillaries

(extravasation) and establish colonies.

Fortunately, progress has been

made in the last two decades towards understanding the metastatic
process.
Metastasis and Invasion
The extracellular matrix is a major barrier to a tumor cell in the
metastatic cascade.

A tumor cell must invade the extracellular matrix

at multiple points during metastasis.

The extracellular matrix is a

complex meshwork of collagens and elastin embedded with a ground
substance consisting of glycoproteins (for example: laminin and
fibronectin) and various proteoglycans.

Some of the functions of the

extracellular matrix include supporting tissues, influencing cell
attachment, mitogenesis, morphogenesis, cellular differentiation and
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determining tissue architecture.

A specialized portion of the

extracellular matrix is the basement membrane (the electron microscopic
term is basal lamina).

Tumor cells must cross basement membranes in

order to invade most organ parenchyma, and to intravasate and
extravasate.

Liotta has proposed a three-step hypothesis to describe

tumor cell invasion.

The tumor cell must first attach to the matrix.

Subsequently, the tumor cell secretes various proteolytic enzymes which
locally degrade the matrix.

Lastly, the tumor cell must migrate into

the space created by proteolytic digestion (Liotta et al., 1983).
Many investigators have chosen to examine the interaction of tumor
cells with the extracellular matrix as part of a reductionist strategy
in order to begin to understand the complex nature of the metastatic
process.
Invasion Assays
Various in

invasion assays have been used to study the

mechanisms of invasion (Liotta et al., 1982) as well as evaluating
various drugs for anti-invasive properties (Welch et al., 1989).

These

methods include: (1) organ culture with such diverse targets of
invasion as embryonic heart muscle (Mareel et al., 1979), lung tissue
(Paweletz et al., 1986), kidney (Castro and Cass, 1974), murine
mesentery (Lee et al., 1988), and brain tissue microspheres (Waller et
al., 1986), (2) cellular monolayers of fibroblasts (Chew et al., 1988),
endothelial cells (Waller et al., 1986; Nakajima et al., 1987), and
endothelial cell-fibroblast gels (Schor et al., 1985), (3) the chick
chorioallantoic membrane (CAM) (Scher et al., 1976), (4) the human
amnion basement membrane (HABM) (Liotta et al., 1980; Schleich et al.,
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1981), (5) the lens capsule (Starkey et al., l984a; l984b) and most
recently (6) reconstituted basement membrane (Terranova et al., 1986;
Albini et al., 1987).
well as detractors.

Each of these protocols has their proponents as
What is required is an

vitro assay that is

repeatable, easy to perform and quantifiable as well as one that
closely mimics the clinical situation (Poste, 1982).
Malignant Melanoma
The most lethal form of skin cancer is malignant melanoma.

It is

estimated that in 1990, twenty-two percent of the patients diagnosed
with melanoma will die (CA).

Melanoma accounts for only 1% of all

cancer, but the incidence of melanoma continues to rise.

The five year

survival rate of patients presenting a clinically localized disease can
be estimated from the level of invasion.

Those diagnosed with a

distant metastases have less than a ten percent chance of survival (for
a review see, Liotta et al., 1987).
most drug therapies.

Human melanoma is refractive to

Dacarbazine (DTIC) is viewed as the treatment of

choice for patients that present with metastasis.

The overall response

(complete and partial) rate has been reported to be 21% with the
majority of the responses being partial and of short duration. A
complete response is defined as disappearance of the tumor for five
years.

Phase II clinical trials of multiagent regimens with

dacarbizine, cisplatin, 1,3-bis-2 chloroethyl 1-nitrosourea, and
tamoxifen had a overall response rate of 52.5% with 7 complete and 14
partial responses (McClay and Mastrangelo, 1988).
Cancer Chemotherapy
Cancer chemotherapy is currently being reevaluated for several
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reasons including:

(1) drug carcinogenicity to normal tissues

(Benedict et al., 1979), (2) enhancement of tumor cell diversity
(McMillian and Hart, 1986), and (3) progression of invasive and
metastatic capabilities (Nicolson, 1984).

Chemotherapeutic drugs have

been shown to damage normal tissues and allow surviving tumor cells to
metastasize more easily (Nicolson and Custead, 1985).

The damage done

by antitumor agents to the host may include immunosuppression such as
reduced natural killer cell activity (Nolibe and Poupon, 1986), or
vascular injury such as damage done to endothelial cells (Nicolson and
Custead, 1985).

One chemotherapeutic strategy is to use cytostatic

agents or so called differentiation agents that are less host-toxic and
less mutagenic than conventional chemotherapy.

Cytostatic agents may

be used as adjuvants between cycles of highly cytotoxic drugs to
prevent regrowth and tumor cell diverification (Nicolson and Lotan,
1986).
Differentiation and Malignancy
The relationship between differentiation and malignancy has
received a great deal of attention.

Certain common tumors in man, such

as squamous cell carcinoma of the lung, represent a change in the
pathway of differentiation.
mucous secreting.

Normal lung epithelium is columnar and

The term used for abnormal differentiation is

transdifferentiation (Wyllie et al., 1981).

It also has been observed

that as a cancer progresses, the neoplasm becomes more dedifferentiated
(anaplastic) (for review, see Freshney, 1985).

A general histological

progression can be seen in the production of the malignant phenotype.
Loss of growth control is a hallmark of benign as well as malignant
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tumors, but local invasion (including degradation of local basement
membranes) is the hallmark of a malignant twnor.
The normal cell counterpart to malignant melanoma is the
melanocyte.

Melanocytes are unique cells found in the mucous

membranes, the choriod of the eye, the piaarachnoid of the nervous
system, and in basal layer of the epidermis.

Melanocytes have a

phenotype that is distinctive from other cell types.

These

characteristics include (1) dendritic formation, (2) pigmentation due
to production of melanin in specific organelles (melanosomes) and, (3)
expression of the specific enzyme tyrosinase.

Tyrosinase converts

tyrosine to 3,4-dihydroxy-phenylalanine (dopa) and dopa to dopaquinone.
Melanocytes are derived from cells migrating out of the neural crest.
Neural crest cells give rise to a number of other differentiated cell
types including neurons and supporting cells of the dorsal root and
autonomic ganglia and mesenchyme of the head.

The question remains at

what stage or stages of melanocyte differentation are targets for
malignant transformation.

A possible model for understanding malignant

transformation and progression in human melanoma is benign focal
proliferation of melanocytes in melanocytic nevi.
A panel of 25 different human melanomas have been characterized on
the basis of early, intermediate, or late stages of melanocyte
differentiation (Houghton et al., 1982).

These melanomas were

classified into three groups (early, intermediate and late stage) based
on phenotypic characteristics including pigmentation, morphology,
tyrosinase activity and cell surface antigens.

Four different sets of

melanoma surface antigens were categorized on the basis of reactivity

11
of mouse monoclonal antibodies with fetal, newborn, and adult
melanocytes.

Early stage melanomas were characterized by an epitheloid

morphology, lack of pigmentation, lack of tyrosinase expression, and
early marker antigens.

Early marker antigens are not expressed by

fetal, newborn or adult melanocytes.

Intermediate melanomas had a

bipolar shape and expressed antigens also found on the surface of fetal
or newborn melanocytes.

Late stage melanomas had extensive dendritic

formation, heavy pigmentation, high tyrosinase activity, and expressed
antigens found on adult melanocytes (Houghton et al., 1982).

No

correlation has been found for human melanoma cell lines between
melanogenesis and tumor latency, size, or frequency of metastases
(Aubert et al., 1980).

However, various cell surface antigens have

been linked to melanoma progression.

Antigens K.1.2. and HLA-A,B,C

have been found to be decreased in the course of local and systemic
melanoma spread, while antigens HLA-DR, A.1.43, and A.10.33 were
increased in proportion to invasiveness and metastatic properties
(Brocker et al., 1985).
Murine Melanoma
The Bl6 melanoma cell line is a murine counterpart of human
melanoma.

The Bl6 cell line was adapted to tissue culture by Fidler

(1970) from a transplantable tumor originating spontaneously in the
C57BL/6J mouse in 1954.

The Bl6a (amelanotic) cell line is highly

invasive and spontaneously metastatic and has been fully characterized
by K. Honn (Crissman et al., 1983).

The phenotype of the Bl6a melanoma

cell line does not seem to fit into one of the general melanoma
phenotypes, but instead has dendritic formation without pigmentation.
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Possible differentiation antigens have been identified in the Bl6 cell
line.

The Met-72 antigen has been correlated to increased metastasis

in vivo (Kimura and Xiang, 1986).

The Norm-1 and Norm-2 antigens have

been linked to increased proliferation.

Antibodies to Norm-1 and

Norm-2 decrease proliferation and induce changes in morphology of Bl6
cells (Vollmers et al., 1985).

Low serum content in media, high cell

density or the administration of transforming growth factor beta
(TGF-beta) decreases Norm-2 antigen presentation (Wieland et al.,
1986).
Differentiation Agents and Melanoma
Tumors of ectodermal, neuroectodermal, mesodermal and endodermal
origins have been shown to undergo some form of differentiation in
response to various inducers (for review see Freshney, 1985).
is an interesting model system for differentiation.

Melanoma

Human melanomas

have a varied response to inducers in that differentiation can either
be accompanied by a decrease or increase in tumorgenicity in nude mice
(Aubert et al., 1980).

Tryrosinase activity, changes in proliferation,

modifications in tumor cell phenotype, as well as alterations in cell
surface markers, vary from cell line to cell line in response to a
number of physiological inducers.

Several hormones, including

melanocyte stimulating hormone (MSH) (Fuller and Meyskens, 1981),
corticotropic hormones (Abramowitz and Chavin, 1978) and prostaglandin
A1 and E1 (Fuller and Meyskens, 1981; Bregman et al., 1983) have been
shown to stimulate tyrosinase activity and melanin production in normal
melanocytes as well as melanoma cell lines.
were found to be sensitive to MSH or cAMP.

Low metastatic Bl6Fl cells
Melanocyte stimulating
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hormone or cAMP induced tyrosinase activity and inhibited proliferation
in Bl6Fl cells.

However, highly metastatic Bl6Fl0 cells were not

sensitive to MSH or cAMP (Niles et al., 1978).

Melanocyte stimulating

hormone and theophylline (an inducer of cAMP) inhibited proliferation,
promoted differentiation, and reduced tumorgenicity of murine S91
melanoma cells (Wick, 1981).

Prostaglandin derivitives have been shown

to inhibit the growth of Bl6a cells (Honn et al., 1981).
Nonphysiological inducers such as polar solvents can modify the
phenotype of melanoma cells

vitro.

An inhibitor of polyamine

synthesis, 2-difluromethylornithine (DFMO) stimulated melanogenesis and
inhibit proliferation of S91 cells (Kapyaho and Janne, 1983).
shown to inhibit proliferation of Bl6Fl cells

DFMO was

vitro without an

increase in tyrosinase activity (Sunkara et al., 1983).

Polar solvents

such as dimethyl sulfoxide (DMSO) have been shown to induce growth
inhibition and to produce changes in morphology of human melanoma cells
(Huberman et al., 1979) and murine Bl6 cells (Lampugnani et al., 1987).
Dexamethasone (a glucocorticoid agonist) was shown to inhibit the
proliferation of six different human melanoma cell lines (Osman et al.,
1985).

Even cytotoxic agents, such as the anthracycline antibiotics,

have been shown to inhibit growth and produce irrevisible morphological
changes in Bl6Fl cells after 16 hrs of incubation (Raz, 1982).

The

roles of butyric acid and the metabolites of vitamin A, 13 cis and all
trans-retinoic acid in tumor cell differentiation, will be discussed
later.
The effect of differentiation agents on melanomas in vivo has been
investigated.

Drinking

~ater

containing 2% DFMO has been shown to
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decrease the tumor weight of Bl6Fl tumors by 84% in C57BL6 mice
(Sunkara et al., 1983), and decrease spontaneous metastasis of Bl6a
cells (Sunkara and Rosenberger, 1987).

The mechanism of the inhibition

of spontaneous metastasis was believed to be in the intravasation step
of the metastatic cascade, since the administration of DFMO did not
reduce lung colonization by tail vein inoculation (experimental
metastasis) (Sunkara and Rosenberger, 1987).

Pretreatment of Bl6

melanoma cells, on the other hand, with differentiation agents has been
shown to decrease tumorgenicity (Nordenberg et al., 1985), but increase
experimental metastasis (Bennett et al., 1986; Casali et al., 1988).

A

24 hr incubation of Bl6Fl or Bl6Fl0 cells in medium with a higher pH
(from 6.9 to 7.2) and containing 10
increase in tyrosinase activity
vivo (Bennett et al., 1985).

-9

M MSH was shown to produce an

vitro and experimental metastasis in

Experimental metastasis was also shown to

be significantly increased by DMSO pretreatment of Bl6 cells for 4 days
(Casali et al., 1988).

On the other hand, a delay was observed in the

onset of tumor formation of DMSO pretreated Bl6Fl0 cells (Nordenberg et
al., 1985).
The Retinoids: Function in Normal Development
Vitamin A (retinol) and metabolites are essential for maintainance
of the visual system (Bridges, 1984), for normal embryonic development,
for differentiation and maintenance of epithelial tissue (for review
see Roberts and Sporn, 1984), and for the development and maintenance
of the immune system (Dennert, 1984).

The major sources of vitamin A

in the diet are certain plant carotenoid pigments, such as B-Carotene,
and long chain retinyl esters found in animal tissues.

B-Carotene and
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retinyl esters are converted to retinol by the intestinal mucosa
(Goodman and Blaner, 1984).

Many investigators believe that retinoic

acid is close to the structure of the retinoid that acts within cells
to control development (Frolik, 1984).

Retinoids at low concentrations

are known teratogens and induce major craniofacial deformities in
rodent models (Shenefelt, 1972).
The hypothesis that retinoids may suppress carcinogenesis
(delaying the preneoplastic progression of carcinogen or
radiation-treated cells), induce neoplastic differentiation, inhibit
tumor cell proliferation, and suppress various tumor phenotypic
properties was not difficult to believe given the role of retinoids in
normal development.
Retinoids and Carcinogenesis
The chemopreventitive nature of the retinoids has been shown to be
important in inhibiting the promotion phase of chemically induced
rodent skin, mammary gland, and urinary bladder carcinogenesis (for
review see Moon and Itri, 1984).

A link has been observed between a

decreased human dietary intake of vitamin A and increased incidence of
several carcinomas (for review see Moon and Itri, 1984).

Retinoids

have also been used to treat preneoplastic conditions including
dysplastic nevi (Lippman et al., 1987).

Dysplastic nevus is

characterized by the presence of pigmented flat papules or macules that
frequently undergo transformation to melanoma.

Three patients were

treated for 10 to 12 weeks with topical all trans-retinoic acid.
dysplastic nevus features underwent major changes to benign
nevocellular nevi (Lippman et al., 1987).

The
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Retinoids and Tumor Cell Differentiation
Retinoids have been shown to have direct effects on proliferation
and differentiation of tumor cells.

Most of the studies have been done

on tumor cells in vitro, but some in vivo and clinical studies that
have been performed indicate a possible role of retinoids in the
treatment of tumors and metastasis.

The effect of retinoids on tumor

cells seems to depend on the cell line being studied.

The effect of

retinoic acid on tumor cell differentiation can be divided into two
general categories, terminal and reversible differentiation.
Terminal differentiation occurs in murine embryonal carcinoma
(Strickland and Mahdavi, 1978; Jetten et al., 1979), human
promyelocytic leukemia (Breitman et al., 1980), and rat
rhabdomyosarcoma (Gabbert et al., 1988).

An intermediate phenotype was

induced in retinoic acid-treated F9 teratocarcinoma cells that could
differentiate further into either visceral or parietal endoderm
depending on culture conditions (Hogen et al., 1981).

Differentiation

was measured by the induction of plasminogen activator (Strickland and
Mahdavi, 1978).

Retinoic acid-treated human promyelocytic (HL-60)

cells differentiate into functionally and morphologically mature
granulocytes (Breitman et al., 1980).

Terminal differentiation with

exposure to retinoic acid was shown to occur with a rat
rhabdomyosarcoma cell line (BA-HAN-lC).

There was an increase in the

number of terminally differentiated postmitotic myotube-like giant
cells and an increase in the creatine kinase activity (Gabbert et al.,
1988).
Reversible differentiation occurs in certain retinoid sensitive
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tumor cell lines.

The effect of retinoids on melanogeneisis of murine

or human melanoma cells is again dependent on the cell line and is
reversible upon removal of the retinoid from the growth media.
Retinoic acid induces an increase in tyrosinase activity and
melanogenesis in S91 murine melanoma (Lotan and Lotan, 1980), murine
melanoma Bl6Fl cells (Edward et al., 1988), and Hs939 human melanoma
cells (Lotan and Lotan, 1981).

Retinoic acid has been shown not to

effect melanogenesis of Bl6Fl0 and Bl6BL6 murine melanoma cells, and to
inhibit melanogenesis of UCT-Mel2 human melanoma cells (Hoal et al.,
1982).

Some tumor cell lines have been reported to undergo

differentiation with addition of the retinoids.

These include human

neuroblastoma (IA-N-1) (Sidell, 1982), rat adenocarcinoma and
keratinizing squamous cell carcinoma (Marchak et al., 1981).
Retinoids and Inhibition of Proliferation
The ability of retinoids to induce differentiation of tumor cells
is confined to a few cell lines, while the inhibition of proliferation
by retinoids is more commonly observed.

Inhibition of proliferation in

either tiisue culture or the soft agar assay is concentration
dependent, time dependent, independent of cell density, and reversible.
The natural retinoids with the most potent effects on tumor cell
proliferation are 13 cis and all trans-retinoic acid (Lotan, 1980).
The amount of RA induced inhibition varies from having no effect on
proliferation (<10% inhibition) in some tumor cell lines to inhibiting
proliferation by greater than 75 percent in other tumor cell lines
(Lotan and Nicolson, 1977).

Two of the tumor cell lines shown to be

highly sensitive to retinoic acid were the murine melanoma S91 and Bl6
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cell lines.

Differences in sensitivity to retinoic acid were observed

in clones of the Bl6 cell line.
~

The parental Bl6 line as well as in

selected Bl6Fl and Bl6Fl0n (selected for brain metastasis) cells

were extremely sensitive, while the in vivo selected Bl6Fl0, Bl6Fl00
(selected for ovarian metastasis), and the in vitro selected Bl6BL6
cells were less sensitive to retinoic acid (Lotan and Nicolson, 1979;
Edward et al., 1988).

An important clinical application for the

assessment of retinoids in treatment of cancer was made using an in
vitro tumor colony forming assay (Meyskens et al., 1983).

This group

had shown that a correlation existed between a clinical response and
inhibition of colony formation of human melanoma cells by cytotoxic
drugs in the soft agar assay (Meyskens et al., 1981).

Four of the

twenty-five human melanomas obtained from fresh biopsies were sensitive
(reduction of 70% or more) to 13 cis-RA treatment and three of twenty
were sensitive to 4 hydroxyphenyl-all-trans-retinamide (4-HPR) (a
synthetic retinoid) treatment (Meyskens et al., 1983).
The inhibition of proliferation induced by retinoids is believed
to be linked to a block in the progression of cells through the G
1
phase of the cell cycle (for review see Roberts and Sporn, 1984).

Flow

microflurometric analysis of S91 melanoma cells showed that retinoic
acid increased the amount of cells in the G phase and slowed the rate
1
of entry of cells into the S phase of the cell cycle (Lotan et al.,
1981).

Niles (1987) has shown that inhibition of proliferation in Gl

occurs without an inhibition of protein synthesis.
Retinoids and Changes in Morphology
Morphological changes and differences in the pattern of protein
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synthesis have been noted in retinoic acid-sensitive tumor cell lines.
Some phenotypic changes are seen in terminally differentiated F9
embryonal carcinoma cells (Linder et al., 1981; Lehtonen et al., 1983).
Changes in morphology were characterized by progressive flattening and
were shown to be time dependent taking approximately five days.
Retinoic acid has been shown to induce the synthesis of type IV
collagen, laminin, the intermediate protein vimentin, and the
actin-myosin related protein tropomyosin (Linder et al., 1981).
Retinoic acid treatment was shown to induce after two days the
formation of vinculin rich adhesion plaques followed by the appearance
of actin stress fibers (Lehtonen et al., 1983).
distribution of vimentin was profound.

The change in the

Vimentin in untreated cells was

found around the nucleus, while RA-treated cells had a distinct
fibrillar pattern throughout the cytoplasm.

Another intermediate

protein, keratin, was found to be induced in many of the
differentiating F9 cells (Lehtonen et al., 1983).
Morphological changes induced by retinoic acid have also been
characterized in a rat osteogenic sarcoma cell line (UMR 106-06) (Ng et
al., 1985).

The phenotypic changes are apparently related to both

cellular adherence and cell size.

Retinoic acid-treated cells were

larger and more adherant to the substrate.

Changes in size and

adherence were correlated by immunofluorescence and transmission
electron microscopy to increases in microfilaments (stress fibers) and
microtubules (Ng et al., 1985).

Retinoic acid has also been observed

to induce in the apparently undifferentiated mononuclear
rhabdomyosarcoma cells the formation of thick and thin myofilaments
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(Gabbert et al., 1988).

Changes in the tumor phenotype induced by

retinoic acid in other cell lines have been noted but are not well
characterized.

For example, retinoic acid induced progressive

flattening in the morphology of three human osteosarcoma and two
chondrosarcoma cell lines (Thein and Lotan, 1982).

However, no

characterization of the morphological changes were performed in these
human sarcoma cell lines (Thein and Lotan, 1982).
Changes in the tumor cell surface have been linked to alterations
in malignancy and metastasis (Stanford et al., 1986; Gabius et al.,
1987).

Retinoic acid induces changes in cell surface glycoproteins of

a head and neck squamous cell carcinoma (1483) (Lotan et al., 1987a),
cervical carcinoma (HeLa) (Lotan et al., 1980), and murine S91 melanoma
cells (Lotan et al., 1983; 1987b).

Retinoic acid treatment increases

the radioactive labelling of high molecular weight (MW>400,000)
galactoglycoconjugates and sialoglycoconjugates and a 280,000 MW
sialoglycoconjugate in a well differentiated head and neck squamous
cell carcinoma cell line.

A less well differentiated head and neck

tumor was not sensitive to retinoic acid (Lotan et al., 1987a).

The

varied effect of retinoic acid on the the head and neck carcinoma cell
lines was believed to be related to the state of differentiation of the
tumor, the control of tumor cell proliferation and surface markers.

A

correlation apparently also exists between homotypic aggregation and
metastasis (Updyke and Nicolson, 1987).

Retinoic acid has been shown

to decrease homotypic aggregation of S91 melanoma cells (Lotan et al.,
1987).

A link between the induction by retinoic acid of glycosylation

of a 160,000 MW sialoglycoconjugate and decreased homotypic aggregation
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may be important (Lotan et al., 1987).
Inhibition of proliferation by retinoic acid is not necessary in
some cases to induce phenotypic changes in tumor cells.

All trans-

retinoic acid has been shown to reduce production and activity of type
IV collagenase in rat mammary adenocarcinoma (13762NF) cells at a
concentration that did not inhibit proliferation (Nakajima e tal.,
1989).

Growth inhibition was also not observed with 13 cis retinoic

acid in murine squamous carcinoma (KLN205) cells.

However, 13

cis-retinoic acid caused an increase in expression of lectin receptors
(Couch et al., 1987).

The alterations in lectin receptors might have a

role in the induced decrease seen in experimental metastasis by
RA-pretreated murine squamous carcinoma (KLN205) cells by increasing
natural killer cell activity (Couch et al., 1988).
Retinoids and In Vivo Control of Cancer
The evidence is strong that retinoids can inhibit proliferation,
induce differentiation, and change the morphology of many tumor cell
lines in vitro.

Evidence is also accumulating for a role of retinoids

in the therapeutic control of human tumors and metastasis (for a review
see Lippman et al., 1985).

Retinoids have a role in decreasing tumor

size and tumorgenicity in animal models (Felix et al., 1975; Drewa and
Schachtschabel, 1985; Olsson et al., 1985; Halter et al., 1988; McCue
et al., 1988; Dillehay et al., 1989).
decrease in proliferation
vivo.

There is a link between a

vitro and decrease in tumorgencity in

For example, all human squamous-cell (RH-SCL-Lll) and small-cell

(RH-SCC-LlO) lung carcinoma clones found to be sensitive to RA in the
soft agar assay were found not to be tumorgenic in nude mice after in
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vitro pretreatment (Olsson et al., 1985).

---------

been shown enhance T cell protection.

13 cis-retinoic acid has

Dillehay et al. (1989) treated

preimmunized mice, athymic mice and euthymic mice with 13 cis-RA.

Only

the euthymic mice had decreased lymphoma tumor growth (Dillehay et al.,
1989).
The results of pretreatment of tumor cells

vitro with RA before

tail vein inoculation (experimental metastasis) are not as simple.
some investigations, RA pretreatment

In

vitro caused a decrease in lung

colonies (Couch et al., 1988 and Edward et al., 1989), while
pretreatment of F9 embryonal carcinoma cells with RA and dibutyl cAMP
caused a change in the pattern of organ metastasis (Terrana et al.,
1987).

However, the change in pattern of organ metastasis might have

been induced by the dibutyl cAMP.
A role for retinoids (without pretreatment) in the reduction of
metastasis of a hamster melanoma cell line (HMl-FS) in athymic mice has
been established by Schleicher et al. (1988).

The number of

spontaneous metastases was shown to be decreased by 13 cis-RA and two
synthetic retinoids (2 hydroethyl retinamide and N-4(-hydroxyl-phenyl)
all trans retinamide (4HPR)).

One of the synthetic retinoids (4HPR)

was also shown to decrease the incidence of metastasis (Schleicher et
al., 1988).
Retinoids and Clinical Control of Cancer
Retinoids have been used in the clinic for the treatment of
neoplastic disease (for review see Lippman et al., 1987).

Retinoids

appear to have value in the treatment of basal cell carcinoma, advanced
regional or metastatic cutaneous squamous cell carcinoma, melanoma,
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mycosis fungoides (an uncommon T-cell lymphoproliferative disease),
leukemia, and squamous cell cancer of the head and neck.

Topical all

trans-RA (tretinoin) was reported to produce 16 complete responses and
32 partial responses in 49 patients with basal cell carcinoma
(Schumacher and Stuttgen, 1971; Belisario, 1972; Bollag and Ott, 1975;
Sankowski et al., 1984).

Oral 13 cis-RA was reported to produce a

complete response in 39 lesions and a partial response in 162 lesions
(out of 248 lesions in 11 patients having multiple lesion basal
carcinoma) (Peck et al., 1979).

Oral 13 cis-RA produced 1 partial

response in a patient with basal cell carcinoma (Meyskens et al.,
1982).

A synthetic retinoid, oral etretinate, was effective in

treating basal carcinoma with 3 complete responses 14 partial responses
and 14 minor responses reported in 40 patients.

The reports on

retinoid treatment in advanced cutaneous squamous cell carcinoma are
limited to four studies with a total of 14 patients evaluated.

Oral

etretinate produced one complete response and one partial response (out
of 4 patients) (Grupper and Berretti, 1983).

Another synthetic oral

retinoid, arotinoid, was shown to produce one partial response (out of
one patient evaluated) (Kingston et al., 1983).

Oral 13 cis-retinoic

acid produced 2 complete responses and 5 partial responses (out of nine
patients evaluated) (Meyskens et al., 1982; Lippman and Meyskens,
1987).

Successful treatment of mycosis fungoides has been reported

with systemic 13 cis retinoic acid (Warrell et al., 1983; Molin et al.,
1985; Kessler et al., 1987) and systemic etretinate (Souteyrand et al.,
1981; Zachariae et al., 1981; Claudy and Rouchouse, 1985).

The

clinical data is limited with leukemias, but there is promise for
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retinoic acid in the treatment of acute promyelocytic leukemia (Flynn
et al., 1983).

Systemic 13-cis RA showed some efficacy in the

treatment of advanced head and neck cancer with 3 partial responses
observed out of 19 patients (Meyskens et al., 1982).
Treatment of patients with topical all trans-retinoic acid or oral
13 cis-retinoic acid with either cutaneous and metastatic melanoma have
met with success, but have been limited in scope.

Topical all

trans-retinoic acid used to treat two patients with cutaneous melanoma
produced a complete regression in one patient and a partial regression
in the other (Levine and Meyskens, 1980).

Partial responses were

observed in three out of 20 patients that received oral 13 cis-retinoic
acid in a phase II trial (Meyskens et al., 1982).
Acute and Chronic Toxicity of Retinoids
In vivo animal experiments and clinical trials with retinoids have
been limited by both acute and chronic toxicity (for a review see Kamm
et al., 1984).

Dosage and timings are critical in evaluating potential

antitumor effects.

Major side effects of acute toxicity include

central nervous system symptoms such as severe headaches, increased
cerbrospinal fluid pressure, irritablity and dizziness, nausea,
vomiting, fatigue, weakness, and somnolence.

Minor side effects of

acute toxicity include skin disorders such as inflammation of the lips,
dryness and swelling of the skin, and dry mucous membranes.
disorders are also common.

Eye

They include conjunctival inflammation,

dryness, diplopia, and blurry vision.

Tenderness of the long bones, an

enlarged liver or spleen and edema are also commonly seen in acute
toxicity.
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Major effects of chronic toxicity include abnormalities in
reproductive function and embryological development, defects in liver
function and the skeleton.

Hypertriglyceridermia is also observed.

Minor chronic side effects include dry skin and mucous membranes,
itching inflammation of the lips, hair loss, visual disturbances and
occipital headaches (Koerner and Voellm, 1975).

Synthetic retinoids

may be critical for possible therapeutic trials.

Synthetic retinoids

tend to have less severe and fewer central nervous system and liver
side effects (Lippman et al., 1987).

Arotinoids, for example, can be

used at lower concentrations and still have effects

vitro simliar to

retinoic acid (Klaus et al., 1983).
Butyric Acid
I have investigated another differentiation agent, butyric acid.
Butyric acid (and its sodium salt) is a natural four carbon fatty acid
normally present in lipids and is formed by the hydrolysis of
ethylbutyrate.

Much less research has been done on the role of butyric

acid in the normal functioning of an organism.
is based on

Most of what is known

vitro studies on normal and tumor cell lines.

As with

other differentiation agents, butyric acid has been shown to induce
differentiation, inhibit proliferation, induce changes in morphology,
and reduce tumorgenicity of various tumor cell lines (for a review see,
Kruh, 1982).

Nontoxic BA concentrations are at the millimolar level

(less than 5 mM), though the cytostatic and noncytotoxic concentrations
vary from cell line to cell line.

Thus butyrate levels needed to

induce functional changes in cells are much more than the
concentrations of various retinoids (from 10

-6

to 10

-9

M).
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~tyrate

and Differentiation

Butyate induces reversible differentiation in many tumor cell
lines.

The first report of differentiation induced by butyrate was in

murine Friend virus-transformed erythroleukemia cells that had been
shown to synthesize hemoglobin (Leder et al., 1975).

The embryonal

carcinoma cell lines, as observed with the experiments with retinoic
acid, presents an interesting model for differentiation.

The

PCC4(RA) 1 cell line that is resistant to differentiation by retinoic
acid has been shown to be partially differentiated by BA.

However,

further differentiation takes place when retinoic acid and BA are added
together (McCue et al., 1984).

In contrast, BA has been shown to

inhibit the differentiation of RA-treated F9 embryonal carcinoma cells
(Levine et al., 1984), and stimulate the differentiation of 6050AJ and
PCC4azaR embryonal carcinoma cells (McCue et al., 1984).

Thus, these

similiar cell lines may be used in studies to elucidate the action of
RA and BA at the molecular level.
As with other differntiating agents, the effect of BA on melanoma
cells is unique.

Tryrosinase production (a classical marker for

differentiation) is inhibited by BA in murine Bl6Fl0 melanoma cells
(Malik et al., 1987).

However, BA stimulated the activity of other

enzymes including NADPH cytochrome c reductase (indictive of the
development of the endoplasmic reticulum) (Nordenberg et al., 1987).
In a human melanoma (SKMEL-28) cell line, BA has been shown to induce
marker enzymes such as alkaline phosphatase, y-glutamyl transpeptidase,
and NADPH cytochrome c reductase(Nordenberg et al., 1987).
increases

protei~

Thus, BA

production in ways not previously observed in cells
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induced to differentiate by other agents.
Butyrate and Inhibition of Proliferation
Butyrate induced reversible inhibition of proliferation is
sometimes accompanied by induction of marker enzymes that are
indicative of differentiation.

Human tumor cell lines that have been

shown to be sensitive to butyrate induced inhibition of proliferation
include two colonic carcinomas (SW 480 and Sw 620) (Kim et al., 1980),
three pancreatic adenocarcinornas (MIA PaCa, PANC-1, and CAPAN-1)
(Mcintyre and Kirn, 1984), two poorly differentiated ovarian
adenocarcinomas (PEOl and PE04)(Langdon et al., 1988); one salivary
adenocarcinoma (HSG) (Azuma et al., 1986), one squamous cell carcinoma
of the tongue (HNl) (Bijman et al., 1987), and a human melanoma
(SKMEL-28) (Nordenberg et al., 1987).

Inhibition of soft agar

clonogenicity was also induced by BA (Nordenberg et al., 1987).

The

soft agar assay is believed to be a good indicator for tumorgenicity
(Meyskens et al., 1983).

Arrest of proliferation has been shown to

occur in the Gl phase of the cell cycle (RA arrests proliferation in
Gl) (Thorgeirsson et al., 1984).
Butyric acid inhibits proliferation in cell lines that are not
sensitive to RA.

Retinoic acid did not inhibit proliferation but did

induce alkaline phosphatase activity in 9-lC rat prostatic
adenocarcinorna cells.

Butyric acid, on the other hand, inhibited

proliferation at a concentration of 5 rnM or more (Reese et al., 1985).
Butyrate was also the most effective short chain fatty acid in the
induction of alkaline phosphastase activity, inhibition of
proliferation, and increasing the protein content of 9-lC cells (Reese
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et al., 1985).
~utyrate

and Changes in Morphology

Changes in proliferation induced by butyrate are usually
accompanied by dramatic time dependent changes in morphology.

The most

characterized changes in morphology are in virus transformed
fibroblasts (KNRK) (Altenburg et al., 1976; Ryan and Higgins, 1988) and
rat hepatoma (72/22) cells (Borenfreund et al., 1980; Ryan et al.,
1987).

In virus transformed fibroblasts, butyrate was shown to produce

the formation of long cytoplasmic processes within 12 to 24 hrs after
which there was a progressive flattening of cells at 72 hr.
Ultrastructural and immunofluorescent analysis of the KNRK cells found
that there was a dramatic increase in the amount of microfilaments and
microtubules, and an enhanced formation of adhesion plaques (Altenburg
et al., 1976).

The changes in KNRK cells were further characterized by

gel electrophoresis (Ryan and Higgins, 1987).

There was a 2.5 to 3.0

fold increase in actin, alpha actinin (an actin binding protein), and
fibronectin.

However, the amount of tropomyosin, vimentin, alpha and

beta tubulin in the KNRK cells was found to be significantly reduced
(Ryan and Higgins, 1987).

The reduction in the amount of alpha and

beta tubulin conflicts with the results in the experiments of Altenberg
et al. (1976).

The electrophoresis pattern of butyrate-treated KNRK

cells appear to contain little if any alpha or beta tubulin.

This is

odd noting the elaboration of microtubules in KNRK cells (Altenburg et
al., 1976).
Reorganization of the cytoskeleton with inhibition of
proliferation also occurs in 72/22 cells treated with butyrate
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(Borenfreund et al., 1980; Ryan et al., 1987).

F-actin was observed to

accumulate at the cellular edges (peripheral band) and in the central
portion of the cell.

The total actin was measured by densitometry of

electrophoretic patterns and flow cytometry.

Total actin was found to

be increased in butyrate-treated 72/22 cells without an increase in
mRNA.

The structure of the intermediate filaments, which consists of

both vimentin and keratin, in 72/22 cells, was also changed by
treatment with butyrate (Borenfreund et al., 1980).

Untreated hepatoma

cells have been shown to have distinct genetically stable, acentric,
abnormal, juxtanuclear aggregates composed of intermediate filaments
(Borenfreund et al., 1978).

Butyrate treatment induces a progressive

disintegration of the aggregrates with a resultant normal display of
filaments (Borenfreund et al., 1980).

A flattened morphology is

typical of BA-treated cells including Bl6Fl0 cells (Nordenberg et al.,
1986), but a further characterization of cytoskeletal changes is
needed.

Most morphological changes produced by butyrate in many tumor

cell lines are reversible within three days.

However, changes

persisted after 14 months without butyrate in the human salivary
adenocarcinoma cells (Azuma et al., 1986).
Butyrate and In Vivo Control of Cancer
Few reports have investigated the role of butyrate in the in vivo
or clinical settings.

A correlation was shown to exist in the delay of

tumor appearance, decreased size of tumors and BA-pretreatment of
Bl6Fl0 cells (Nordenberg et al., 1986).

However, a correlation for a

decrease in tumorgenicity and BA-treatment was not observed in human
colon cancer cells (Kim et al., 1980).

BA-pretreatment has been
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observed to produce, as with other differentiation agents such as DMSO,
a concentration and time dependent increase in experimental metastasis
of low metastatic Lewis lung carcinoma (P-29) cells (Takenaga, 1986).
Only two studies have reported using butyrate in a therapeutic setting
(Bourgeade et al., 1979; Novogrodsky et al., 1983).

Butyrate and

interferon were administered (i.p.) on alternate days to Swiss or DBA/2
mice that received murine sarcoma (180 TG) cells (i.p.).

Treatment

with BA and interferon was found to increase mean survival time and
final survival rate over untreated or interferon treated mice
(Bourgeade et al., 1979).
The effect of butyrate on cells from peripheral blood of five
human patients with acute leukemia was also examined in vitro
(Novogrodosky et al., 1983).

One patient (a five year old boy) that

had acute myelogenous leukemia received 2% butyrate (500 ml/kg/24 hrs)
for ten days.

After this time period, it was observed that myeloblasts

were eliminated from the peripheral blood, the number of mature myeloid
cells was increased, and the number of bone marrow myeloblasts was
reduced by 70 to 80%.

There were no signs of toxicity in the animal

study or clinical trial.
The Synergistic Action of Differentiation Agents
The use of differentiation agents as adjuvant or in combination
with cytotoxic drugs or other differentiation agents may be an
important concept for preventing tumor progression.
with some success

vitro.

The notion has met

Butyrate, in combination with retinoic

acid, produced an inhibition of proliferation of human retinoblastorna
(Y-79) that was synergistic in nature (Kyritis et al., 1984).

The
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addition of PGA

1

to media containing both dexamethasone (a synthetic

glucocorticoid) and all trans-retinoic acid was shown to
synergistically inhibit the colony forming ability of C8146c human
melanoma cells (Bregman et al., 1983).

A similiar enhanced inhibition

of colony forming ability was found with the combination of
dexamethasone, alpha interferon, all trans retinoic acid, and DFMO
(Bregman and Meyskens, 1986).

This in vitro study by Bregman and

Meyskens (1986) is important since the drug concentrations used in
vitro were within the limits that are pharmalogically achievable in the
clinical setting.
The Seed and Soil Theory in Metastasis
Much of the experimental ground work of the current theories of
tumor cell metastasis comes from experiments done on the Bl6 cell line.
Fidler's 1970 study found that only 0.1% of tumor emboli survive after
14 days to give rise to lung nodules after tail vein injection
(experimental metastasis assay).

A great deal of information has been

gleened since this time using the Bl6 cell line that substantiates much
of the 'seed and soil' 1889 theory of Paget.

Paget proposed that

metastasis was the result of certain tumor cells ("seeds") to find an
appropriate organ microenvironment ("soil") to develop and grow.

Paget

believed this process was nonrandom and only partially due to
circulation patterns and mechanical lodgement.

Clinical examples of

metastasis believed not to be due to random events include ocular and
cutaneous malignant melanoma.

The primary sites for these melanomas

are in the eye and skin, respectively.

Ocular melanoma metastasizes

primarily to the liver, while cutaneous melanoma metastasizes primarily
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to the brain, liver and bowel.

The parent Bl6 melanoma (primary) tumor

was found to be heterogeneous in regard to metastasis (Poste et al.,
1981).

An indication of this was the ability to select for the highly

metastatic cells by in vivo (Fidler, 1973; Fidler and Nicolson, 1976)
or

vitro methods (Hart, 1979).

Metastasis resulted from prexisting

variant cells within the parental tumor rather than an adaptation to a
specific site environment (Brunson and Nicolson, 1980; Nicolson and
Custead, 1982).

This is the seed part of the hypothesis.

experiments included studies that utilized ectopic grafts.

The 'soil'
Bl6Fl0

cells metastazied not only to the lung but to subcutaneous lung tissue
grafts (Hart and Fidler, 1980).
The Cytoskeleton and Malignancy
There are three major classes of cytoskeletal filaments found in
eukaryotic cells: microfilaments, microtubules, and intermediate
filaments.

The cytoskeleton has many different functions essential for

the normal functioning of the cell including such diverse activities as
intracellular transport, mitosis, control of cellular proliferation,
ciliary movement, cellular migration, and maintenance of cell shape.
Microfilaments are 5-7 nm in thickness and composed of F-actin
(filamentous actin) which is polymerized from globular monomers
(G-actin).

F-actin and G-actin interact with numerous actin associated

proteins that regulate the length, distribution, and stability of
microfilaments.

An important probe for analysis of actin filaments is

the cyclic oligopeptide phallodin.

Phalloidin, which is derived from a

toadstool (Amanita phalloides), binds to actin filaments
stoichiometrically (Miyamoto et al., 1986).

Microtubules are
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approximately 25 run in diameter.

The wall of the microtubule is

composed of protofilaments consisting of two polypeptides, alpha and
beta tubulin.

Attached to the walls of the microtubules are numerous

microtubule associated proteins.
In the discussion of the changes induced in tumor cells by various
differentiation agents, one of most obvious are phenotypic changes.
Investigators have used immunofluorescence since 1975 to speculate on
the role of the cytoskeleton in neoplastic transformation (Brinkley et
al., 1975; Puck, 1977).

Current thought attributes the decrease in

microtubules observed in transformed cells by Brinkley et al.

(1975)

and Puck (1977) to the shape and spreading of transformed cells that
obscured the microtubule networks in immunofluorescent studies (DeMey
et al., 1978; Tucker et al., 1978; Asch et al., 1979).

Laboratories

are now using immunofluorescence and electron microscopy to find
changes in tumor cell cytoskeleton and are correlating possible
alterations with biochemical analysis.

Immunofluorescence is not

easily quantifiable given the variable nature of the interactions
between antibody and cytoskeleton antigen or antigens.
Malignant transformation has been found to induce many different
cytoskeletal changes in cell lines.

Whether cytoskeletal changes are

found only in specific cell lines needs further study.

Kirsten virus-

transformed rat NRK cells were found to have almost twice as much
pelletable tubulin compared to NRK cells using a colchicine binding
assay and a stabilization buffer (Rubin and Warren, 1978).

The amount

of tubulin (without the use of a stabilization buffer) was found by
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transformed murine Swiss 3T3 or Rous sarcoma virus-transformed NRK
cells, but there was a two fold decrease in calmodulin (Chafouleas et
al., 1981).

Calmodulin is a protein present in most eukaryotic cells

that binds calcium with high affinity and specificity (for a review see
Means and Dedman, 1980).
including Ca

+2

Calmodulin has a number of functions

-dependent regulation of microtubule assembly-diassembly

(Schiwa et al., 1981), cell cycle regulation (Chafoules et al., 1982),
and conferring stablity to DNA in tumor cells (Lonn and Lonn, 1986).
Calmodulin has been shown by immunofluorescence to be closely
associated with the cytoplasmic microtubule complex (Deery, 1986).
Beta tubulin has been shown to be composed of different isotypes (for
review see Sullivan, 1988).

A unique tubulin isotype (hB ) was found
4

by immunofluorescence to be expressed in high levels in tumors of
epithelial origin as compared to normal tissues.

The expression of

this isotype was not as distinctive with cultured malignant cell lines
(Walker et al., 1987).

This is one example of the concerns in using

cultured cell lines.
Microfilaments and Malignancy
Morphological changes in neoplastic transformation have been
studied with respect to alterations in microfilaments (Pollack et al.,
1975; Rubin et al., 1978; Tucker et al., 1978).

Immunofluroescence and

phallocidin flourescent studies have noted in some tumor cell lines
(including the Bl6 cell line) the lack of stress fibers and
accumulation of structures called F-actin aggregates (Carely et al.,
1981).

Aggregates contain not only F-actin but also alpha actinin,

vinculin, talin and fimbrin but not tropomyosin (Carely et al., 1986).
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Vinculin, talin and fimbrin are proteins found in adhesion plaques
(David-Pfeuty and Singer, 1980; Burridge and Connell, 1983; Carely et
al., 1986).

Adhesion plaques and substrate interactions are apparently

weakened or disrupted in neoplastic transformation (Nigg et al., 1986).
Vinculin is a target for tyrosine phosphorylation by the src oncogene
(Sefton et al., 1981).

Reorganization of vinculin, actin, and

alpha-actinin into aggregates was observed in virally transformed cells
that were encoded for the production of tyrosine kinases.

In contrast,

cells transformed by viruses without tyrosine kinase activity did not
produce aggregates (Nigg et al., 1986).

Rous sarcoma virally

transformed fibroblasts had less vinculin and talin than normal chick
fibroblasts (Otto, 1985).

Other modifications in adhesion plaques may

occur in malignant transformation.

Rous virus transformed chick

fibroblasts also showed more than a three fold reduction in the
acylation of vinculin (Burn and Burger, 1985).

Alpha-actinin is

associated with adhesion plaques and stress fibers (Mangeat and
Burridge, 1984).

Stress fibers are large bundles of microfilaments,

thought to be a higher level of organization of actin filaments.

These

results are important since, it has been observed in a number of
transformed fibroblast cell lines, that there was a decrease in the
levels of one or two major tropomyosins and an increase in the levels
of one or two minor tropomyosins (Matsumura et al., 1983).

These

experiments were done by biochemical analysis of isolated
microfilaments (Matsumura et al., 1983).

Alpha-actinin and tropomyosin

isotypes have an apparent function in stabilization of stress fibers.
Alpha-actinin was colocalized with actin to the leading edge of motile
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rabbit V2 carcinoma cells, while tropomyosin was not observed in the
motile leading edge (Jockusch et al., 1983).

It is interesting to note

an increase in a-actinin was observed in butyrate-treated KNRK cells
with a decrease in tropomyosin (Ryan and Higgins, 1987).

An increase

in migration induced by BA-treatment may be a consequence of an
increase in alpha-actinin (McGarvey and Persky, 1989).

Many of the various s

involved in tumor cell metastasis are

related to the cell's ability to deform, to make and break
intracellular contacts, and to actively migrate.

These processes are

known to be controlled by the components of the cytoskeleton (Raz and
Ge

, 1982).

The evaluation of possible differences between the

cytoskeletons of low and high metastatic cells has been limited by the
same problems in experiments looking for differences between
transformed and normal cell cytoskeletons.

These problems include the

the use of immunofluorescence, which is at best only semiquantitative,
and the use of a limited number of tumor cell lines.

Whether changes

seen in tissue culture are valid in vivo is another question.

The use

of biochemical techniques may be helpful to find if there are any
actual differences between high and low metastatic cells.
Immunofluorescent studies have shown that highly metastatic
variants of the murine K-1735 melanoma and of the UV2237 fibrosarcoma
have been shown to exhibit distorted actin bundles, a reduction in the
number of focal contacts, and a reduced organization of vinculin (Raz
and Ge

, 1982).

These results were confirmed using various clones

of the K-1735 cell line (Volk et al., 1984), in the Dunning R3327 rat
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prostatic adenocarcinoma system (Zachary et al., 1986), and rat
pancreatic adenocarcinoma (BSp73) variants (Raz et al., 1986).

The

loss of actin organization was shown to be an important part of the
transition from noninvasive benign human colonic tumors to invasive
malignant tumors (Friedman et al., 1984).

On the other hand, three

distinct phenotypes were observed in human breast carcinoma cells and
the cytoskeleton seemed to be more dependent on cell shape (Brinkley et
al., 1980).

In addition, the organization of the cytoskeleton in the

rat adenocarcinorna cells varied between clones, not with the metastatic
potential of the clones (Lichtner and Nicolson, 1987).
Biochemical studies may further define the role of the
cytoskeleton in metastasis.

The cytoskeletal core actin (Triton X

insoluble) assembly was increased by 35% in highly metastatic clones of
Bl6Fl0 cells grown in the presence of fetal calf serum.

This increase

was measured by the DNase I inhbition assay and was not seen in the low
metastatic clones (Holme et al., 1987).

Parental and low metastatic

Bl6 cells also displayed a newly found actin polypeptide (Ax), which
comprised 30% of the total actin.

This peptide, isolated by a number

of biochemical techniques including the microfilament isolation
techique of Matsumura et al. (1983) and two dimensional
electrophoresis, was not found to be expressed in highly metastatic
Bl6BL6 or Bl6Fl0 cells (Taniguchi et al., 1986).

Given the importance

of actin in motility and cell shape, one can only speculate on the role
of different actin isotypes or the assembly patterns of actin in
metastatis.
The synthesis and expression of intermediate filament types is
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specific for tissue types (Franke et al., 1978).

Melanoma cells

synthesize intermediate filaments composed only of vimentin (Ramaekers
et al., 1983).

The synthesis of vimentin has been shown to be

decreased in the rounded configuration, highly metastatic variant of
the Bl6-Fl0 cell line (Raz and Ben-Ze'ev, 1983).

Modifications of cell

shape are apparently important in metastasis (Stackpole et al., 1985),
but changes in vimentin synthesis may be only part of the story (Nabi
and Raz, 1987).

On the other hand, cyclohexamide decreased the

synthesis of vimentin (as well as actin and tubulin) and also decreased
lung nodule formation (Ben-Ze'ev and Raz, 1985).

Is a decrease in

vimentin associated with a decrease or increase in metastasis?

The

effect of cyclohexamide on metastasis might not be directly due to the
disorganization or decrease in the synthesis of vimentin, but due to a
decrease in general protein synthesis (Thorgeirsson et al., 1984).
Further characterization of the role of the cytoskeleton in
metastatic spread is needed.

Agents that have disruptive effects on

the cytoskeleton are important tools, but given the wide range of
functions that the cytoskeleton has in a cell, dissecting a specific
role for the cytoskeleton in individual steps of the metastatic cascade
will be a difficult job.

The microfilament system appears to have a

crucial role in lung implantation.

Bl6Fl and Bl6Fl0 cells pretreated

with tertiary amine local anesthetics have decreased lung colonization
abilties (Nicolson et al., 1986).

Tertiary amine local anesthetics

result in cell rounding and the loss of stress fibers (Nicolson et al.,
1976).

However, pretreatment of Bl6 cells with either cytochalasin B

(an actin depolymerization agent) and colchicine (an antimicrotubule
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agent) decreased lung colonization with a surprising increase in
extrapulmonary metastasis (Hart et al., 1980).

These three agents have

been shown to decrease homotypic adhesion and endothelial cell adhesion
(Hart et al., 1980; Nicolson et al., 1986).

Further work is also

required to find the mechanisms in which cytochalasin B and colchicine
increased extrapulmonary metastasis.
Metastasis is a complex series of events that can be investigated
by holistic and reductionistic experiments.

We attempt using in vitro

models to understand the overall process of metastasis under specific,
defined conditions that reduce the numbers of variables.
of each in vitro model will become known only when
is understood.

The revelance

vivo metastasis

Chapter III

PURPOSE
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This dissertation will examine the affect of two antitumor drugs,
all trans retinoic acid (RA) and butyric acid (BA), on Bl6a murine
melanoma cells.

The five parameters to be investigated are:

(1)

cytotstatic and cytotoxic concentrations, (2) in vitro migration, (3)
in vitro invasion, (4) in vivo experimental metastasis (tail vein
injection), and (5) cytoskeletal morphology.

Retinoic acid and BA can

be less host toxic and less mutagenic than conventional chemotherapy
when administered at cytostatic concentrations.

Both drugs deserve

investigation because their effect on the individual steps of the
metastatic cascade is undefined.

My hypothesis, which is supported by

my in vitro preliminary studies and by the literature, is that BA
inhibits growth yet increases in vitro migration, in vitro invasion,
and

vivo experimental metastasis.

In contrast, RA suppresses

migration, invasion, and experimental metastasis.

My study stresses

the importance of testing the invasive and metastatic effects of
potential antitumor agents.

The net effect of RA and BA on invasion

and metastasis may be due to their differential action on the
cytoskeleton.

This project may lead to a further understanding of the

metastatic process.

In Chapter IV, I determined the effect of RA and

BA on the proliferation, migration and cytoskeleton.

In Chapter V, I

determined the effect of RA and BA on adhesion, invasion, and
experimental metastasis.

vivo

In Chapter IV, I quantitated the effect of

migration, invasion, RA and BA on the actin cytoskeleton.

CHAPTER IV

THE EFFECTS OF RETINOIC ACID AND BUTYRIC ACID
ON IN VITRO MIGRATION BY MURINE Bl6a MELANOMA CELLS:
A QUANTITATIVE SCANNING ELECTRON MICROSCOPIC STUDY
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ABSTRACT

Retinoic acid (RA) and butyric acid (BA) were investigated for
their effect on in vitro migration of highly metastatic murine Bl6a
melanoma cells.

These potential antitumor agents are known to alter

the cytoskeleton.

Our initial studies determined the 72 hr

cytostatic/cytotoxic concentration of RA (1 X 10BA (1.5 mM/2 mM).

6

M/>l X 10-

5

M) and

Cytostasis by RA and BA was confirmed by

autoradiography and radioisotope incorporation.

For the migration

assays, cells were plated on 3 urn and 5 urn diameter pore polycarbonate
membranes.
plating.

Complete media was added containing RA or BA at the time of
For BA-pretreatment studies, BA was added to cells for 72 hr

prior to plating cells on the membranes in fresh media + BA.

Top and

bottom surfaces were examined after 72 hr of incubation by scanning
electron microscopy.

Although RA and BA induced cells on the top of

the membrane to change morphology as shown by phase contrast,
transmission, and scanning electron microscopy, only BA enhanced the
migration of cells to allow for passage through the 3 um diameter
pores.

Butyric acid enhanced migration through the 3 um diameter pore

membranes by 511%.

For the 5 um pore membranes, 55% of the plated

number of untreated early passage cells migrated to the bottom surface
as compared to 57% for the BA-treated cells and 15% for RA-treated
cells.

However, if cellular proliferation over the 72 hr period was

factored in, BA-treatment increased migration by 456% and pretreatment
of cells with BA increased migration by 893%.

Without considering

proliferation, RA inhibited migration by 75% over untreated cells.

The
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decrease in migration observed in RA-treated cells was due to an
inhibitory effect on cellular migration and decrease in proliferation.
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INTRODUCTION

Progress in the treatment of cancer has been hampered by the
inherant ability of tumor cells to metastasize.

Metastasis is a

complex, multistep process that is poorly understood.

Tumor cells must

invade the extracellular matrix (ECM) at multiple stages during the
metastatic process.

Tumor cell invasion of the ECM has been proposed

to be a three step process: (1) attachment to endothelial cells and the
ECM, (2) proteolytic digestion of the ECM, and (3) locomotion (Liotta
et al., 1983).

Although the role of tumor cell locomotion in invasion

and metastasis has been studied (Werling et al., 1986; Raz and
Ben-Ze'ev, 1987; Maslow, 1987; Verschueren et al., 1988), the specific
step of migration needs to be clearly distinguished from the overall
process of metastasis (Grimstad, 1987, 1988).
The modified Boyden chamber has been a major instrument to
quantitate migration (Varani et al., 1978; Nabeshima et al., 1986;
Fliegel et

al., 1985; 1986; Wewer et al., 1987).

Membrane invasion

culture system (MIGS) chambers, (Gehlsen et al., 1984), Transwell
chambers (Repesh, 1989) and numerous other chambers that are
modifications of the Boyden chamber have been used to evaluate
migration and invasion.

Early studies on quantitating migration in the

Boyden chamber (Varani et al., 1978) have now evolved to analyze the
effect on migration by various chemotactic agents (Orr et al., 1978;
Lam et al., 1981; Thorgeirsson et al., 1982; Varani et al., 1985),
haptotaxic agents (McCarthy and Furcht, 1984; McCarthy et al., 1986)
and drugs (Spiro and Mundy, 1980; Daughaday et al., 1981).

Light
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microscopy (Thorgeirsson et al., 1982), radiolabelling (Repesh, 1989)
and scanning electron microscopy (Albrecht-Buehler, 1986) have been
used to evaluate cell locomotion and migration.
Agents that interfere with either microtubules (e.g. colchicine or
taxol) or microfilaments (e.g. cytochalasin B) inhibit tumor cell
migration (Spiro and Mundy, 1980).

Raz and Geiger (1982) speculated

that the role of the cytoskeleton was not only active in migration, but
also in the tumor cell's ability to deform and make/break intercellular
contact.

Retinoic acid (RA) and butyric acid (BA) inhibit growth and

induce differentiation of tumor cells (Nordenberg et al., 1986; Roberts
and Sporn, 1984) as well as affect the cytoskeleton (Lehtonen et al.,
1983; Ng et al., 1985; Borenfreund et al., 1980).
In my investigation, I quantitated by scanning electron microscopy
(SEM) the migration of untreated, RA-treated, and BA-treated Bl6a cells
through porous polycarbonate membranes.
by SEM.

I calculated migration rates

The migration rate of Bl6a cells was defined as the number of

cells adhering to the bottom of a polycarbonate membrane divided by the
number of cells plated.

The number of cells adhering to the bottom of

the entire membrane was extrapolated from the number of cells counted
within 50 random fields as observed by SEM.

This study demonstrated

that RA inhibited while BA increased the migration rate of Bl6a cells.
I have also shown by transmission electron microscopy (TEM) that RA and
BA induce changes in the cytoskeleton of Bl6a cells.
cytoskeleton in tumor cell migration is discussed.

The role of the
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MATERIALS AND METHODS

Cell Culture
Murine Bl6a (amelanotic) melanoma cells were obtained from the DCT
Tumor Repository (NCI Frederick Cancer Research Facility, Frederick,
Maryland).

Cells were cultured in Eagle's Minimum Essential Medium

(MEM) (Gibco, Grand Island, NY) containing Hank's salts and 1-glutamine
supplemented with sodium pyruvate (110 mg/l) (Sigma, St Louis, MO), 10%
heat inactivated fetal bovine serum (FBS) (Gibco), 1% penicillin
G-streptomycin sulfate-amphotericin B (Fungizone) (Gibco), MEM
non-essential amino acids (10 ml/l) (Gibco), sodium bicarbonate (1.27
g/l) (Sigma), and Hepes (5.96 g/l) (Sigma).
was 7.3.

The final pH of the medium

Cells were cultured in a humidified incubator (37°C in 5%

co 2 ) and were refed every three days.

Cells were subcultured with

trypsin/EDTA (Sigma) in Hanks Balanced Salt Solution without Ca++ and
Mg++ (Gibco) during the log phase of growth.
standard.

All other parameters were

The experimental metastatic assay (tail vein injection) of

Poste et al. (1980) was used to verify the lung-colonizing potential of
the cells in C57BL6 mice.

The metastatic potential of the cells was

confirmed prior to initiating the migration assays and

after

completing all assays.
In Vitro Growth Curves of RA, BA, Calf Serum, and Colchicine-Treated
Cells
Cells were plated in triplicate for each experiment at a
concentration of 150,000 cells per 35 mm dish (50,000 cells per ml).
24 h later, RA (OM, 10

-8

M, 10

-7

M, 10

-6

Mand 10

-5

M in complete medium
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containing 0.1% ethanol+ 10% FBS ), BA+ 10% FBS (0.0mM, O.lmM, 0.2mM,
0.5mM, lmM, l.5mM and 2mM in phosphate buffered saline), 10% calf serum
(CS), and colchicine (OM, 10

-8

M, 10

-7

Mand 10

-5

Min complete medium

containing 0.1% ethanol+ 10% FBS) were added independently.

Retinoic

acid and colchicine were obtained from Sigma, BA from J.T. Baker
(Phillipsburg, N.J.) and CS from Gibco.

Different concentrations of RA

were prepared under minimal light conditions according to the method of
Lotan and Nicolson (1979).

Retinoic acid was dissolved in 100% ethanol

to produce a series of stock solutions from 10
f or up to a wee k at -60

°c.

-1

to 10

-5

M, and stored

Stock solutions were diluted 1:1000 with

complete medium prior to usage.

Two sets of controls were run.

control contained complete medium.

One

The second control contained 0.1%

ethanol (the final ethanol concentration) in complete medium.

The FCS

was exposed to ultraviolet light for 1 h in order to destroy vitamin A
activity (Ng et al., 1985).

The concentration of RA in the control

medium was therefore considered to be 0 M.

5
The 10- M concentration of

taxol used in the migration assay was the same concentration used in
the motility assay of Keller and Zimmermann (1986).

Viability and cell

number were determined at 72 h by the trypan blue dye exclusion test
and the hemacytometer, respectively.

The data was reported as the mean

number of cells + standard deviation.
Incorporation of

3

H Thymidine by BA-treated Cells

The incorporation of

3

H-thymidine was determined by

autoradiography and beta scintillation counting according to the method
of Ryan et al.

(1987).

For autoradiography, untreated and BA-treated

(1.5 mM) were incubated for 72 h on acid-washed glass slides.

One
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uCi/ml of

3

H-thymidine (specific activity 6.7 Ci/mM) was added 24 and
Slides were washed with cold 0.1 M

54 h after the start of incubation.

thymidine in phosphate buffered saline (PBS) and fixed for 2 min at
room temperature in freshly prepared 4% paraformaldehyde in PBS
(pH=7.4).

Slides with unlabelled cells were run as a control.

were washed with PBS, dehydrated in ethanol and air dried.

Slides

They were

coated with Kodak NTB2 emulsion, dried overnight in the dark, placed in
a light tight box and refrigerated for 2, 4, and 6 days.
developed in Dl9 developer for 5 min.
acetic acid (30-60 sec) and fixed.

Slides were

Each slide was rinsed in 1%

Finally, slides were rinsed in

running water and stained with Giemsa (Fisher Diagnostics, Orangeburg,
NY).

Analysis of

3

H-thymidine incorporation for autoradiography was

done by (1) counting the number of labelled and unlabelled cells, and

(2) measuring the percent area of labelling in cells using a PGT
digitizer.

Background was defined as < 25 grains/window on the PGT

digitizer at a total magnification of 1550X.
The total incorporation of
was determined as follows.

3

H-thymidine using beta scintillation

Control and growth inhibitory

concentrations of BA were added in triplicate 24 h after cell plating.
After 54 h, 1 or 2 uCi/ml of

3

H thymidine was added for 18 h.

Cells

were washed with Hank's Balanced Salt Solution (HBSS) without Ga ++ or
Mg++ and lifted by trypsin/EDTA.

Collected cells were either harvested

onto glass filter paper or not filtered.

Aqueous scintillation fluor

(Packard Instrument Co., Inc., Downers Grove, IL) was added to the
filters and to the unfiltered cell suspensions.

Counts per minute were

determined by liquid scintillation spectrophotometry.

so
!_ncorporation of

3

H-IdUR by RA-treated Cells

The incorporation of

3
H-IdUR was determined by autoradiography and

beta scintillation as in the above section with the following
exceptions:
uCi/ml of

(1) for both autoradiography and beta scintillation one

3
H-5-Iodo- deoxyuridine (Amersham Inc., Arlington Hts., IL)

(specific activity of 5 Ci/mM) was added at 54 h after the start of
incubation, (2) the cytostatic concentration of RA was used for both
autoradiography and beta scintillation, (3) analysis of incorporation
of 3H-IdUR by autoradiography was done only by counting labelled and
unlabelled cells, and (4) cellular suspensions were filtered for beta
scintillation.
Migration Assay
The methodology in this investigation was a modification of the
migration assay of Varani et al. (1978).

I utilized either the

Transwell chamber system (Costar, Cambridge, MA) or a diffusion chamber
(Persky and Grganto, 1987).

Transwell chambers have a well within a

well design containing a 3 or 5 um diameter pore polycarbonate membrane
(10 um in thickness) in the inner well.
Trial 1

In the first investigation, polycarbonate membranes with

3 urn pores were utilized.

Cells were plated at least in triplicate in

the upper wells of the Transwell chambers (70,000 cells/well, 50,000
cells/well and 5,000 cells/well).

Cells were allowed to attach to the

polycarbonate membranes for 24 h prior to treatment with cytostatic
concentrations of RA, BA, colchicine, or taxol.
incubated for three days without refeeding.
during the migration assays.

Cells were then

Drugs were not replenished

Cytostasis was defined as the
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concentration of drug that inhibited cell growth without measurable
cell death.

The experiment in which cells were treated with or without

BA (50,000 cells/well) was quantitated by SEM (n=4, 500X).

The percent

migration was determined from the number of cells counted/field times
50 (the number of fields counted) times 15.36 (50 fields at 500 X is
equal to 1/15.36 of the total surface area).

Colchicine, RA, and

taxol-treated cells were qualitatively examined.
Trials 2 - 4

In the second investigation, quantification of

migration by SEM was done using 5 um diameter pore polycarbonate
membranes (Nuclepore, Pleasanton, CA) in diffusion chambers or 5 um
pore Transwell chambers.

Migration was evaluated by counting cells on

the bottom surface of the membranes after 18 (Trial 4) and 72 h (Trials
2 and 3) of incubation.

The number of migratory cells was determined

by counting cells within 50 fields per membrane, each field at l,700X.
This magnification was selected in order to properly delineate cell
boundaries.

Percent migration was determined by two different methods.

The first method was defined as the number of migratory cells counted
per field times 50 (the number of fields counted) times 177.59 (50
fields at 1700X is equal to 1/177.56 of the total surface area) divided
by 50,000 (the number of cells originally plated).

For the 18 h time

period, untreated and BA-treated early passage (less than six passages)
cells were plated into Transwell chambers (50,000 cells/well).

For the

72 h time period, untreated, BA-treated, BA-pretreated (72 h before
plating), RA-treated, and calf serum-treated early passage (Trial 2)
cells were plated into either the Transwell system or a diffusion
chamber (50,000 cells/well).
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·The second methodology for determining percent of migration was
calculated only for untreated and BA-treated cells by incorporating a
proliferation factor, Pf, for cellular proliferation in 35 mm dishes
during the 3 day incubation period.

The two Pf values were obtained

with a hemacytometer by counting the number of untreated and BA-treated
cells after 3 days of incubation.

The Pf values were 777,275 and

177,500 for untreated and BA-treated cells, respectively.

This method

was thus defined as the number of cells per l,700X field times 50
divided by Pf.
Trial 3

Quantification of migration was done on later passage

Bl6a cells (greater than 6 passages) .

Untreated, BA-treated, and

BA-pretreated (72 h before plating) cells were plated into a Transwell
chamber (n=4, 50,000 cells/well).
Statistics
Students' t tests were performed for the results of all
experiments except for the data from trials two and three of the
migration assays where Welch's tw (t') unequal variance or
Bechhofer-Dunnett-Krishnaiah-Armitage equal variance multiple
comparison tests were done (Wilcox, 1987).
Scanning Electron Microscopy
All membranes were prepared according to standard techniques
except that the membranes were air dryed instead of critical point
dryed.

Briefly, membranes were washed in 0.2M cacodylate buffer, fixed

in 2% glutaraldehyde, and post fixed in 1% osmium tetroxide.

The

membranes were dehydrated, air dryed, mounted, and sputter coated with
gold (27 nm coating; Polaron ESlOO Series II sputter coater).
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Membranes were viewed with a JEOL JSM-840A scanning electron
microscope.
!!ansmission Electron Microscopy
A preliminary ultrastructural study was undertaken to provide
evidence that RA and BA modify the cytoskeleton of Bl6a cells.

The

transmission electron microscopy (TEM) was done according to the method
of McDonald (1984) and Costar Corporation (personal communication) in
order to preserve microfilaments.

Briefly, a migration assay was run

with untreated, RA-pretreated, and BA pretreated cells in Transwell
chambers.

All steps were run with membranes still in the Transwell

chambers.

Membranes were fixed after 72 h with 2% glutaraldehyde in 50

mM cacodylate buffer (pH=7.4) containing 5 mM CaC1

2

for 30 min at 37°C.

The membranes were rinsed in buffer (3X) for 5 min at 37°C and
incubated in buffer containing 0.8% K Fe(CN) for 30 min.
6
3
membranes were incubated in buffer containing 0.5% Oso

4

The

and 0.8%

K Fe(CN) for 30 min, rinsed in buffer, and then rinsed in distilled
3
6
water (3X).

The membranes were stained en bloc with 2% uranyl acetate

(distilled water) for 60 to 120 min, rinsed in distilled water (3X) and
then dehydrated in grades of ethanol.

Membranes were infiltrated into

resin (Epon-Araldite), cut out of the Transwell inner well, and
polymerized in blocks at 60°C for several days.

Thin sections were

cut, stained in 1% uranyl acetate (in 70% methanol) and lead citrate,
and viewed with a Hitachi H-600 transmission electron microscope.
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RESULTS

Growth Curves
In vitro growth curves of BA (Fig. 1), RA (Fig. 2), and
colchicine-treated (Fig. 3) cells were determined by hemacytometer.
Cell viability for the six different treatment groups (control medium,
control medium+ 0.1% ethanol, RA, CS, BA, and colchicine) as
determined by the trypan blue exclusion test was always greater than
90%.
Cells were treated for 72 h with different concentrations of BA
A concentration of 2 mM BA was found to be cytotoxic as

(Fig. 1).

fewer cells were found after 72 h (130,500

±

33,600) than were plated

A concentration of 1.5 mM BA was not cytotoxic yet

(150,000).

inhibited proliferation by 77% + 6% as compared to the controls (0 mM).
After 72 h of incubation in 1.5 mM BA, viability was comparable to 72 h
controls (0 mM), i.e., 97.3%

± 1.5%

and 98.9%

± 0.3%,

respectively.

There was a range of cytostatic concentrations between 0.5 mM and 1.5

mM that did not cause cytotoxicity.

However, the 'cytostatic'

concentration of 1.5 mM BA was chosen to be used for all further
experiments.

It was also observed that the lowest concentration of BA

(0.1 mM) inhibited proliferation by 35%.
The cytotoxic/cytostatic concentrations for RA were determined to
be 1 X 10-

5

M/l X 10-

6

M, respectively (Fig. 2).

concentration was a range of values between 10
10-

6

-6

The cytostatic
and 10

-7

M.

The 1 X

concentration of RA inhibited proliferation as compared to the

0.1% ethanol control by 65% and was used for all further cell
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proliferation and migration experiments.
tested (1 X 10-

8

contained 1 X 10cells than 1 X 10

The lowest concentration

M) inhibited proliferation by 50%.
4

The dishes that

M concentration of RA were found to have more viable

-7

M.

Since crystals of RA were found in the 1 X 10-

4

M concentration medium, I believe that this concentration produced a
supersaturated condition such that the RA was not able to completely
dissolve in ethanol.

The addition of 0.1% ethanol did not affect

proliferation (p<0.05) (Table 1).

Proliferation was significantly

inhibited (p<0.001) by 59.1% when 10% CS was substituted for 10% fetal
calf serum (Table 1).
Figure 3 is the growth curve of colchicine-treated cells.
cytostatic concentration was determined to be 5 X 10-

7

The

M.

3
H-Thymidine Incorporation in BA-treated Cells
Inhibition of

3

H-thymidine incorporation by BA was determined by

autoradiography and beta scintillation counting.
using autoradiography, two different
h and 48 h, were used.

In the experiments

3
H-thymidine incubation times, 18

Two separate experiments were done in which the

cells were labelled for 18 h, starting 54 h after cell plating.
Unlabelled and labelled cells were counted from twelve different fields
(average of 125 cells counted/field, 200X) from three different slides
(two slides from the first 18 h protocol, one from the second 18 h
protocol).

Autoradiography revealed that after 18 h 59.1% (SEM

of the untreated cells had incorporated the

3

9.3)

H-thymidine, while only

32.9% (SEM = 0.6%) of the BA-treated cells had incorporated the label.
The percent inhibition of

3

H-thymidine incorporation was calculated to

be 42.0% (SEM = 7.1%) (p<0.001).

Figure 4a and 4b illustrate two
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autoradiographs of BA-treated cells that were (Fig. 4A) or were not
treated with

3

H-thymidine for 18 hr.

Three of nine cells in Fig. 4A

were interpreted to be labelled.
Two autoradiography methods (A and B) were used for counting cells
· h
that were 1 a b e 11 e d wit

3

H-t h ymi·d·ine f or 48 h .

were labelled 24 h after plating.

For both methods, cells

For method A, the absolute number of

labelled and unlabelled cells was counted.

After 48 h of incubation,

96% of the untreated cells were labelled, while 58.5% of the BA-treated
cells were labelled (data not shown).
3

incorporation of

The percent inhibition of

H thymidine was calculated to be 39%.

For method B,

the amount of labelling was calculated on a PGT digitizer from the

2

percent of a set area containing the label (739.8 um, 689X).

A total

of 53 cells were digitized for each group, i.e., untreated and
BA-treated cells.
each group.

A minimum of 10 random fields were investigated for

The area labelled in untreated and BA-treated cells was

calculated to be 6.6% (S.D= 3.2) and 3.2% (S.D.=3.7), respectively.
The percent areas were significantly different (p>0.0001).
Lastly,

3

H-thymidine incorporation for untreated and BA-treated

cells was measured after an 18 h incubation period by beta
scintillation.

The average percent inhibition of

3

H-thymidine

incorporation was 80% (p<0.001) (Table 2).

3

H-IdUR Incorporation in RA-treated Cells
Inhibition of

3

H-IdUR incorporation by RA was determined by

autoradiography and beta scintillation counting.

For the

autoradiography, unlabelled and labelled cells were counted from 21
(untreated) or 24 (RA-treated) different fields (200X) from three
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different slides.

Autoradiography revealed that 64.5% (SEM=l.6) of the

untreated cells were labelled after 18 h incubation with

3

H-IdUR, while

only 29.8% (SEM=l.5) of the RA-treated cells had incorporated the
label.

The percent inhibition of

3

tt-IdUR was calculated to be 53%.

For the beta scintillation, the percent inhibition of

3

H-IdUR

incorporation was 72% (p<0.0001) (Table 3).
Migration Assay
The initial experiments using 3 um diameter pore polycarbonate
membranes led to further analysis and quantification of migration with
5 um diameter pore membranes.

Light microscopy showed untreated cells

grown on plastic to be heterogeneous in morphology (round to flat) as
well as diverse in cell size.

In contrast, BA-treated cells were a

homogeneous population of large, flattened cells.
The morphology of untreated cells (Figs. 5 and 6), RA-treated
(Fig. 7), BA-treated (Fig. 8), colchicine-treated (Fig. 9) and
taxol-treated (Fig. 10) cells was also evaluated by SEM on both 3 and 5
um diameter pore polycarbonate membranes.

In all cases, cells on the

top surface of the polycarbonate membranes had morphology similar to
comparable treated cells grown on plastic.

Butyric acid (Fig. 8),

colchicine (Fig. 9), and taxol (Fig. 10) treatment induced a flattened
morphology as compared to untreated cells whether the cells were grown
on plastic or on polycarbonate membranes.

Colchicine and taxol-treated

Bl6a cells on top of the membrane were not as flattened in shape as
BA-treated cells.

The majority of colchicine (Fig. 9) and taxol

treated cells (Fig. 10) were covered with blebs.
a spindle-shaped morphology.

Retinoic acid induced

The major observation was that many more
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BA-treated cells migrated through 3 um pore membranes than untreated,
RA, colchicine, or taxol-treated cells.

The experiment in which cells

were treated with or without BA (50,000 cells/well) was quantitated
using SEM.

The increase in the percent migration induced by BA over

untreated controls was calculated to be 511% (Trial l, Table 4).

If

migration rates were formulated to incorporate proliferation during a
three day incubation period (Fig. 1), BA enhanced migration by 2300%.
Migration through the membrane for untreated (Fig. 5), RA treated,
colchicine (Fig. 9) or taxol (Fig. 10) was < 2% of the original plated
number.

Cell plating density, which ranged from 5,000 to 75,000 cells

per well, did not have an effect on the migration of untreated and
BA-treated cells through the 3 um pore polycarbonate membrane (data not
shown).
Later experiments quantitated by SEM the migration of untreated
and treated cells through 5 um pore diameter membranes after 18 (Trial
4, Table 4) and 72 hrs (Trials 2 and 3, Table 4) of incubation.
diffusion chambers and Transwell chambers were used.

Both

Table 4

illustrates that Transwell chambers were used for Trials 3, 4, and PBA,
RA, CS treatments of Trial 2.

Diffusion chambers were used for the

other parameters of Trial 2.
Trial 2.

Using early passage cells (passage less than six), an

average of 3.11 control cells/field (SEM=l.22) and 3.23 BA-treated
cells/field (SEM=l.13) were observed on the bottom of the membrane
(Table 4).

The number of cells per field initially suggest no

significant difference in migration between untreated and BA-treated
cells.

However, these numbers do not take into account the partial
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cytostasis induced by BA.

If migration rates were formulated to

incorporate cellular proliferation (Fig. 1) during a three day
incubation period, BA-treatment enhanced migration by 456% over
controls (p< 0.05) (Table 5).

The migration of BA-treated cells using

10% FCS was 192% greater than untreated cells using 10% calf serum (p<
0.05) (Trial 2, Table 4).

A further enhancement of migration was

induced by BA if cells were pretreated for 72 h with BA before plating.
Pretreatment increased migration over non-pretreated BA-treated cells
by 196% (p<0.05) and similarly increased migration over untreated cells
by 203% (p<0.05) (Trial 2, Table 4).

If 72 h migration rates were

formulated to incorporate proliferation, the rate for the BA pretreated
cells was 893% (p< 0.05) greater than untreated cells (Table 5).

There

was no significant difference in migration in the 18 h incubation
period between untreated and BA-treated cells (Trial 4, Table 4).

In

contrast, the migration of RA-treated cells during the 72 h incubation
period was decreased by 75% (p<0.05) as compared to untreated cells.
(Trial 2, Table 4).

If 72 h migration rates were formulated to

incorporate proliferation, the rate for the RA-treated cells was not
significantly different from the untreated cells (Table 5).

There was

no significant difference in migration rates between 10% CS-treated
cells and 10% FCS-treated (CO) cells.
Trial 3.

Migration was quantified using later passage Bl6a cells.

The methodology above was used to quantitate migration of untreated,
BA-treated, and PEA-treated cells (n=4).

The percent migration of

untreated cells was calculated to be 3.72% of the plated number.
Again, I found that BA or PBA increased migration by 438% and 919%,

60
respectively, over the untreated controls (p<0.05, p<0.05).

If 72 h

migration rates were formulated to incorporate proliferation, the rate
for the BA-treated late passage cells was 1900% (p<0.05) greater and
the rate for the BA-pretreated late passage cells was 4000% (p<0.05)
greater than untreated late passage cells (Table 5).
Transmission Electron Microscopy.
The analysis of the cytoskeleton of untreated, RA treated and
BA-treated Bl6a cells was a qualitative TEM study.

Analysis of

untreated Bl6a cells found two distinct cytoskeletal phenotypes.

Cells

that were not visibly attached to the substrate displayed few
microtubules and intermediate filaments.
only along cell margins.

Microfilaments were visible

Cells that were attached to the substrate

displayed a disorganized microtubule and intermediate filament system.
Microfilaments were found in the cortical areas of the cytoplasm (Fig.
10).

In contrast to untreated cells, RA and BA treatment altered the

structure of the cytoskeleton.

Retinoic acid-treated cells displayed

parallel arrays of microtubules and intermediate filaments (Fig. 11).
Less cortical microfilaments were seen with wider focal adhesion
contacts than in untreated cells.

Butyric acid-treated cells also

displayed parallel arrays of microtubules and intermediate filaments
oriented along the longitudinal axis of the cells.

An extensive

cortical microfilament network was seen (Fig. 12).

This preliminary

ultrastructural study supports the evidence presented in the literature
that RA and BA alter the structure of the cytoskeleton.
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DISCUSSION

In this investigation, BA enhanced while RA decreased the
migration of Bl6a cells through 3 and 5 um diameter pores.

Migration

of untreated and RA-treated cells through 3 um pore membranes was
negligible (< 2% of cells plated).

In contrast to untreated cells,

treatment with BA resulted in a 511% increase in migration through 3 um
diameter pores.

The 3 um diameter pore is near the minimum 1-2 um pore

size that allows passage of Bl6 cells (Tullberg and Burger, 1985),
although there are more 3 um diameter pores per membrane than in 5 um
or 8 um diameter pore membranes (Costar Co., personal communication).
Untreated early passage (<6 passages) cells migrated significantly
through 5 um diameter pores (55.1%).

The effect of BA on the percent

change of migration through 5 um pores was not as pronounced as through
3 um diameter pores (104% vs 511% migration, respectively).
other hand,

On the

RA-treated cells migrated through 5 um pores at 14.0%,

i.e., 75% less than untreated cells.
It was important to determine the cytotoxic/cytostatic
concentrations of RA and BA since they vary from cell line to cell line
(Reese et al., 1985; Kyritsis et al., 1984; Lotan and Nicolson, 1979).
The use of non-cytotoxic drug concentrations in in

migration

assays is important since cytotoxicity will mask enhancement or
inhibition of migration

(Mareel and DeMets, 1984).

I used

hemacytometer counts to demonstrate that RA and BA decreased
proliferation during the three day incubation period.

I used

autoradiography and beta scintillation counting to show that RA and BA
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also inhibited the incorporation of

3

H-thymidine and

3

H-IdUR.

Both RA

and BA have been shown to inhibit proliferation in various tumor cell
lines in the Gl phase of the cell cycle (Roberts and Sporn, 1984;
Thorgeirsson et al., 1984).
In my study, phase microscopy and SEM revealed morphological
changes in RA and BA-treated cells.
migration is not known.

How these changes are related to

The untreated cell population on top of 3 and

5 um pore membranes is heterogeneous (Figs. 4 and Sa).

There are,

however, more flattened cells on top of 3 um pore membranes than 5 um
pore membranes.

Concomitantly, bottom surfaces of 5 um pore membranes

are dominated by flattened cells.

I concluded that increasing the pore

size from 3 to 5 um allowed more flattened cells to migrate to the
bottom surface.

Rounded-up cells, i.e., mitotic cells, do not migrate.

It is therefore not surprising that incubation with BA, which enhances
cell flattening, increases cell migration.

The morphology of

RA-treated cells differs from either untreated or BA-treated cells.
The RA-treated cell population consisted of spindle to flattened shaped
cells.
Various methods have been used to quantify motility (Volk et al.,
1984; Keller and Zimmermann, 1986), deformabilty (Ochalek et al., 1988)
and to correlate these properties to metastatic potential.

Methods

used to quantify motility include time lapse photography (Keller and
Zimmermann, 1986) and the phagokinetic assay (Volk et al., 1984).
from the above experiments have in some cases been found to be in
direct conflict with data from migration assays (Spiro and Mundy,
1980).

Our experimental protocol emphasizes that migration

Data
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incorporates both active cellular deformabilty and motility
(locomotion) (Daughaday et al., 1981).

Migration is therefore defined

as the net summation of cellular deformability and motility.
Microtubule (MT) inhibitors, e.g., colchicine, and microfilament (MF)
disrupting agents, e.g., cytochalasin B, inhibited the migration of
tumor cells in a micropore filter system (Spiro and Mundy, 1980) even
though cell motility was enhanced (Keller and Zimmermann, 1986).

The

decreased migration seen with microtubule inhibitors may be due to
reduced cellular deformabil

(Ochalek et al., 1988).

Retinoic acid

is not a microtubule inhibitor, so the decrease in migration of
RA-treated cells may be due to affecting motility rather than
deformability.

In contrast, since the percent increase in migration of

early passage BA-treated cells through the 3 um diameter pore membrane
is greater than through the 5 um pore membrane, BA may be affecting
deformability rather than motility.
Retinoic acid and BA are being investigated as potential
antitumor-antimetastatic agents.

Studies on various cell lines

(Roberts and Sporn, 1984; Thorgeirsson et al., 1984; Ryan et al.,
1987), including the Bl6 melanoma cell line (Lotan and Nicolson, 1979;
Nordenberg et al., 1986) have stressed the effect of RA and BA on
growth inhibition and differentiation.

The change in morphology in

these cell lines has been linked to a change in the cytoskeleton
(Lehtonen et al., 1983; Ng et al., 1985; Altenburg et al., 1976;
Borenfreund et al., 1980).
The role of the cytoskeleton in migration has been demonstrated by
rnicrotubule inhibitors (e.g., colchicine, vinblastine) and
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microfilament inhibitors (e.g., cytochalasin B) (Spiro and Mundy 1980).
These inhibitors reduce migration.

Both RA and BA have been shown in

various tumor cell lines to increase the formation of microfilaments
and vinculin plaques, and to reorganize vimentin intermediate filaments
(Lehtonen et al., 1983; Ng et al., 1985; Altenburg et al., 1976;
Borenfreund et al., 1980).

I also observed by TEM an increase in

microtubule and microfilament organization in Bl6a cells.

Retinoic

acid and BA induced changes in the cytoskeleton appear to be similar,
although the surface morphology and shape of RA or BA-treated cells
differ as examined by phase contrast microscopy and SEM.

Subtle

changes in the cytoskeleton may induce migration of BA-treated cells
while inhibiting the migration of RA-treated cells.

Butyric acid may

have a role in increasing the amount of acetylated a-tubulin (Grant et
al., 1987) thus contributing to the stabilization of microtubules
(Piperno et al., 1987).
The role of cellular migration in invasion and metastasis needs
further investigation.

The Transwell system has merit for both

migration and invasion assays.

Various investigators have studied

invasion by using porous polycarbonate membranes coated with a
reconstituted basement membrane (Matrigel) (Albini et al., 1987;
Hendrix et al., 1987; Repesh, 1989).

An increase in migration of tumor

cells in vitro has been linked to enhanced invasion in
1987; Verschueren et al., 1988).

(Grimstad,

However, enhanced in vitro migration

of tumor cells may not necessarily lead to increased metastasis.
Grimstad (1988) found that hypermotile selected fibrosarcoma cells were
less metastatic than the original parent population.

Mohler et al.
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(1988) found, in contrast, a positive correlation between metastatic
potential of Dunning R-3327 rat prostatic adenocarcinoma cells and
motility.

Invasive cells that form specialized pseudopodia have been

interpreted by Kramer et al. (1986) to form adhesion contacts with the
matrix.

I observed that migratory cells (e.g., Fig. Sb) also form

pseudopodia when passing through 5 um diameter pores.

In addition, I

have observed by TEM focal adhesion contacts (not illustrated).
Cell motility has been linked to various parts of the cell cycle
in 3T3 fibroblasts (Thurston and Palcic, 1987).

Thurston and Palcic

(1987) found a peak in the rate of cell movement in G2 and a
significant increase in the average rate of movement as cells transit
from Gl to S phase.

The significance of their data, which was obtained

on 3T3 cells, as applied to a tumor cell system is not known.

Since RA

and BA block entry into the S phase of the cell cycle (Roberts and
Sporn, 1984; Thorgeirsson et al., 1984), Thurston and Palcic's data may
not be applicable.

Thurston and Palcic (1987) also found a weak

correlation between the rate of cell motility and the rate of cell
proliferation.

It is extremely important to emphasize that a decrease

in proliferation is not sufficient to explain an increase in migration
of BA-treated cells.

A 5 X 10

proliferation and migration.

5

M concentration of RA inhibits both

Calf serum (CS) does not have as many of

the growth factors that are in fetal calf serum.

Calf serum was found

to inhibit cell proliferation by 59.1% as compared to 10% FCS (Table
1).

However, the migration of CS-treated cells was not significantly

decreased from the untreated and BA-treated cells.

The migration of

calf serum-treated cells, however, is significantly greater than the
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RA-treated cells (P<0.05).

Another method of evaluating the migration

data is the use of a proliferation factor.

If the proliferation factor

is applied to migration rates of RA-treated cells, there is no
significant decrease in migration.

Therefore, I conclude that the

decrease in migration produced by RA was due to both an inhibitory
effect on cell migration and a decrease in proliferation.

A purely

speculative explanation for the anti-migratory effect of RA is that
changes in glycoproteins found on the cell surface may influence
migration (Lotan et al., 1987 a,b; Couch et al., 1987, 1988).
The migration rates for untreated and BA-treated early passage
cells were similar (Table 4).

However, if the decrease of cellular

proliferation by BA is included in defining migration, the enhancement
of migration by BA is significant (Table 5).

Hendrix et al. (1985)

have stated that cells which invaded the amnion had similar
proliferation rates as cells which did not invade.

The observation

that migration by preincubated BA-treated cells was significantly
different from untreated and BA-treated cells suggests that further
changes occur in the phenotype of these cells after 3 days.
Tumor cell migration has been investigated

vitro using short

time periods (4-18 h) (Varani et al., 1985; Nabeshima et al., 1986;
Grimstad, 1988).

It is questionable whether four hours is long enough

to quantitate migration in this or any other assay.
short period does not adequately reflect the

Perhaps such a

vivo condition.

I

noted that there was no significant difference between the migration of
untreated and BA-treated cells at 18 h (even if 18 h proliferation data
were used in the calculations, data not shown).

Cells treated for 72 h
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with BA before plating show a significant increase in migration
(greater than both the untreated and BA-treated cells) in a three day
assay (Tables 4 and 5).

It would be of interest to pretreat cells with

BA or RA for 72 h prior to an 18 h migration assay.

This project would

make unnecessary the use of a proliferation factor in comparing
migration rates.
In summary, RA and BA warranted investigation for two main
reasons.

First, these two drugs can be less host toxic and less

rnutagenic than conventional chemotherapeutic drugs when administered at
cytostatic concentrations.

Second, the effects of RA and BA on the

individual steps of the metastatic cascade are only beginning to be
known.
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Figures 1-3.

Dose response curves as measured by hemacytometer for BA, RA, and
colchicine-treated Bl6a cells.
ml total) in culture dishes.

Cells were plated (50,000 cells/ml, 3
Various concentrations of BA, RA, and

colchicine were added after 24 hrs.
after plating.

Cell number was determined 96 hrs

Dotted line indicates number of cells plated.
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Figure 4.

Two autoradiographs of BA-treated cells that were (Fig. 4A) or were not
. 4B) treated with

\1

thymidine for 18 hr.

The number of

over all nuclei were counted by two independent investigators.

For

4A, the mean + SE of the number of grains over the nuclei of the
six cells that "appeared" unlabelled was 10

±

0.7 grains.

nuclei that "appeared" contained> 40 grains per nuclei.
an average of 13.3 + 1.1

The three
For Fig. 48,

were counted for the 10 nuclei.

comparing Fig 4A to 48, three of the nine cells in Fig. 4A were
interpreted to be labelled cells (arrows).

By
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Figure 5.

Scanning micrograph of untreated cell on the top surface of a 3 um pore
polycarbonate membrane after 72 hrs of incubation.

(Bar

=

10 um)
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Figures 6-8.

Scanning micrographs of untreated (Fig. 5), RA-treated (Fig. 6), and
BA pretreated (Fig. 7) cells on the top ("a") and bottom ("b")
of 5 um diameter pore polycarbonate membranes after 72 hrs of
incubation.
(arrow).

Note the pseudopod coming out of a pore in Figures 5 and 6.

(Bar

10 um)
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Figure 9 -10.

Scanning micrographs of colchicine and taxol-treated cells on the top
surface of 5 um diameter pore polycarbonate membranes after 72 hrs of
incubation.

(Bar

=

10 um)
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Figure 11-13.

Transmission micrographs of untreated (Fig. 11), RA-treated (Fig. 12),
and BA-treated cells (Fig. 13).

The untreated cell (Fig. 11) displays

a disorganized microtubule and intermediate filament system with
microfilaments in the cortical area of the cytoplasm.

The RA-treated

cell (Fig. 12) shows an organized microtubule and intermediate filament
system with less cortical actin than untreated cells.

The BA-treated

cell (Fig. 13) displays an extensive system of parallel microtubules
and a large amount of cortical actin.

Microtubules (black arrow),

intermediate filaments (open arrow), and microfilaments (arrow head)
are present in all three cell types

(Bar= 0.2 um).
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TABLE 1.

The means of the untreated and 0.1% ethanol groups were not
significantly different (p > 0.05).

The means of the hemacytometer

counts for 10% FCS-treated cells and 10% CS-treated cells were
significantly different (p

< 0.001).
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NUMBER OF CELLS AFTER 72 HOURS OF INCUBATION
AS DETERMINED BY HEMACYTOMETER

UNTREATED

Mean

4.8 x 10

St. Dev.

4.3 x 10

N

4

5
4

0.1% ETHANOL

4.5

x 10 5

4.3

6. 8

x 10 4

4.2 x 10

3

10% cs

10% FCS

x 10 5

3

4

1.8 x 10

5

x 10 4

2.1

3
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TABLE 2.

The

3

tt-thymidine incorporation by untreated and BA-treated cells after

18hr incubation was measured.

Cells were lifted with trypsin/EDTA and

the cell suspension was either unfiltered or filtered with a cell
harvester.

The percent inhibition by BA of

3

tt-thymidine incorporation

was 67% for unfiltered cell suspensions and 93% for filtered
suspensions.

The average percent inhibition was 80%.
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3

INCORPORATION OF

H-THYMIDINE

CPM AS DETERMINED BY BETA SCINTILLATION

UNFILTERED CON

UNFILTERED BA

FILTERED CON

1 uCi/ul

Mean

6.3

x

10

St Dev

2.7

x

10

N

3

5
4

FILTERED BA

2 uCi/ul

2.0 x 10
7.6

x
3

10

5
4

1.5

x

10

1.4 x 10
3

6
5

1.0 x 10

x

2.7
3

10

5

4
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TABLE 3.

The

3

H-IdUR incorporation by untreated and RA-treated cells after 18 hr

incubation was measured.

Cells were lifted with trypsin/EDTA and the

cell suspension was filtered with a cell harvester.
inhibition of

3

H-IdUR incorporation by RA was 72%.

The percent
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INCORPORATION OF

3
H-IdUR

CPM AS DETERMINED BY BETA SCINTILLATION

FILTERED CONTROL

Mean

1. 9

x

10

St Dev

2.4

x

10

N

3

4

3

FILTERED RA

5.2 x 10
1.0

x
6

10

3
3
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TABLE 4.

The migration of Bl6a cells through 3 urn and 5 um diameter pore
polycarbonate membranes.

There was a significant difference in the

migration through a 3 um diameter pore membrane between untreated and
BA-treated cells (p < 0.013) (Trial 1).

In contrast, there was no

significant difference between untreated and BA-treated early passage
cells (Trial 2), but there was a significant difference between
untreated and BA-treated late passage cells after 72 h incubation
(Trial 3).

Interestingly, there was a significant increase in

migration of BA-pretreated early passage cells as compared to control
and BA-treated cells (p < 0.05, p < 0.05, respectively, Trial 2).
There was also a significant decrease in migration of RA-treated cells
as compared to control and calf serum-treated cells (p < 0.05, p <
0.05, respectively).

Lastly, there no was a significant difference

between untreated and BA-treated cells after 18 h incubation.

This

table includes percent migration and percent change in migration.
percent change in migration of untreated cells was considered to be
100%.

The

TABLE IV
TRIAL

TIME

MEf\IORANE
PORESIZ!i

TREATMENT

~

MAGNIFICATION

MEAN!

% MIGRATION

OF~J:~!~

~n!M~f&

SIGNlfJCANCE

INMIG~ILON

i.± SE)

#1

72 hr
72hr

lfYf1

311m

Control

4

500x

0.82± 0.02

1.26

311m

DA

4

500x

4.19 ± 0.62

6.42

+41 l

5
6
5

1700x"
170ox•

3.11±0.89
3.23 ± 0.72

11oox•
170ox•
170ox•

6.32 ± 0.19
0.79 ± 0.15

55.13
57.26
74.69
14.00

+4
+203
-75

0.05
005

1.68 ± 0.18

29.78

-54

N.s:••

0.21±0.04

3.72

0.013

EARLY PASSAGE

#2

Conlrol
13A

5µm
5µm

RA

cs

5
5

72hr

5µm

Control

4

72hr

5µm

4

0.92 ± 0.17

16.31

338

0 05

72 hr

5µm

DA
PDA

11oox•
11oox•

4

1700x"

1.93 ± 0.23

35.68

819

005

18 hr

5µm

Control

1700x•

1.07 ± 0.21

18.97

18 hr

5µm

DA

3
3

1700x•

1.16 ± 0.30

20.56

72 hr
72 hr
['

co

..

5µm
5µm
5µm

72hr
72 hr
72 hr

PUA

LA TE PASSAGE

#3

EARLY PASSAGE

#4

8

• The 1700x magnification was used to delineate cell boundaries. Care was taken not to overlap between cells.
• • Refer to proliferation table, Table V.
••• NS
. 'f'1cant.
.. = not s1gm

N.s:••
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TABLE 5.

The migration rate of control, BA-treated, BA-pretreated and RA-treated
cells after 72 hr incubation with a proliferation factor incorporated
into the migration rate (data obtained from trials 2 and 3, Table IV).
Note that early an late passage cells were used for BA experiments
while only early passage cells were used for the RA experiments.

The

migration value was defined as the number of the cells per field times
50 divided by the final hemacytometer cell population after 72 hr
incubation (Fig. 1).

There was a significant increase in migration of

BA-treated and BA-pretreated cells as compared to control cells (p <
0.05, p < 0.05, respectively).

Retinoic acid treatment did not

significantly change migration rates.

89
MIGRATION VALUES
(INCLUDING THE PROLIFERATION RATE)
CONTROL (CO)

BUTYRATE (BA)

PRE-BUTYRATE (PBA)

5

6

1. 99 x 10-4

4
9.08 x 10-

4
17. 8 x 10-

ST DEV

4
1. 26 x 10-

4
4.95 x 10-

4
1. 27 x 10-

STEM

4
0.56 x 10-

4
0.20 x 10-

4
0.06 x 10-

N
MEAN

5

(EARLY PASSAGE)

% MIG.

456*

893>'<

4

4

4

1. 36 x 10-5

4
2.58 x 10-

4
5.44 x 10-

ST DEV

5
0.51 x 10-

4
0. 96 x 10-

4
1. 28 x 10-

STEM

0.26 x 10-5

0.48 x 10-4

4
0.64 x 10-

N
MEAN
(LATE PASSAGE)

% MIG.

CONTROL (CO)
N

4000>'<

1897*

RETINOIC ACID (RA)

5

5

MEAN

4
1. 99 x 10-

4
2.36 x 10-

ST DEV

1. 26 x 10-4

4
1. 27 x 10-

STEM

0.56 x 10-4

4
0.45 x 10-

% MIG
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* SIGNIFICANTLY DIFFERENT FROM THE CONTROL (P < 0.05)

CHAPTER V

THE EFFECT OF BUTYRIC ACID AND RETINOIC ACID
ON INVASION AND EXPERIMENTAL METASTASIS
OF MURINE MELANOMA CELLS
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ABSTRACT

The effect of butyric acid (BA) and all trans-retinoic acid (RA)
on murine melanoma cells was investigated in vitro and in
vitro assays included
invasion experiments.

3

The in

H-IdUR incorporation, adhesion, migration and
Butyric acid decreased

3

H-IdUR cellular

incorporation within 24 hrs and increased adhesion as measured by
trypsin release of

3

H IdUR labelled cells from either polycarbonate

(p.c.) or Matrigel-coated p.c. membranes.

Migration and invasion rates

after 72 hrs were quantified by scanning electron microscopy (SEM).
The invasion barrier consisted of Matrigel coated p.c. membranes.
Butyric acid significantly enhanced migration and invasion of Bl6a
cells, while

RA significantly decreased migration and invasion Bl6a

and K-1735 cells.

Subcutaneous administration of either BA or RA

pellets significantly decreased the number of lung nodules in the
experimental metastatic assay.

The experimental metastatic assay is

defined as a tail vein inoculation protocol followed by subsequent lung
evaluation.
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INTRODUCTION

The role of differentiating agents in the treatment of neoplasms
and metastases is becoming increasingly important.

Since

differentiating agents may be less host-toxic and less mutagenic than
chemotherapy, they may be used between rounds of chemotherapy to help
prevent regrowth and diversification of remaining tumor cells (Nicolson
and Custead, 1985).

One such agent, 13-cis-RA (topically applied) has

produced partial responses in patients with melanoma (Lippman et al.,
1987).
In

pretreatment of tumor cells with differentiation agents

such as BA (Takenaga, 1986), dimethyl sulfoxide (DMSO) (Takenaga,
1984), and N-methylformamide (NMF) (Tofilon et al., 1986) has increased
in

experimental metastasis.

In addition, in vitro pretreatment

with both RA and dibutyl cyclic AMP together has changed the pattern of
organ metastasis of F9 embryonal carcinoma cells (Terrana et al.,
1986).
Few studies have investigated the in vivo effect of
differentiation agents on metastasis without drug pretreatment.
Experimental evidence indicates that both the route and timing of the
administration of differentiation agents is critical.
N-methylformamide, when given prior to tail vein injection of tumor
cells, increased experimental metastases, while NMF given after tail
vein injection decreased experimental metastases (Tofilon et al.,
1986).

Dietary retinoids given to athymic mice decreased the number of

spontaneous metastases produced by untreated hamster melanoma HMI-FS
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cells (Scheicher et al., 1988).
A positive correlation has been shown between the in vitro
recombinant basement membrane (RBM) invasion assay and
metastasis (Albini et al., 1987; Repesh, 1989).

vivo

The RBM model consists

of a porous Transwell p.c. membrane (Costar Co., Cambridge, MA) that is
coated with a reconstituted basement membrane (Matrigel, Collaborative
Res., Bedford, MA).

Matrigel is derived from the murine

Engelbreth-Holm-Swarm (EHS) sarcoma cell line and consists of laminin,
collagen type IV, heparan sulfate proteoglycan and entactin (Kleinman
et al., 1986).

During invasion, tumor cells locally degrade the

Matrigel and migrate through the porous p.c. membrane.

The cells can

then be quantified on the underside of the p.c. membrane by light
microscopy (Albini et al., 1987; Hendrix et al., 1989), radioactive
labelling (Repesh, 1989) or scanning electron microscopy.
The RBM model has been used to test the effect of various drugs on
the invasion process.

Drugs tested include cytoskeletal agents such as

Colchicine (Welch et al., 1989) and estramustine (Wang and Stearns,
1988).

The two drugs chosen for this study, RA and BA, effect the

cytoskeleton in some tumor cell lines (Ng et al., 1985; Lehtonen et
al., 1983; Altenburg et al., 1976; Ryan and Higgins, 1988).

I have

previously reported the effect of these two agents on the migration of
murine Bl6a cells (McGarvey and Persky, 1989.

The short term effects

of BA on the invasion process in the human amnion basement membrane
(HABM) assay have been reported (Thorgeirsson et al., 1984).
Pretreatment for 24 hrs with BA enhanced the invasion of M5076 sarcoma
cells (Thorgeirsson et al., 1984).

Likewise, pretreatment of murine
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Bl6Fl0 melanoma cells for 24 hrs with RA increased invasion through the
amnion.

However, pretreatment with RA for 48 to 72 hrs decreased

invasion (Wood et al., 1985)).

Retinoic acid has been shown to inhibit

invasion of tumor cells in the RBM assay without effecting cellular
proliferation (Nakajima et al., 1989).
In my study, both in vitro and in vivo protocols were used to
study invasion and metastasis.

For the in vitro migration and invasion

studies, Bl6a and K-1735 melanoma cells were treated with BA or RA for
three to six days.

For the in vivo study, syngeneic female C57BL6 mice

were primed with all trans-RA or BA by subcutaneous implantation of
drug pellets one day prior to tail vein injection of Bl6a cells.
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MATERIALS AND METHODS

Cell Culture:

Murine Bl6a and K-1735 melanoma cells were obtained

from the DCT Tumor Repository, NCI-Frederick Cancer Research Facility
(Frederick, MD).

Murine NIH-3T3 cells were obtained from American Type

Tissue Collection (Rockville, MD).

Cells were cultured in Eagle's

Minimum Medium (MEM) (Gibco, Grand Island, NY) containing Hank's salts
and L-glutamine supplemented with sodium pyruvate (110 mg/ml) (Sigma,
St. Louis, MO), 10% heat inactivated fetal bovine serum (FCS) (Gibco)
or 10% NuSerum (Collaborative Res., Cambridge, MA), 1% penicillin
G-streptomycin- amphotericin B (Fungizone) (Gibco), MEM non-essential
amino acids (Gibco) (10 ml/l), sodium bicarbonate (1.27 g/l) (Sigma),
and Hepes (5.96 g/l) (Sigma) (final pH 7.3).
humidified incubator (37°C, 5%

co 2 )

Cells were cultured in a

and were refed every three days.

Cells were subcultured with trypsin/EDTA (Sigma) during log phase
growth.
Bl6a cells were also obtained from metastatic lung nodules or
subcutaneous tumors according to the following protocol.

The cells,

originally obtained from the repository, were grown to preconfluence in
T-75 flasks, trypsinized, and suspended in PBS without Ca++ and Mg++
Four female C57BL6 mice received an injection of 0.2 ml of PBS-tumor
cell suspension (500,000 cells/ml) either in a subcutaneous site or in
the lateral tail vein.

Mice were killed after 21 days.

Subcutaneous

or lung tumors were removed and minced in MEM containing FCS.

After 24

hours of incubation, unattached cells and debris were removed from the
tissue culture-treated dishes.

The adherent subcutaneous or lung
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nodule-derived cells were passaged twice in
experiments without further passage.
Though a range of cytostatic concentrations of butyric acid (J.T.
Baker, Phillipsburg, NJ) and retinoic acid (Sigma) was observed
(McGarvey and Persky, 1989), a concentration of 1.5 mM BA and 1 X 10
M RA were used in all

-6

3
H-IdUR incorporation, migration and invasion

assays.
Incorporation of

3
H-Iododeoxyuridine:

cells were incubated with 1 uCi/ml

3

Untreated and BA-treated

3
H-Iododeoxyuridine ( H-IdUR)

(Amersham Inc., Arlington Hts., IL) for 24, 48 and 72 hrs.
acid was simultaneously added with the

3

Butyric

H-IdUR to the cells.

Cells

were lifted with trypsin/EDTA, filtered, and the bound radioactivity
was determined as counts per minute (CPM) with a beta scintillation
counter.

The mean (n=4) and standard error of the mean (SE) were

determined for each time point.
Adhesion Assay:
with 1 uCi/ml of

3

Untreated and BA-treated Bl6a cells were labelled

H-IdUR for 24 hrs.

Labelled cells were plated onto

uncoated or Matrigel-coated p.c. membranes and incubated for 72 hrs.
The cell supensions above and below the membrane were collected
individually following incubation with trypsin/EDTA and filtered.

The

membranes were collected, solubilized (Soluene 350, Packard Inc.,
Downers Grove, IL), and liquid scintillation fluor added.

Counts per

minute for each of the three fractions were determined by beta
scintillation counting.
calculated.

The mean (n=8) and SE of each fraction were

Students' t tests compared the means of the

BA-treated cells.

unt~eated

An average of 0.05 counts per minute per cell were
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plated onto the uncoated and Matrigel-coated membranes.
Key:

The key for identification of the migration and invasion

experiments follow an X-Y-Z format whereby X is the drug, Y is the
treatment, and Z is the cell source.

X may be C (control, i.e.

untreated), BA or RA.

Y may be PT (pretreatment), NP (no pretreatment)

or NT (no treatment).

Z may be LN (lung nodule derived), SC
vitro

(subcutaneously-derived), EP (early passage, less than six

passages), LP (late passage, greater than six in vitro passages), or K
(K-1735 cells).
Migration Assay:

The methodology was a modification of the

migration assay of Varani et al. (1978).

Our modifications of this

procedure have been reported in detail (McGarvey and Perksy, 1989).
Three different migration experiments were performed on Bl6a cells
(Figure #2).

Experiment #l compared the migration of untreated lung

nodule-derived (C-NT-LN), untreated subcutaneously-derived (C-NT-SC)
and BA-pretreated lung nodule derived (BA-PT-LN) Bl6a cells.
Experiment #2 compared the migration of untreated (C-NT-LN), RA-treated
(RA-NP-LN), and RA-pretreated (RA-PT-LN) lung nodule-derived cells.
Experiment #3 compared the migration of untreated subcutaneouslyderived (C-NT-SC) and RA-pretreated subcutaneously-derived (RA-PT-SC)
cells.

Each experiment was done at least in triplicate.

experiment, 5 X 10

4

In each

cells in appropriate media (MEM+FCS with or without

BA or RA) were plated in the Transwell insert (inner well).

The

matching outer wells similarly contained MEM + FCS with or without BA
or RA, but no cells.

Drug pretreatment indicated that the cells were

incubated in RA or BA for 72 hrs before the migration assay in T75
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flasks, and for a further 72 hr incubation period during the migration
assay.

Non-pre-treated cells were incubated with BA or RA only during

the time of the migration assay.

At the conclusion of the migration

assay, membranes were processed for SEM.

Cells that migrated to the

bottom of the membrane were quantified by counting cells in 50 random
fields at 500X.
experiment 3.

A Students' t test was performed on the results of
For all other migration experiments, Welch's tw (t')

unequal variance or Bechhofer-Dunnett-Krishnaiah-Armitage equal
variance multiple comparison tests were performed (Wilcox, 1987).
Invasion Assay:

The invasion assay consisted of a Transwell

chamber with an 8 um diameter pore p.c. membrane coated with Matrigel.
Matrigel was diluted 1:20 (71 ug of protein/well) and added to
Transwell inserts kept on ice (Repesh, 1989).

After overnight

dehydration, Matrigel was rehydrated for two hrs with serum free MEM.
The MEM was removed, and cells were added to the top wells of the
Transwell insert (50,000 cells/well).

In some experiments, cells were

preincubated with RA or BA for 72 hr prior to being plated on the
Matrigel.

At the time of plating, RA or BA was added to the top and

bottom wells.

Two sets of controls were done, one containing medium

alone the other containing medium with 0.1% ethanol (the carrier for
RA).

After 72 hrs, membranes were processed for SEM.
Invasive cells were quantified as described in the migration assay

with the noticeable exception that for selected experiments, the entire
bottom surface of the membrane was scored for invasive cells rather
than 50 fields at 500 X.
triplicate.

Each experiment was performed at least in

Six different invasion experiments were done (see Fig. 3).
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Experiment #l compared the invasion rates of untreated early passage (<
6 passages) (C-NT-EP), untreated late passage (>6 passages) (C-NT-LP),
BA-treated late passage (BA-NP-LP), and BA-pretreated late passage
(BA-PT-LP) Bl6a cells.

Experiment #2 compared the invasion rates of

untreated (C-NT-SC), BA-treated (BA-NP-SC) and BA-pretreated (BA-PT-SC)
subcutaneously-derived Bl6a cells.

Experiment #3 compared the invasion

rates of untreated subcutaneously-derived (C-NT-SC) (plated at 50,000
or 25,000 cells/well), untreated lung nodule-derived (C-NT-LN) (plated
at 50,000 cells/well), BA-treated lung nodule-derived (BA-NP-LN) and
BA-pretreated lung nodule derived (BA-PT-LN) Bl6a cells (plated at
50,000 cells/ml).

Experiment #4 compared the invasion rates of

untreated lung nodule-derived (C-NT-LN), RA-treated lung nodule-derived
(RA-NP-LN) and RA-pretreated lung nodule-derived (RA-PT-LN) Bl6a cells.
Experiment #5 compared the invasion rates of untreated (C-NT K) and
RA-pretreated (RA-PT-K) K-1735 cells.

Experiment #6 compared the

invasion rates of untreated (C-NT-LN) and BA-pretreated (BA-PT-LN) lung
nodule derived cells in the presence of NIH-3T3 cell conditioned medium
for 24 and 48 hrs.

The conditioned medium was obtained by incubating

preconfluent NIH-3T3 cells for 24 hrs in serum-free medium containing
1% bovine serum albumin and 0.005% ascorbic acid (Albini et al., 1986).
This conditioned medium was added to the outer well.
cells were refed with fresh media with or without BA.
conditioned medium was also added to the outer well.
test was performed on the results of experiment five.

After 24 hrs,
Fresh
A students' t
For all other

invasion experiments, Welch's tw (t') unequal variance or
Bechhofer-Dunnett-Krishnaiah -Armitage equal variance multiple
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comparison tests were performed.
The In Vivo Assay:

The day before tumor cell injection via

lateral tail vein methodology, each mouse was inplanted subcutaneously
with a pellet containing 5 mg of all trans-RA, BA, or placebo
(Innovative Res., Toledo, OH).

Pellets release the drugs by zero order

kinetics.

A 5 mg pellet over 20 days releases 250 ug/day (10 ug/hr) of

RA or BA.

In addition, a steady state for each drug is reached after

two to four hours (S. Shafie, personal communication).

Lung

nodule-derived and subcutaneous-derived Bl6a cells were suspended in
PBS in a 1:1 ratio.
cell/ml.

The concentration of cells was

a~usted

to 500,000

Cell viability before tail vein injections was always greater

than 90% as determined by the trypan blue exclusion method.

A

0.2 ml

cell suspension was injected into the lateral tail vein of 46 day old
female C57BL6 mice (Harlem Sprague Dawley, Indianapolis, IN).
were divided into 25 controls and 50 experimental.

The mice

Fifteen (5 control,

5 RA-treated, and 5 BA-treated) mice received tail vein injections per
day in order to maximize the proficiency of the injection protocol.
Cell viability was also determined to be greater than 90% in the cell
suspension not injected into the mice.

Thus the subcutaneous pellet

implantation and tail vein injection protocols were spread over five
days.

Mice were killed after 21 days.

Lungs were fixed in Bouin's

fixative and the metastatic nodules were counted with a stereo
dissecting microscope at 6.4 X.

Gross examination of the

thoracic-abdominal viscera and body walls was performed.

Mann-Whitney

U nonparametric test was performed to determine statistical
significance (Wilcox, 1987).
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RESULTS

Butyric acid reduced the incorporation of
within the first 24 hrs of drug incubation.
3

3

H-IdUR in Bl6a cells

The percent inhibition of

H-IdUR incorporation by BA as compared to the control was 79%, 64% and

71% at 24, 48 and 72 hrs, respectively (Fig. 1).

There is a dramatic

increase in cpm from 24 to 48 hrs followed by a leveling off
thereafter.
Adhesion Assay:
of

3

Butyric acid increased significantly the adhesion

H-IdUR labelled Bl6a cells, which were incubated for 72 hr, to both

uncoated and Matrigel-coated p.c. membranes (45%, p<.01; 66%, p<.0001,
respectively).

After fifteen minutes of incubation in a trypsin/EDTA

solution, 43.3% (±6.3%) and 76.8% (±2.9%) of BA-treated cells were
still bound to the uncoated and Matrigel-coated membranes,
respectively, as compared to 23.9% (±3.0%) and 30.2% (±4.6%) for
untreated cells.
Migration Assay:
migration experiments.

Figure 2 illustrates the mean + SE of the three
For each experiment, percent migration of the

untreated (control) cells was adjusted to 100%.

Percent migration is

defined as the number of cells plated on top of the p.c. membrane
divided by the number of cells calculated to be on the bottom membrane
surface multiplied by 100.
In the first experiment, 1.08±0.18 lung nodule-derived untreated
cells were counted per field on the bottom of the p.c. membrane
(percent migration 1.7%).

In contrast, 4.35±0.79 subcutaneously-

derived untreated cells were counted per field (percent migration
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6.7%).

Subcutaneously-derived untreated cells had an increased

migration rate (403%, p<0.05) compared to lung nodule-derived untreated
cells.

The migration rate of lung nodule-derived cells was increased

by pretreatment with BA (667%, p<0.05).

The number of BA-pretreated

cells counted per field was 7.21±0.86 (percent migration was 11.1%).
If the migration rates were formulated to include cellular
proliferation during the 72 hr incubation (Chapter IV, Fig. 1),
BA-pretreatment further enhanced migration (2900% increase, p<0.05).
In the second experiment, 1.13±0.25 lung nodule-derived untreated
cells were counted per field (percent migration 1.7%).

RA-treatment

(0.59±0.14; percent migration 0.9%) or RA-pretreatment (2.24±0.48;
percent migration 3.4%) did not significantly effect the migration rate
of lung-nodule derived cells.

The percent migration values of

untreated lung nodule-derived cells were similiar for experiments 1 and
2.

If the migration rates were formulated to include cellular

proliferation during the 72 hr incubation (Chapter IV, Fig. 2),
RA-treatment and RA-pretreatment enhanced migration (246% increase,
p<0.05; 934% increase, p<0.05, respectively).
In contrast to the migration data of lung nodule-derived cells of
Exp. 2, RA-pretreatment of subcutaneously-derived cells did decrease
migration (62% decrease, p<0.001) (Exp. 3).

For the

subcutaneously-derived cells, 4.48+0.38 untreated cells (percent
migration 6.7%) and

1.67~0.22

2.6%) were counted per field.

RA-pretreated cells (percent migration
If the migration rates were formulated

to include cellular proliferation during the 72 hr incubation·(Chapter
IV,

. 2), then RA-pretreatment did not significantly enhance
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migration.

The rationale for using or not using a proliferation factor

to determine migration rates is found in the Discussion.

It is

noteworthy that the percent migration values of subcutaneously-derived
untreated cells for Exps. 1 and 3 were similiar.
Invasion Assay:

For each of the six invasion experiments, the

percent invasion of untreated cells was adjusted to 100% (Fig. 3).

The

untreated cells were derived from three different sources, i.e. from
stock received from the tumor depository (Exps. 1 and 5), from
subcutaneous passage (Exp. 2), and from tail vein passage (Exps.
3,4,6).

The invasion rates were dependant on the derivation of the

cells.
Invasion experiments 1-3 demonstrate that (1) BA increases
invasion and (2) lung nodule derived cells are more invasive than
subcutaneously derived cells.
In the first invasion experiment, there was no significant
difference amoung the invasion of untreated late passage (0.13±0.12
cells, percent invasion 0.20%), untreated early passage (0.22±0.02
cells per field, percent invasion 0.34%), and BA-treated late passage
(0.29±0.05 cells, percent invasion 0.45%) Bl6a cells.

There was,

however, a significant increase in the invasion rate (490%) of
BA-pretreated late passage cells as compared to both early and late
passage untreated cells (p<0.05, p<0.05, respectively).

An average of

0.64±0.10 BA-pretreated late passage cells were counted per field
(percent invasion 0.98%).
include
Fig. 1),

cellu~ar

If the invasion rates were formulated to

proliferation during the 72 hr incubation (Chapter IV,

BA-treatment and BA-pretreatment further enhanced invasion
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(940% increase, p<0.05; 2100% increase, p<0.05).
In the second experiment, the invasion rate of BA-treated and
BA-pretreated subcutaneously-derived cells was significantly increased
(p<0.05 and p<0.05, respectively) as compared to untreated
subcutaneously-derived cells.

Since there were few untreated

subcutaneous-derived cells on the bottom of the membrane, cells on the
entire bottom surface of the membrane were counted.

An average of 30.7

untreated cells were counted per membrane; percent invasion 0.12%.

On

the other hand, an average of 1.81±0.37 BA-treated and 10.15+0.60
BA-pretreated cells were counted per field.

Percent invasion for

BA-treated and BA-pretreated cells was 2.8% and 15.4%, respectively.
If the invasion rates were formulated to include cellular proliferation
during the 72 hr incubation (Chapter IV, Fig. 1),

BA-treatment and

BA-pretreatment further enhanced invasion (17600% increase, p<0.05;
110000% increase, p<0.05).
In the third invasion experiment, there was no significant
difference in the invasion rate of subcutaneously-derived untreated
cells plated at either 25,000 cells or 50,000 cells/well.

An average

of only 4.7 and 5.7 cells were counted on each of the triplicate
membranes.

Percent invasion for 25,000 and 50,000 cells was 0.02% and

0.04%, respectively.
cells/well.

All experiments except this one plated 50,000

There was, however, a significant increase in the invasion

of lung nodule-derived untreated cells (p<0.05, 0.73±0.10 cells per
field, percent invasion 1.1%).

Butyric acid treatment or pretreatment

increased the invasion rate of lung nodule-derived cells (238%, p<0.05
and 673%, p<0.05, respectively).

An average of 1.74+0.36 BA-treated
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cells (percent invasion 2.67%) and an average of 4.91+0.02
BA-pretreated cells (percent invasion 7.5%) were counted per field.

If

the invasion rates were formulated to include cellular proliferation
during the 72 hr incubation (Chapter IV, Fig. 1), BA-treatment and
BA-pretreatment further enhanced invasion (1051% increase, p<0.05;
2936% increase, p<0.05, respectively).
Experiments four and five illustrate the effect of RA on two cell
lines that have different invasive potential.

The percent invasion of

untreated Bl6a cells (Fig. 3, Exp. 4) and of untreated K-1735 cells
(Fig. 3, Exp. 5) was 0.13% and 23.6%, respectively.

For Exp. 4, there

was an average of 33.6 untreated, 15.2 RA-treated, 43.8 RA-pretreated
cells counted per membrane.
0.18%, respectively.

The percent invasion was 0.13%, 0.06%, and

Thus, invasion was inhibited 54% by RA-treatment

(p<0.05), but not by RA-pretreatment.

If the invasion rates were

formulated to include cellular proliferation during the 72 hr
incubation (Chapter IV, Fig. 2), RA-treatment and RA-pretreatment
enhanced invasion (295% increase, p<0.05; 853% increase, p<0.05).

For

Exp. 5, an average of 1.33±0.38 untreated and 0.38+0.07 RA-pretreated
K-1735 cells were counted per field at 1700X (instead of the usual
500X).

This higher magnification was selected to properly deliniate

cell boundaries due to the

number of invasive cells.

The percent

invasion per 50,000 cells plated was 23.6% and 6.7%, respectively.
There was a 72% decrease in invasion of RA-pretreated cells (p<0.001).
If the invasion rates were formulated to include cellular proliferation
during the 72 hr incubation (Chapter IV, Fig. 2), RA-pretreatment
enhanced invasion (132% increase, p<0.05).
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The sixth experiment determined the affect of conditioned medium
on lung nodule-derived Bl6a cell invasion.

Conditioned medium was

placed in the bottom well and the invasion assay was reduced from the
standaand 2.02±0.29 BA-pretreated cells were counted per field.
Percent invasion was 0.60% and 3.10%, respectively.

For 48 hrs,

1.70±0.09 untreated and 6.15±0.29 BA-pretreated cells were counted per
field.

Percent invasion was 2.6% and 9.4%, repectively.

experiment #6 has two key points.
invasion.

Thus,

First, conditioned medium enhanced

The percent invasion of untreated lung nodule derived cells

after 48 hrs in the conditioned medium (Fig. 3, Exp. 6) was 233%
greater than for lung nodule-derived cells after 72 hrs without
conditioned medium (Fig. 3, Exp. 3).

Second, BA-pretreatment

significantly increased invasion in 24 hrs by 518% and in 48 hrs by
362% as compared to untreated cells of the same incubation period.
In Vivo Assay:

Both RA or BA, which were administered by

subcutaneous pellet, reduced experimental metastasis (p<0.05 and
p<0.05, respectively) according to the Mann-Whitney U test (Fig. 4).
Butyric acid decreased the number of lung nodules as compared to the
placebo pellet by 91.4% (mean decrease) or 99% (median decrease).
Retinoic acid decreased the number of lung nodules as compared to the
placebo pellet by 80% (mean decrease) or 84% (median decrease).
Furthermore, two mice were completely tumor-free in the RA-treated
group and nine mice were tumor-free in the BA-treated group.

Gross

examination of the thoracic-abdominal viscera and body walls revealed
that all metastatic foci were confined to the lungs.

Figure 6

illustrates lungs from untreated, RA, and BA-treated animals.

107

DISCUSSION

The experimental metastatic assay contains different steps
associated with the formation of lung tumors (Fidler, 1970).

These

include blood borne transport, extravasation and tumor growth.
more steps of the assay can be effected by BA and RA.

I used

One or
3

H-IdUR

incorporation, adhesion, migration and reconstituted basement membrane
(RBM) assays as reductionist tools to understand the metastatic
process.
I have shown that 1 X 10

-6

M RA and 1.5 mM BA produce cytostasis

without cytotoxicity in the Bl6a cell line (McGarvey and Persky, 1989).
I have also emphasized the importance of using the cytostatic
concentration of potential anti-invasive drugs in in vitro studies
(McGarvey and Persky, 1989).

Retinoids, which include all

trans-retinoic acid, induce tumor cell differentiation, inhibit tumor
cell growth (Gl phase of the cell cycle), suppress tumor cell
phenotypic properties, and stimulate the host immune response (for a
review see Roberts and Sporn, 1984).

Butyric acid similiarly induces

differentiation and inhibits proliferation (Gl phase of the cell cycle)
of tumor and nontumor cells (Kruh, 1982).
In my study, BA decreased
24 hours of incubation.

3

H-IdUR incorporation within the first

Despite this reduction in proliferation, the

invasion rate increased with longer exposure to BA (Fig. 3, Exps. 1-3).
Drug concentrations necessary to inhibit in vitro invasion may be
similiar or lower than that needed to inhibit proliferation in vitro.
For example, RA reduced invasion of rat mammary adenocarcinoma 13762NF
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cells in vitro without inhibiting proliferation (Nakajima et al.,
1989).
A shortened time period for the invasion assay would be
advantageous to distinguish drug induced inhibition of proliferation
from drug induced inhibition of invasion.
conditioned medium to increase invasion.

Therefore, I used
There was an increase in

invasion of untreated and BA-pretreated lung nodule-derived cells in 48
hrs using conditioned medium (Fig. 3, Exp. #6) as compared to 72 hrs
without conditioned medium (Fig. 3, Exp. #3).

A further enhancement of

the migration and invasion rate by BA was observed if the 72 hr
proliferation data (Fig. l, Chapter IV) were included in determining
these rates (Table 1 and 2).
Retinoic acid decreased the migration and invasion rates of Bl6a
and Kl735 cells.
al. (1989).

These findings support the experiments of Nakajima et

However, if a proliferation factor was used to calculate

migration and invasion rates, then RA enhanced both migration and
invasion.

The usefulness of a proliferation factor in calculating

migration and invasion rates can be questioned in light of my results
obtained from calf serum treated cells.

For example, the migration of

RA-treated Bl6a cells was significantly decreased compared to untreated
and calf serum treated Bl6a cells.

Both RA and calf serum

significantly decreased proliferation as compared to untreated cells
(McGarvey and Persky, 1989).

The concern of using a factor to

"correct" for cellular proliferation in the migration experiments is
also applicable to the invasion experiments.

Therefore, whether RA

decreases or increases migration or invasion of murine melanoma cells
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would be answered by shortening the duration of the assay so that
proliferation would not be a factor.
In this in vivo study, it is possible that once the tumor cells
invaded the lung paranchyma the growth of the lung colonies was
inhibited by the continuous exposure to BA or RA.

This would enhance

the ability of host defenses to eradicate or reduce the tumors.
Retinoids administered by i.p. injection or orally have been shown to
reduce the size of xenotransplanted subcutaneous human mammary
carcinoma (MDA-MB-231) (Halter et al., 1988)), murine embryonal
carcinoma (McCue et al., 1988) and murine Bl6Fl0 melanoma (Drewa and
Schachtschabel, 1985).

However, the precise role of growth inhibition

in experimental metastasis is unknown.

Only recently has inhibition of

primary tumor growth been separated from the reduction of spontaneous
metastasis by retinoids in a hamster melanoma-athymic mouse model
(Scheicher et al., 1988).
Tumor cell adhesion

vitro is important in theories of cellular

invasion (Liotta et al., 1983).

I have shown that BA pretreatment

increases heterotypic adhesion between Bl6a cells and p.c. membranes as
well as Matrigel coated p.c. membranes.

This increase in adhesion

correlates with increased in vitro invasion of BA-treated Bl6a cells.
In contrast to the increased cellular adhesion to Matrigel induced by
BA, a decrease in the number of laminin receptors has been reported in
the BA-treated human pancreatic carcinoma cell line (PANC-1) (Bryant et
al., 1986).

Matrigel contains collagen type IV, heparin sulfate

proteoglycans and entactin as well as laminin.

Therefore, it is

possible that a decrease in binding to one element of a basement

llO
membrane does not imply a decrease in binding to all components.
Tumor cell adhesion in vivo is central to the 'seed and soil'
hypothesis of Paget (1889).

Decreased adhesion has been correlated

with both increased and decreased experimental metastasis (Takanaga,
1984; Takanaga, 1986; Raz and Ben-Ze'ev, 1983; Werling et al., 1986).
Butyric acid has been shown to increase homotypic and heterotypic
adhesion of Lewis lung carcinoma (P-29) cells and pretreated cells have
been shown to have increased experimental metastasis (Takanaga, 1986).
In contrast to the increase in heterotypic adhesion induced by BA,
RA has been shown to decrease the adhesion of a Bl6Fl variant to
elements of the basement membrane (laminin, entactin and collagen type
IV) and collagenous stroma (collagen type I) (Edward et al., 1989).
This decrease in adhesion may be one of the factors that decreased
vitro invasion and experimental metastasis in my study.

The same

reasoning may apply to the results observed in in vitro invasion assays
(Fazely et al., 1988; Fazely et al., 1985; Nakajima et al., 1989) and
experimental metastasis assays (Edward et al., 1989; Couch et al.,
1987).
The role of proteolytic enzymes in the degradation of the
extracellular matrix by tumor cells in invasion has been correlated
with the in vivo metastatic potential of many tumor cell lines
including the Bl6 melanoma cell line (Wang et al., 1980; Sloane et al.,
1982; Liotta et al., 1980).

Both BA and RA have been shown to modulate

the activity and production of degradative enzymes.

Increased invasion

of M5076 sarcoma cells in the HABM assay by butyric acid has been
correlated with increased type IV collagenase activity (Thorgeirsson et
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al., 1984).

The increase in collagenase type IV activity supports my

observation that BA-treatment enhances invasion.

On the other hand, RA

has been shown to decrease the degradation of the collageneous capsule
surrounding subcutaneous murine tumors (Takahashi et al., 1985), and to
decrease both type IV collagenase and the invasion of 13762NF cells in
the RBM assay (Nakajima et al., 1989).

The reported decrease in type

IV collagenase by RA-treatment likewise supports my finding that RA
treatment decreased the invasion of Bl6a and K-1735 cells in the
Matrigel assay.
There appears to be a correlation between increased migration and
increased invasion.

The K-1735 cells used in this study are highly

invasive and highly migratory (Silberman et al., 1990).

There are,

however, exceptions to the theory that highly migratory cells are
highly invasive.

For example, subcutaneously derived cells were

significantly more migratory than lung nodule derived cells.

This may

be due to the heterogeneous nature of the subcutaneously-derived cells.
On the other hand, lung nodule-derived cells invaded the Matrigel in
significantly greater numbers than subcutaneously-derived cells.

This

is expected since the lung nodule-derived cells represent a special
subpopulation that are invasive in vivo.
migratory cells has already been reported.

Selection for invasive or
For example, repeated

passage of invasive cells in the RBM assay produced more invasive cells
(Wang and Stearns, 1988; Hendrix et al., 1989).

Likewise, cells

obtained from repeated serial passages through the human amnion have
produced more experimental metastases (Persky and Chmielewski, 1987)
and spontaneous metastases (Tullberg et al., 1989).

In contrast,
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hypermotile

c~lls

from repeated passage through microporous membranes

decreased the number of experimental and spontaneous metastases
(Grimstad, 1988).

It is possible that selection of either the

migratory or the invasive phenotype may select a subpopulation that is
not as competent at completing another step of the metastatic cascade.
The cells used in the in vitro assays were derived from multiple.
sources (the tumor depository, subcutaneous tumors and lung nodules)
and had different migration and invasion rates.

Therefore, each

migration and invasion experiment must be independently evaluated.

The

use of cells from different sources, different passage numbers or
different cell lines should not cloud the main in vitro concept that BA
increases migration and invasion and that RA decreases migration and
invasion.

An important observation in the migration and invasion

assays is that retinoic acid has a greater effect on highly invasive
(K-1735 cells) or highly migratory cells (subcutaneously derived Bl6a
cells) whereas butyric acid has a greater effect on the migration and
invasion of low invasive cells (McGarvey and Persky, 1989).

However,

if the decrease in proliferation induced by RA and BA is included in
the invasion rates, RA and BA enhanced invasion.

In addition,

increasing the in vitro invasion rate by either using lung
nodule-derived cells or conditioned medium did not obliterate the
overall effect of BA on increasing

vitro invasion.

I believe that drug administration by pellet prior to tumor cell
injection primed the animal.

Administration by subcutaneous pellet

allowed for constant drug exposure during the entire experiment, unlike
i.p., i.v. or dietary intake.

Blood serum levels of mice that received
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a 5 mg pellet of RA have been shown to contain 5 X 10et al., 1987).
study.

8

M RA (Mariotti

Tissue concentrations of RA were not reported in this

However, administration of all trans-RA by intravenous

injection found that tissue concentrations were higher than blood serum
levels (Wang et al., 1980).

Pellets containing higher concentrations

resulted in toxicity to the mice (Mariotti et al., 1987).
determined the murine serum levels of BA in this study.

I have not
However, the

animals in these experiments did not show signs of BA toxicity.

The BA

concentration was based on information provided by Dr. S. Shafie from
Innovative Research Inc. (personal communication).

To my knowledge, no

information is available on blood serum or tissue concentrations of BA
by pellet administration.
Although BA and RA have a myriad of effects on the multiple steps
of the metastatic cascade, both drugs significantly reduced in vivo
experimental metastasis in our study.

Further combined

vitro and in

investigations with these drugs and other differentiation agents
are warranted.
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Figure 1:

Counts per minute (CPM) of

3

H-IdUR labelled cells

plotted at 24, 48, and 72 hrs. as the mean (n=4) + standard error
of the mean.
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Figure 2:

The percent migration of Bl6a cells.

experiments were done.
results section.
error of the mean.

Three separate

For details see "Migration Assay" in the

Each bar is the percent migration

~

standard

An asterisk (*) represents a value that is

significantly different from the controls.
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Figure 3:

The percent invasion of Bl6a cells.

experiments were performed.
the results section.

Four different

For details see "Invasion Assay" in

Each bar is the percent invasion

standard error of the mean.

±

An asterisk (*) represents a value

that is significantly different from the controls.

In experiment

#3, the percent invasion of lung nodule-treated cells was
significantly different from the percent invasion of the
subcutaneously-derived cells plated at either 25,000 or 50,000
cells/well.
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Figure 4:

The percent invasion of Bl6a and K-1735 cells.

differrent experiments were performed.
Assay" in the results section.

+ standard error of the mean.

Two

For details see "Invasion

Each bar is the percent invasion
An asterisk (*) represents a value

that is significantly different from the controls.

The double

asterisk (**) in experiment #6 represents a value that is
significantly different from the controls at 24 hrs.
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Figure 5:

The in vivo experimental data.

Subcutaneous pellets

containing either a placebo, BA, or RA were implanted into C57BL6
mice one day prior to injection via tail vein with Bl6a cells.
Mice were killed 21 days after tumor cell injection.

An average

of 102.7±49.4 (mean± S.D.), 8.8±14.4, and 20.3±15.8 lung nodules
were counted per the placebo, BA, and RA-treated groups,
respectively.
group.

The median scores were also determined for each
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Figure 6. A photograph of lungs from control (placebo)
treated animals.

The lungs in Figs. 6, 7 and 8 were printed

at different magnifications.
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Figure 7.

A photograph of lungs from BA-treated animals.
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Figure 8.

A photograph of lungs from RA-treated animals.
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TABLE 1.

The migration rate of untreated, BA-treated, BA-pretreated, RA-treated
and RA-pretreated cells after 72 hr incubation with a proliferation
factor incorporated into the migration rate.

The migration value was

defined as the number of the cells per field times 50 divided by the
final hemacytometer cell population (Fig. 1 and Fig. 2, Chapter IV).
There was a significant increase in migration of BA-treated and
BA-pretreated cells as compared to untreated Bl6a cells (p<0.05,
p<0.05, respectively).

There was a significant increase in migration

of lung nodule-derived RA-treated and RA-pretreated cells as compared
to untreated Bl6a cells (p<0.05, p<0.05, respectively).
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MIGRATION VALUES
(INCLUDING THE PROLIFERATION RATE)

MIGRATION EXPERIMENT 1
LUNG NODULE CELLS
4

N

PRE-BUTYRATE

SUBCUTANEOUS CELLS

3

4

MEAN

6.93 x 10-5

5
28.0 x 10-

5
203 x 10-

SD

5
1. 62 x 10-

5
7.30 x 10-

5
42 x 10-

SEM

5
3.60 x 10-

5
3.60 x 10-

5
24 x 10-

404 *

% MIG

2929 *

MIGRATION EXPERIMENT 2
LUNG NODULE CELLS
N

RETINOIC ACID

3

PRE-RETINOIC ACID
6

3

MEAN

4
0. 72 x 10-

4
1. 77 x 10-

4
6.73 x 10-

SD

4
0.28 x 10-

0. 72

x

10- 4

4
3.53 x 10-

SEM

4
0.16 x 10-

0.41

x

10-4

1.44

246 *

% MIG

N

PRE-RETINOIC ACID
6

3

MEAN

4
2.86 x 10"

SD

0.44

10" 4

4
1.67 x 10-

SEM

4
0.25 x 10-

4
0.68 x 10-

% MIG

*

x

5.01 x 10

10- 4

934 *

MIGRATION EXPERIMENT 3
SUBCUTANEOUS CELLS

x

4

175
- indicates a significant difference at p < 0.05.
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TABLE 2.

The invasion rate of untreated, BA-treated and BA-pretreated cells
after 72 hr incubation with a proliferation factor incorporated into
the invasion rate.

The invasion value was defined as the number of the

cells per field times 50 divided by the final hemacytometer cell
population (Fig. 1, Chapter IV).

There was a significant increase in

invasion of BA-treated and BA-pretreated cells as compared to untreated
Bl6a cells (p<0.05, p<0.05, respectively).
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INVASION VALUES
(INCLUDING THE PROLIFERATION RATE)

5

N

5

6

MEAN

0.86

x

10- 5

8.07

x

10- 5

17.9

x

10- 5

SD

0.49

x

10- 5

3.56

x

10- 5

6.30

x

10- 5

SEM

0.22

x

10- 5

1.45

x

10- 5

2.80

x

10- 5

2081 *

938 *

% INV

INVASION EXPERIMENT 2
SUBCUTANEOUS CELLS

BUTYRATE

PRE-BUTYRATE

4

4

4

N
MEAN

3.98

x

10- 5

700

x

10- 5

4350

x

10- 5

SD

1.09

x

10- 5

330

x

10- 5

320

x

10- 5

SEM

0.54

x

10

165

x

10

160

x

10- 5

5

5

17588 *

%INV

109296 *

INVASION EXPERIMENT 3
LUNG NODULE CELLS

BUTYRATE

4

N

PRE-BUTYRATE

4

4

MEAN

4. 70

10- 5

49.4

x

10- 5

138

SD

5
1.26 x 10-

14.5

x

10- 5

21.1

x

10- 5

SEM

0.63

10- 5

7.20

x

10- 5

10.5

x

10- 5

x
x

1051 *

%INV

*

- indicates a significant difference at p < 0.05.

x 10- 5

2936 *
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TABLE 3.

The invasion rate of untreated, RA-treated and RA-pretreated cells
after 72 hr incubation with a proliferation factor incorporated into
the invasion rate.

The invasion value was defined as the number of the

cells per field times 50 divided by the final hemacytometer cell
population (Fig. 2, Chapter IV).

There was a significant increase in

invasion of lung nodule-derived RA-treated and RA-pretreated cells as
compared to untreated Bl6a cells (p<0.05, p<0.05, respectively).

There

was a significant increase in invasion of RA-pretreated Kl735 cells as
compared to untreated Kl735 cells (p<0.05).
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INVASION VALUES
(INCLUDING THE PROLIFERATION RATE)

INVASION EXPERIMENT 4
LUNG NODULE CELLS

RETINOIC ACID

5

6

N

x

10- 5

PRE-RETINOIC ACID
4

9.0 x 10- 5

x

26.1

10- 5

MEAN

3.1

SD

0.81

x

10- 5

2.4 x 10- 5

8.0 x 10- 5

SEM

0.08

x

10- 5

1.0 x 10- 5

4.0 x 10- 5

295 *

853

%INV

··k

INVASION EXPERIMENT 5
UNTREATED - K1735 CELLS

PRA - Kl735 CELLS
4

4

N

MEAN

34 x 10- 4

SD

1.6

SEM

0.3 x 10- 4

x

10- 4

%

INV

*

- indicates a significant difference at p < 0.05.

4
45 x 10-

3.0

x

10- 4

4
1.0 x 10132

...k

CHAPTER VI

QUANTIFICATION OF F-ACTIN IN
MIGRATORY AND INVASIVE
MURINE Bl6a MELANOMA CELLS
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ABSTRACT

Butyric acid (BA) and retinoic acid (RA) affect the cytoskeleton
(McGarvey and Persky, 1989).

In this study, F-actin of migratory,

nonmigratory, invasive and noninvasive murine Bl6a melanoma cells was
digitized and quantified by image analysis.

Cells were untreated or

pretreated for three days with BA or RA before being plated onto
uncoated (the migration assay) or Matrigel-coated (the invasion assay)
polycarbonate membranes.

Butyric acid or RA was added to the

pretreated cells at the time of plating onto the membranes.

After 72

hrs of incubation, cells were fixed, permeablized and stained with
Bodipy phallacidin for F-actin, and examined by fluorescent microscopy.
The F-actin was divided into two categories, nonfilamentous and
filamentous actin.

Untreated migratory cells had less filamentous

F-actin than BA-pretreated migratory cells (78% decrease, p<0.05) and
RA-pretreated migratory cells (65% decrease, p<0.05).

BA-pretreated

invasive cells had less nonfilamentous F-actin than RA-pretreated
invasive cells (9% decrease, p<0.05).

Migratory untreated cells had

less filamentous actin than invasive untreated cells (26.1% decrease,
p<0.05).

Invasive and migratory cells were capable of bundling actin.

Few actin cables were found in noninvasive untreated cells, while actin
cables were numerous in nonmigratory untreated cells.

In addition,

large bundles of actin were predominate in nonmigratory and noninvasive
cells, regardless of whether the cells were drug treated or not.
F-actin phenotype is dependent on drug treatment, substrate
interactions, migration and invasion.

The
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INTRODUCTION

The cytoskeleton has many different properties essential for
normal functioning including maintenance of cell shape, cellular
adhesion and cellular migration.

The cytoskeleton has been divided

into three different classes based on the size and composition of the
proteinaceous filaments present in the cytoplasm.

They are

microfilaments, intermediate filaments and microtubules.
Microfilaments are essential for cell motility and have been shown
by fluorescent and transmission electron microscopic (TEM) techniques
to be present in the leading edge of motile cells (Lewis et al., 1982;
Jockusch et al., 1983).

They are composed of F-actin, myosin, filamin,

tropomyosin, and alpha-actinin.

The organization of F-actin has been

inversely correlated with motility (Lewis et al., 1982; Herman et al.,
1981).

Diffuse actin fluorescence in HeLa cells has been observed in

the areas of motile cytoplasm such as leading lamellae and ruffling
membrane (Herman et al., 1981).

Large bundles of microfilaments,

called stress fibers, are lacking in rapidly moving embryonic chick
cells, human skin fibroblasts (Lewis et al., 1982), and murine K-1735
melanoma cells (Raz and Geiger, 1982).

In addition, motility is

inhibited by microfilament disrupting agents such as cytochalasin B
(Keller and Zimmermann, 1986).
Microtubules affect cellular migration.

Microtubule

depolymerizing agents colchicine and vinblastine stimulate random
motility (Keller and Zimmermann, 1986) while inhibiting deformability
and chemotaxis (Spiro and Mundy, 1980).

Immunolabeling has shown that
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microtubules stabilize contacts for stress fiber assembly (Rinnerthaler
et al., 1988).
Changes in tumor cell morphology, migration rate and invasion rate
have been observed in response to BA and RA (McGarvey and Persky,
1989a; McGarvey et al., 1990).

An increase or appearance of stress

fibers occured in RA-treated F9 teratocarcinoma (Lehtonen et al.,
1983), RA-treated rat osteoblastic sarcoma cells (Ng et al., 1985),
BA-treated virus transformed (KNRK) fibroblasts (Altenburg et al.,
1976), and BA-treated rat hepatoma cells (Borenfruend et al., 1980).
In order for metastasis to occur, tumor cells must invade tissue
boundaries and basement membranes at multiple points.

Invasion is a

three step process that includes: (1) cellular adhesion to a substrate,
(2) proteolytic digestion of the substrate, and (3) migration of the
cell into the space created by proteolytic digestion (Liotta et al.,
1983).

Few reports have investigated the role of actin microfilaments

in tumor cell migration or invasion.

Psuedopodal extension has been

observed in migratory and invasive cells (Kramer et al., 1986; McGarvey
and Persky, 1989b).

Actin filaments of low metastatic human melanoma

variants (A375P) become disorganized after invasion through the human
amnion basement membrane (Hendrix and Seftor, 1986); however, the cells
that had successfully invaded the amnion were enzymatically detached
and then plated onto glass slides.

Thus, actin analysis was performed

on cells that had invaded and attached to a different substrate than
originally used.
In our study, the actin cytoskeleton of untreated, BA-treated and
RA treated Bl6a cells was visualized by fluorescence and quantified by
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computer image process

and analysis.

Cells on the top and bottom of

uncoated and Matrigel-coated polycarbonate (p.c.) membranes were
visualized directly by fluorescent microscopy and transmission electron
microscopy (TEM).
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MATERIALS AND METHODS

Cell Culture:

Murine Bl6a (amelanotic) melanoma cells were

obtained from the DCT Tumor Repository (NCI Frederick Cancer Research
Facility, Frederick, Maryland).

Cells were cultured in Eagle's Minimum

Essential Medium (MEM) (Gibco, Grand Island, NY) containing Hank's
salts and L-glutamine supplemented with sodium pyruvate (110 mg/l)
(Sigma, St. Louis, MO), 10% Nu-Serum (Collaborative Research, Bedford,
MA), 1% penicillin G-streptomycin sulfate amphotericin B (Fungizone)
(Gibco), MEM non-essential amino acids (10 ml/l) (Gibco), sodium
bicarbonate (1.27 g/l) (Sigma), and Hepes (5.96 g/l) (Sigma) (final pH
of the medium was 7.3).
(37°C in 5%

co 2 )

Cells were cultured in a humidified incubator

and were refed every three days.

Cells were removed

from flasks with trypsin/EDTA (Sigma) during log phase growth.

Cells

were injected into 46 day old female C57BL6 mice (Jackson Laboratories,
Bar Harbor, ME) either subcutaneously or by lateral tail vein.
Subcutaneously-derived Bl6a cells were used in the migration assay.
Lung nodule-derived Bl6a cells were used in the invasion assay.

The

derivation of these cells is detailed elsewhere (McGarvey et al.,
1990).

The cytostatic concentrations of butyric acid (J.T. Baker,

Phillipsburg, NJ) and all trans-retinoic acid (Sigma) were chosen from
a range of concentrations that were previously shown to be cytostatic
(McGarvey and Persky, 1989).

The cytostatic concentrations of BA and

RA used in all migration and invasion assays were 1.5 mM and 1 X 10-

6

M, respectively.
Migration

Assays were performed as described
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in two previous studies (McGarvey and Persky, 1989; McGarvey et al.,
1990).

Briefly, Bl6a cells were untreated or pretreated with BA or RA

for three days.
10

4

or 1 X 10

3

In both the migration and invasion experiments, 5 X
cells in appropriate media (MEM + NuSerum with or

without BA or RA) were plated in each Transwell insert (inner well)
(Costar Inc., Cambridge, MA).

The matching outer wells contained MEM +

NuSerum with or without BA or RA, but without cells.

The 1 X 10

3

cell

concentration was chosen in order to be able to quantitate the actin of
individual nonmigratory and noninvasive cells.

Polycarbonate (p.c.)

membranes in the migration experiment contained 5 um diameter pores
(7.9% of the membrane is represented by pores) and were uncoated.

The

p.c. membranes in the invasion experiment contained 8 um diameter pores
(5.0% of the membrane is represented by pores) and were coated with
Matrigel (Collaborative Research, Bedford, MA).

The Matrigel was

diluted 1:20 in media prior to application to the Transwell inserts in
the cold (71 ug protein per 6.5 mm diameter membrane).

The duration of

the migration and invasion assays was 72 hrs.
Fluorescent Staining:

Bodipy phallacidin (Molecular Probes Inc.,

Eugene, OR) staining of F-actin was performed as described by Barak et
al. (1980).

In brief, cells on uncoated p.c or Matrigel coated p.c.

membranes were rinsed 2x with PBS, fixed with 2% paraforaldehyde in
PBS, rinsed with PBS, permeablized with 0.5% Triton X, rinsed in PBS,
stained with Bodipy phallacidin, and rinsed again with PBS.

Matrigel

and cells on top of the p.c. membrane were removed with a cotton swab
from some of the p.c. membranes in order to remove background staining
(cells on top of the membrane); this removal procedure was performed in
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order to permit accurate analysis of the fluorescence of the migratory
or invasive cells that were located on the bottom of the p.c. membrane.
Photography and Image Analysis:

Cells were photographed with a

Leitz Orthoplan microscope utilizing an epifluorescent light source and
a number I2 filter block.
Tri-X film at 400 ASA.

The fluorescent image was recorded on Kodak

Exposure time for each negative was determined

automatically by the camera system within the films minimum and maximum
density.

Minimum density is defined as that point where exposure time

and light intensity make a first recording on the film.

Maximum

density is defined as that point where increasing either time or
intensity fails to further enhance the density of the image on the
film.

Increasing exposure time or light intensity past the maximum

density point causes the entire negative to turn progressively black
(Practical Densitometry, Kodak Publication No. E-59, 1985).

Because

the intensity of the fluorescence varies with exposure time for the
Tri-X film and because film development varies from film strip to film
strip, it was necessary to standardize each negative for quantitative
image analysis.

The morphological depiction (i.e. micrograph) of

F-actin was achieved by the optimal exposure for each negative.

Thus,

because each fluorescent micrograph represents the ideal photograph, it
is not possible to compare the actin from one photomicrograph to the
next.

In short, the fluorescent micrographs are qualitative and

nonstandardized (uncorrected) while the image analysis data are
quantitative and standardized (corrected).
For the image analysis, each 35 mm negative was subsequently
digitized using a Javelin MOS solid state high resolution television
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camera interfaced through a Colorado Video Inc. digitizer that was
connected to a Princeton Gamma-Tech image analyzer.

A total of 90

migratory (30 control, 30 BA-pretreated, and 30 RA-pretreated) and 90
invasive (30 control, 30 BA-pretreated, and 30 RA-pretreated) cells
were individually digitized (400 x 512 pixels).

A total of 90

nonmigratory (30 control, 30 BA-pretreated, and 30 RA-pretreated) and
90 noninvasive (30 control, 30 BA-pretreated, and 30 RA-pretreated)
cells were individually digitized (400 X 512 pixels).

For each

digitized image, the 256 grey levels were arbitrarily divided into 7
grey levels: 0-87, 88-112, 113-132, 133 157, 158-174, 175-184 and
185-256.

Each grey levels was assigned a color.

The extracellular

background for each negative was standardized by using the intensity
control on the Colorado video digitizer until the extracellular
background was always within the 175-184 grey level range.

Several

attempts were usually required to standardize the background.

This

standardization procedure is an "internal standard protocol" and is a
recommended procedure for the PGT image analysis work (personal
communication; Princeton Gammma-Tech; Peter Quigley, Product Manager;
George Helmstetter, Senior Service Specialist (609-924-7310)).

After

this standardization procedure for each negative, no data was observed
in the 185-256 grey levels.
final digitized image.

Thus only 6 grey levels remained in the

The percent area for each of these 6 grey level

was determined for each negative.

This initial percent area included

both cellular and extracellular data.

The grey level group that was

extracellular was removed (grey levels 175-184) and new percent areas
were calculated based only on cellular grey levels.

Five grey level
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groups thus represented the cell.

Fluorescent intensity was

arbitrarily divided into five final grey levels defined as: (1)
greatest intensity of stained actin aggregates or actin cables
(designated actin 3, grey level 0-87); (2) intermediate intensity of
stained actin aggregates or actin cables (designated actin 2, grey
level 88-112); (3) least intense stained actin cables, diffuse actin,
or actin aggregates (designated actin 1, grey levels 113-132); (4)
diffuse actin (grey levels 133-157; no actin cables or aggregates); and
cellular background (grey levels 158-174; nonfluorescent nonactin
cytosol).

The intensely stained actin cables appear to be due to an

increase in the number of cables rather than the size of the cables.
Figures 1 and 2 illustrate the image analysis protocol.
Measurement of Cell Area:

The area of each migratory or invasive

cell (180 total) was measured by a Videoplan system (Carl Zeiss Inc.)
and analyzed with a measuring histogram software program.

The five

final grey level groups were converted"into area by multiplying the
2
2
2
area (um ) of each cell by the percent area of the actin (um /um ) in
each cell.
Statistics:

The percent of actin and cell areas of the three grey

levels of migratory BA-pretreated cells were individually compared to
the percent of actin and areas of untreated or RA-pretreated cells
using the either the Welch's tw (t') test unequal variance or the
Bechhofer-Dunnett-Krishnaiah-Armitage muliple comparison test (Wilcox,
1987).

Both percent of actin and cell area of the three cellular grey

levels of migratory RA-pretreated cells were individually compared with
the percent actin and areas of untreated cells using the either the
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Welch's tw (t') test unequal variance or the Bechhofer-Dunnett-Krishnaiah-Armitage multiple comparison test (Wilcox, 1987).

The

percent actin and areas of migratory cells were compared separately
from invasive cells.

Percent actin from similiarly treated migratory

and invasive cells were also compared.

For example, the nonfilamentous

actin was compared between untreated migratory and invasive cells.

The

percent actin of the three grey levels of nonmigratory untreated,
BA-pretreated and RA-pretreated cells were individually compared with
the matching percent actin of the three grey levels of similarly
treated migratory cells.

The percent actin grey levels of invasive and

noninvasive cells were similarly evaluated.
A significance level of p<0.05 was defined as significant for all
experiments.
Transmission Electron Microscopy:

Transmission electron

microscopy was performed as described in a previous study (McGarvey and
Persky, 1989b).

Briefly, membranes were fixed for 30 min at 37°C with

2% glutaraldehyde in 50 mM cacodylate buffer (pH 7.4), rinsed in buffer
(3X) for 5 min at 37°C and incubated for 30 min in buffer containing
0.8% K Fe(CN) .
6
3

Membranes were then incubated for 30 min in buffer

containing 0.5% Os0

4

and 0.8% K Fe(CN) , rinsed in buffer, rinsed in
3
6

distilled water (3X), stained en bloc with 2% uranyl acetate (dH 0) for
2
60 to 120 min, rinsed in distilled (3X) and dehydrated in ethanol.
Membranes were infiltrated into resin (Epon-Araldite), cut out of the
Transwell insert, and polymerized.

Thin sections were cut, stained in

1% uranyl acetate (in 70% methanol) and lead citrate, and viewed with a
Hitachi H-600 microscope at 75 kV accelerating voltage.
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RESULTS

The data from the results of the image analysis were simplified as
follows.

The percent area of background, diffuse actin, and actin 1

were combined into a major group designated nonfilamentous actin.
Likewise, the area of background, diffuse actin, and actin 1 were
combined.
Quantification of F-actin in Migratory Cells (Table 1):
BA-pretreated cells have less nonfilamentous actin than untreated cells
(19.2% decrease, p<0.05).

BA-pretreated cells have less nonfilamentous

actin than RA-pretreated cells (13.3% decrease, p<0.05).

Untreated

cells have less actin 2 than RA-pretreated cells (42% decrease, p<0.05)
and BA-pretreated cells (64% decrease, p<0.05).

Untreated cells also

have less actin 3 than RA-pretreated cells (66% decrease, p<0.05) and
BA-pretreated cells (83% decrease, p<0.05).
Quantification of the Total Area and
Cells:

of Actin in Migratory

BA-pretreated cells had more total area than untreated cells

(189% increase, p<0.05).

There was no significant change in area with

RA-pretreatment (Fig. 3).

BA-pretreated cells had more nonfilamentous

actin and filamentous actin (actin 2 and 3) in area than untreated
cells (158% increase, p<0.05; 601% increase, p<0.05; and 701% increase,
p<0.05, respectively) (Table 2).

There was an increase in the area of

actin 2 and actin 3 of RA-pretreated cells compared to untreated cells
(188% increase, p<0.05,; and 272% increase, p<0.05, respectively)
(Table 2).
Fluorescence, Migration Assay:

At a plating concentration of 5 X
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10

4

cells, cell processes usually overlapped on top of the uncoated

p.c. membrane (Fig. 4A, C, and E).

Few F-actin filaments were observed

on top of the membrane in untreated or drug-treated cells (Fig. 4A, C,
and E).

Individual cells were seen on the bottom of the p.c. membrane.

F-actin aggregates and stress fibers were evident in untreated
migratory cells (Fig. 4B).

An organized pattern of F-actin filaments

predominates throughout BA-pretreated cells.
were seen (Fig. 4D).

No F-actin aggregates

Parallel F-actin filaments and F-actin aggregates

were observed in RA-pretreated cells (Fig. 4F).
Quantification of Actin in Invasive Cells (Table 1):

There was no

significantly difference in nonfilamentous actin, actin 2 and 3 of
untreated cells compared to BA-pretreated cells and RA-pretreated
cells.

However, there was a significant increase in nonfilamentous

actin in RA-pretreated cells compared to BA-pretreated cells (110%
increase, p<0.05).

In addition, there was a significant decrease in

actin 2 in RA-pretreated cells compared to BA-pretreated cells (56%
decrease, p<0.05).
Quantification of the
Cells:

in Invasive

BA-pretreated cells had a significantly larger total area than

untreated cells (160% increase, p<0.05).

There was no significant

difference in total area between untreated and RA-pretreated cells
(Fig. 5).

BA-pretreated cells had a larger area of nonfilamentous

actin, actin 2 than untreated cells (131% increase, p<0.05;
increase, p<0.05, respectively) (Table 2).

and 231%

There was a significant

decrease in the area of actin 2 and 3 of RA-pretreated cells compared
to untreated cells (51% decrease, p<0.05; and 34% decrease, p<0.05,
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respectively). (Table 2).
Fluorescence, Invasion Assay:
10

4

At a plating concentration of 5 X

cells, individual cells on top of Matrigel-coated p.c. membranes

can not be delineated.

Diffuse or filamentous actin observed at

different focal points renders high magnification difficult (Fig. 6A, G
and E).

Untreated cells on top of the membrane have diffuse actin at

the cell borders (Fig. 6A).

RA-pretreated and BA-pretreated cell

processes contain F-actin filaments (Fig. 6C and E).

An untreated

invasive cell on the bottom of the p.c. membrane has parallel F-actin
filaments and F-actin aggregates (Fig. 6B).

A dense pattern of F-actin

is observed in BA-pretreated invasive cells (Fig. 60).
are observed in RA-pretreated cells (Fig. 6F).

Stress fibers

Both BA-pretreated and

RA-pretreated invasive cells apppear to lack F-actin aggregates, but
diffuse staining actin is observed (Fig. 6A and F).
Stress fibers are not apparent in a BA-pretreated invasive cell
(Fig. 1).

Two pores of the polycarbonate membrane are surrounded with

diffuse actin.
pores.

A ring of organized actin surrounds one of the two

F-actin microspikes can be observed within the leading edge of

the cell ending at the cell border.

A trailing tail can also be seen

(Fig. 1).
Gomparision of F-Actin between Migratory and Invasive Cells:
There was an increase in actin 2 in untreated invasive cells compared
to untreated migratory cells (151%, p<0.05).

There was an increase in

actin 2 and 3 in RA-pretreated migratory cells compared to
RA-pretreated invasive cells (169%, p<0.05; 214% p<0.05).

There was

more actin 3 in BA-pretreated migratory cells than in BA-pretreated
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invasive cells (258% increase, p<0.05).
Quantification of Actin in Nonmigratory and Noninvasive Cells
(Table 3):

There was more nonfilamentous actin in RA-pretreated

nonmigratory cells than BA-pretreated nonmigratory cells (135%
increase, p<0.05).

There was less actin 2 in nonmigratory

RA-pretreated cells than untreated nonmigratory cells (29% decrease,
p<0.05).

Nonmigratory BA-pretreated cells had more actin 3 than

untreated or RA-pretreated cells (182% increase, p<0.05; 249% increase,
p<0.05, respectively).

There was more actin 3 in BA-pretreated

noninvasive cells than untreated noninvasive cells (167% increase,
p<0.05).
Comparison of F-Actin between Nonmigratory and Migratory Cells
(Tables 1 and 3):

Migratory untreated cells had more nonfilamentous

actin than untreated nonmigratory cells (147% increase, p<0.05).

There

was more actin 2 and 3 in untreated nonmigratory cells compared to
untreated migratory cells (425% increase, p<0.05; 850% increase,
p<0.05, respectively).

There was more nonfilamentous actin in

migratory BA-pretreated cells than nonmigratory BA-pretreated cells
(137% increase, p<0.05).

Nonmigratory BA-pretreated cells contained

more actin 3 than migratory BA-pretreated cells (266% increase,
p<0.05).

There was more actin 2 and 3 in RA-pretreated nonmigratory

cells compared to RA-pretreated cells (174% increase, p<0.05; 211%
increase, p<0.05, respectively).
Comparison of F-Actin between Noninvasive and Invasive
(Tables 1 and 3):

Untreated invasive cells had more nonfilamentous

actin than untreated noninvasive cells (125% increase, p<0.05).

There
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was more actin 2 and 3 in untreated noninvasive cells compared to
untreated invasive cells (237% increase, p<0.05; 342% increase, p<0.05,
respectively).

BA-pretreated invasive cells had more nonfilamentous

actin than BA-pretreated noninvasive cells (127% increase, p<0.05).
Noninvasive BA-pretreated cells contained more actin 2 and 3 than
invasive BA-pretreated cells (153% increase, p<0.05; 381% increase,
p<0.05).

RA-pretreated invasive cells had more nonfilamentous actin

than RA-pretreated noninvasive cells (137% increase, p<0.05).

There

was more actin 2 and 3 in RA-pretreated noninvasive cells than
RA-pretreated invasive cells (314% increase, p<0.05; 664% increase,
p<0.05, respectively).
Fluorescence, Nonmigratory and Noninvasive

Individual

cells were observed on top of uncoated (Fig. 7A, C, and E) and
Matrigel-coated (Fig. 7B, D, and F) p.c. membranes at a plating
concentration of 1 X 10

3

cells.

Prominent stress fibers are seen in

untreated nonmigratory cells (Fig. 7A).

In contrast, few stress fibers

were visualize in untreated noninvasive cells (Fig. 7B).

Organized

stress fibers can be observed in the drug-treated cells on top of
either substrate (Fig. 7C, D, E, and F)

However, RA pretreated

nonmigratory cells contain paranuclear actin staining not observed in
RA-pretreated noninvasive cells (Fig. 7E and F)
Transmission Electron Microscopy of Migratory and Invasive Cells:
This investigation observed the cytoskeleton of migratory and invasive
cells above, below and within the pores of the polycarbonate membrane
(Figs. 8-10).

Higher magnification of the cytoplasm within the pore of

migratory or invasive cells reveals microtubules and cortical actin.
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The microtubules are parallel to the apparent movement of the cell
(Figs. 8-9).

Cortical actin is most often observed adjacent to the

Matrigel, the p.c. membrane, and at cell margins in noninvasive and
invasive BA-pretreated cells (Fig. 10).
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DISCUSSION

This report quantitatively compared the actin cytoskeleton of
untreated and drug-treated cells that had or had not migrated or
invaded in a three dimensional assay.
this study.

There were two major goals of

The first purpose was to quantitate nonfilamentous and

filamentous actin between noninvasive and invasive cells as well as
between nonmigratory and migratory cells.

The second purpose was to

describe morphologically F-actin when modulated by drug treatment,
substrate, and the processes of migration and invasion.
Past reports have compared cells on two dimensional substrates
such as glass or plastic.

Serniqualitative analysis of irnrnunolabelled

or phalloidin labelled cytoskeletons has been limited to studies of
motility or chemotaxis (Volk et al., 1984; Anderson et al., 1982).
Flow cytofluorimetry has been used to compare total F-actin
fluorescence between chemotactically active and nonactive
polyrnorphonuclear neutrophils (PMNs) (Howard and Meyer, 1984) and has
shown an increase in total actin in BA-treated hepatoma cells (Ryan et
al., 1987).

The ability to quantitate F-actin by fluorescence is based

on the unique stoichiometric binding of F-actin to phallacidin (1:2)
(Miyamoto et al., 1986).
Both area of actin and percent of actin within cells were computed
in this study.

The area of actin data showed that BA-pretreated

migratory and invasive cells were larger in size and had more
nonfilamentous actin and actin 2 than untreated migratory and.invasive
cells.

In contrast, the percent of actin demonstrated differences in
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actin groups that were not based on cell size.
Cell shape, degree of confluency, and cell spreading affect
cytoskeleton visualization (DeMey et al., 1978; Wolin and Kucherlapati,
1979).

In my study, individual cells on top of uncoated or

Matrigel-coated p.c. membranes could not be delineated when the cell

4
plating density was 5 X 10 , and thus actin fluorescence was quantified
3
at the lower density (1X10 ).
Substrate interactions are important in the morphology of actin
filaments.

The actin cytoskeleton appears nondistinct in untreated or

treated cells plated at 5 X 10
membranes.

4

cells on top of uncoated p.c.

This was in contrast to the morphology of the F-actin

cytoskeleton of cells plated at 5 X 10
p.c. membranes.

4

cells on top of Matrigel-coated

The actin fluorescence of untreated cells on top of

Matrigel appeared similiar to the actin morphology of epithelial cells
in situ where F-actin fluorecence is largely confined to cell periphery
(Friedman et al., 1984) (Fig. 6A).

In addition, the actin cytoskeleton

was still diffuse in untreated cells plated at a concentration of 1 X
10

3

cells (Fig. 7B).

Extensive actin filaments, on the other hand,

were observed in BA or RA-treated cells on top of the Matrigel at
either plating concentration (Fig. 6C and E, Fig. 7D and F).
Restoration of stress fibers and adhesion plaques has been reported in
some transformed cells when grown on fibronectin (Ali et al., 1977;
Willingham et al., 1977).

Glass or plastic substrates allow for the

formation of stress fibers which are generally absent from most cells
in situ (Burridge et al., 1987).

Nuclear F-actin aggregates or

peripheral stress fibers observed in glass grown untreated Bl6a cells
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(Persky and McGarvey, 1990) were not observed in migratory or invasive
untreated Bl6a cells.

Therefore, F-actin expression appeared to be

dependent on both the cell substrate and cell activity.

Thus, the

value of comparing noninvasive and invasive cells can be questioned,
since noninvasive cells were on a Matrigel substrate and the invasive
cells were attached to an uncoated p.c. membrane.
The actin morphology of the BA-treated cell in Figure 2A appears
to typical of migratory cells (Lewis et al., 1982; Rinnerthaler et al.,
1988).

Prominent stress fibers were not present.

Instead, diffuse

actin was prominent with microspikes bundles at the leading edge and a
retracting tail.

This morphology was similiar to that observed for

migratory fibroblasts (Lewis et al., 1982; Rinnerthaler et al., 1988).
On the other hand, nonmigratory fibroblasts have prominent stress
fibers (Lewis et al., 1982).

Large stress fibers seem to have a

structural role rather than a migratory role.

I observed an increase

actin 3 in all nonmigratory and noninvasive cells compared to migratory
and invasive cells.

The most striking increase in stress fibers was

seen in untreated nonmigratory cells compared to migratory untreated
cells (Fig. 7A).
Transmission electron microscopy of untreated and drug treated
cells demonstrated parallel bundles of microtubules and intermediate
filaments were observed by TEM in the pseudopods that were within the
pores of the p.c. membrane.

Microtubules, intermediate filaments, and

cortical actin bundles are known to be involved in migration and
invasion.

Anti-microtubule agents such as colchicine·inhibit-

deformability (Daughaday et al., 1981).

Both deformability and

156
motility are necessary for migration through a porous membrane.
Chemotactic activation of PMNs has been shown to increase the average
length of microtubules parallel to the direction of cell migration
without affecting the number of microtubules per cell (Anderson et al.,
1982).
Changes in the cytoskeleton may affect the organization,
distribution, and amount of actin or tubulin protein.

Ryan and Higgins

(1988) found by biochemical analysis that total actin (globular and
filamentous actin) represented only 5.45% of total cellular protein in
transformed fibroblasts and 18.05% of total cellular protein in
BA-treated transformed fibroblasts.

I compartmentalized the F-actin

fluorescence according to fluorescent intensity and showed that
cortical actin is prominent in BA-pretreated noninvasive and invasive
cells (Fig. 10).

Obviously, the percents of F-actin presented here

represented the compression of a three dimensional structure into two
dimensions.

This compression is seen in Fig. 6D by the overlapping of

actin structures.

Confocal microscopy would allow for optical

sectioning through the cell and can accurately quantify actin at
varying cell heights.

An increase in actin close to the substrate, as

viewed with confocal microscopy, has been reported to be indicative of
highly migratory cells (Hay, 1985).
Fluorescent microscopy (Figs. 4 and 6) and image analysis data
show that migratory and invasive Bl6a cells organize actin into cables.
The organization of actin is most prominent in invasive untreated,
migratory RA pretreated and migratory/invasive BA-pretreated cells.
The ability of a cell to organize actin into a structural component of
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the cytoskeleton or into a intergral part of the migratory process may
predict the migratory/invasive nature of the cell.

My invasion data

are in contrast to the findings of Hendrix and Seftor (1986), although
the differences may be attributed to the protocols used.

Hendrix and

Seftor studied actin filaments after the invasive cells were detached
from the amnion and then allowed to attachment to a glass substrate.
They used a different cell line and they utilized the human amnion
rather than Matrigel as the invasive barrier.

Their study was

significant in that the morphology of actin in low metastatic cells
that were invasive for the amnion appeared similar to the morphology of
high metastatic cells that were noninvasive for the amnion.
Motile fibroblasts possess diffuse actin (Lewis et al., 1982).
Interferon treatment of transformed cells restores or increases the
number of the stress fibers as well as inhibits tumor cell motility on
glass (Pfeffer et al., 1980; Bourgeade et al., 1981).

Thus, migratory

and invasive cells would be expected to contain only diffuse F-actin.
However, migratory and invasive cells contained varying amounts of
filamentous actin.

Migratory and invasive BA-pretreated cells contain

a complex organization of actin filaments compared to migratory and
invasive untreated cells.

There was a significant increase in actin

organization of migratory RA-pretreated Bl6a cells as compared to
migratory untreated cells.

The increase in F-actin organization would

be indicative of a nonmigratory phenotype.

In contrast to the

migration data, I did not observe an increase in F-actin organization
in RA-pretreated invasive cells as compared to untreated invasive
cells.

In addition, it would be expected that BA-pretreated cells
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would be less invasive and migratory than untreated cells, but the
converse has been shown (McGarvey and Persky, 1989; McGarvey et al.,
1990).

Therefore, the function of filamentous actin with respect to

motility, migration, and invasion still has to be elucidated.
A shift in the pool of actin from G-actin (globular actin) to
F-actin (filamentous actin) has been reported in chemotactically
activitated neutrophils (Howard and Meyer, 1984).

My study was limited

in that I could not determine if there was a shift in the pool of G to
F-actin, or measure total actin.

It has been noted that BA-treatment

of transformed KNRK cells increases the amount and organization of
F-actin.

However, BA-treatment of tranformed KNRK cells does not

completely restore actin to the pattern observed in untransformed KNK
cells (Ryan and Higgins, 1988).
organization of F-actin.

My study only quantitated the

Both total actin and F-actin organization are

probably important for motility.
An important question in my study is whether F-actin subgroups are
selected by migratory and invasive cells.

The increase in certain

F-actin subgroups in invasive untreated cells compared to untreated
migratory cells could indicate that a certain F-actin phenotype is
necessary for invasion.

In addition to the selective pressure of

invasion on F-actin subgroups, F-actin subgroups are modified by drug
treatment.

In addition, drug treatment may affect a selected

cytoskeletal phenotype before or after the migratory and invasive
process.
The image analysis system is based on fluroescent intesity of the
F-actin, not on the organization of the actin.

Thus, image analysis
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does not distinguish between intensely stained F-actin aggregates and
cables that were observed in migratory and invasive untreated cells.
Only F-actin cables were observed in BA-pretreated cells.

Therefore,

there were more changes that took place with drug treatment than could
be quantitated by image analysis.

These differences may be important

to the enhanced migratory and invasive rates induced by BA.
Other cytoskeletal components may function in conjunction with
F-actin to regulate migration and invasion.

Butyric acid or RA may up

or down regulate the production of other cytoskeletal proteins or
effect their interaction with F-actin.

Regulation of actin

polymerization, including gelation, bundling, capping, severing and
stabilizing of actin filaments, is a known function of numerous
actin-binding proteins (Weeds, 1982).

It is possible that each

actin-binding protein is necessary in cell motility, but little is
known about most of these proteins.

One gel-bundling protein,

alpha-actinin, has been localized to both stress fibers and to the
leading lamellae of motile V2 carcinoma cells (Jockusch et al., 1983).
Other actin-binding proteins, such as tropomyosin and myosin that have
a role in muscle tissue contractility, are not found in the motile
leading edge (Jockusch et al., 1983).

Ryan and Higgins (1987) found

that BA-treated transformed fibroblasts (KNRK) had a three fold
increase in total cellular actin, detergent resistant actin, and
alpha-actinin.

Linder et al. (1981) observed an increase in synthesis

of tropomyosin in RA-treated F9 teratocarcinoma cells.

An increase in

alpha-actinin or tropomyosin may play a role in migration of Bl6a
cells.

Further study must be done on the role of actin binding
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proteins, and the modulation of migration by BA or RA treatment.
In conclusion, this study reports on F-actin in nonmigratory,
migratory, noninvasive, and invasive cells.

The isolation of migratory

and invasive cells in the Transwell chamber may allow for future
quantitation of changes in the cytoskeleton by biochemical analysis or
sensitive radioimmunoassays (Bernal et al., 1983; Ball et al., 1986).
Further work utilizing confocal microscopy, monoclonal antibodies and
biochemical techniques may help evaluate the mechanisms involved in
cell migration and invasion.
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Figure 1 - 2.

Fluorescent micrographs (lA and 2A), the digitized (lB and 2B) and the
color enhanced images (lC and 2C) of two invasive cells.

Figures lC

and 2C illustrate the extracellular background (deep grey),
nonfilamentous background (black), least intense filamentous actin
(grey), and most intense filamentous actin (white).
and Methods for further detail.

See the Material
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Key to Fig. 3

2

Clear bar - Mean± S . E . area (um ) of untreated (control) cells.

2

Top right to bottom left hatch bar - Mean+ S.E. area (um ) of
RA-pretreated cells .
Top left to bottom right hatch bar -

2

Mean+ S.E. area (um ) of

BA-pretreated cells.

Asterisk (*) - Defines a value that is significantly different
(p<0.05) from untreated cells.
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Figure 3.

Total area of untreated, RA-pretreated and BA-pretreated migratory

cells.
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Figure 4.

Flourescent micrographs of cells on the top (A,C,E) and bottom (B,D,F)
of uncoated p.c. membrane.

Labels A and B are for untreated cells,

and D are for BA-pretreated cells, and E and F are for RA-pretreated
cells.

Bar

=

20 um.

c
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Key to Fig. 5

2

Clear bar - Mean± S.E. area (um ) of untreated (control) cells.
2

Top right to bottom left hatch bar - Mean+ S.E. area (um ) of
RA-pretreated cells.
Top left to bottom right hatch bar -

2

Mean + S.E. area (um ) of

BA-pretreated cells.

Asterisk (*) - Defines a value that is significantly different
(p<0.05) from untreated cells.
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Figure 5.

Total area of untreated, RA-pretreated and BA-pretreated invasion
cells.
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Figure 6.

Flourescent micrographs of cells on the top (A,C,E) and bottom (B,D,F)
of Matrigel-coated p.c. membranes.

Labels A and B are for untreated

cells, C and D are for BA-pretreated cells, and E and Fare for
RA-pretreated cells.

Bar= 20 um.
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Figure 7.

Fluorescent micrographs of cells on top of uncoated (A,C,E) and
Matrigel-coated (B,D,F) p.c. membranes.

Labels A, B are for untreated

cells, labels C, D are for BA-pretreated cells, and labels E and Fare
for RA-pretreated cells.

Bar= 20 um.

174

175

Figures 8A and B.

Transmission electron micrographs of a migratory untreated cell within
a pore of the p.c. membrane (p.c.).

Cortical actin (a) and

microtubules (arrow) are found in the cytoplasm within a pore.
37A, Bar = 2 um.

Fig. 38B, Bar = 1 um.

Fig.
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Figures 9A and B.

Transmission electron micrographs of untreated cells on the top, within
and on the bottom of a Matrigel (m) coated p.c. membrane (p.c).
Cortical actin (a) and microtubules (arrows) are found in the cytoplasm
within the pore.

Fig. 9A and B, Bar= 1 um.
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Figure 10.

Transmission electron micrograph of BA-pretreated cells on top of
Matrigel (m) and on the bottom of a p.c. membrane (p.c.).

Cortical

actin (arrows) is found in both non-invasive and invasive cells. Bar

2 um.
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TABLE 1.

The percent of the form of F-actin in untreated, BA-pretreated, and
RA-pretreated migratory and invasive cells.
Results.

For details see the

FORM OF ACTIN (%)
TREATMENT I CONDITION

N.F.
X±S.E.

L.l.F.
X±S.E.

M.I.F.
X±S.E.

UNTREATED/MIGRATORY

92.6±1.0

5.7± 0.9

1.6 ± 0.3

BA-TREATED /MIGRATORY

74.8 ± 2.8*

16.0 ± 1.9*

9.3±1.3*

RA-TREATED /MIGRATORY

86.3 ± 1.8**

9.8 ± 1.1*

4.7 ± 0.9*

UNTREATED /INVASIVE

88. 6±1.8

8.6±1.5

2.4±0.6

BA-TREATED /INVASIVE

83.1±1.6

13.2± 1.4

3.6± 0.7

RA-TREATED/INVASIVE

91.7 ± 1.3**

5.8 ± 0.9**

2.2 ± 0.4

N

co

.--t

N.F. - Nonfilamentous actin
L.l.F. - Least intense filamentous actin (Actin 2)
M.l.F. - Most intense filamentous actin (Actin 3)
* Significant p < 0.05 level, untreated vs. drug-treated cells.
** Significant p < 0.05 level, BA-treated vs. RA-treated cells.
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TABLE 2.

2
The area (um ) of the form of F-actin in untreated, BA-pretreated, and
RA-pretreated migratory and invasive cells.
Results.

For details see the

AREA OF F-ACTIN
TREATMENT /CONDITION

ro
"""

..-i

N.F.
X±S.E.

L.l.F.
X±S.E.

M.I.F.
X±S.E.

UNTREATED/MIGRATORY

2013.0±179.5

110.3±19.3

35.4 ± 9.9

BA-TREATED/MIGRATORY

3172.0 ± 299.8*

662.4 ± 109.3*

248.1±41.0*

RA-TREATED/MIGRATORY

1900.0 ± 182.6**

207.3 ± 28.9*

96.6 ± 22.8*

UNTREATED /INVASIVE

1790.0 ± 214.8

218.3 ± 42.70

49.5± 12.4

BA-TREATED/INVASIVE

2650.0 ± 273.7*

505.3 ± 72.2*

142.5 ± 34.0

RA-TREATED/INVASIVE

1673.0 ± 121.9**

107.4 ± 16.7*

32.6 ± 5.9*

N.F. - Nonfilamentous actin
L.l.F. - Least intense filamentous actin (Actin 2)
M.I.F. - Most intense filamentous actin (Actin 3)
* Significant p < 0.05 level, untreated vs. drug-treated cells.
**Significant p < 0.05 level, BA-treated vs. RA-treated cells.
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TABLE 3.

The percent of the form of F-actin in untreated, BA-pretreated, and
RA-pretreated nonmigratory and noninvasive cells.
Results.

For details see the

FORM OF ACTIN (%)
N.F.
X±S.E.

L.I.F.
X± S.E.

M.I.F.
X±S.E.

UNTREATED/NONMIGRATORY

62.8±3.4

24.2± 2.3

13.6±1.8

BA-TREATED /NONMIGRATORY

54.5±3.2

20.7± 1.4

24.7± 2.6*

RA-TREATED/NONMIGRATORY

73.5 ± 2.5**

17.1±1.5*

9.9 ± 1.4**

UNTREATED/NONINVASIVE

70.9 ± 2.4

20.4± 2.2

8.2±1.0

BA-TREATED /NONINVASIVE

65.3 ± 2.8

20.2± 1.9

13.7 ± 1.4*

RA-TREATED/NONINVASIVE

67.0± 2.7

18.2±1.1

14.6 ± 2.3

TREATMENT /CONDITION

l.O

co
r-1

N.F. - Nonfilamentous actin
L.I.F. - Least intense filamentous actin (Actin 2)
M.I.F. - Most intense filamentous actin (Actin 3)
* Significant p < 0.05 level, untreated vs. drug-treated cells.
** Significant p < 0.05 level, BA-treated vs. RA-treated cells.

CHAPTER VII

GENERAL DISCUSSION
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I have studied the affect of two antitumor agents, butyric acid
(BA) and all trans-retinoic acid (RA), on the proliferation, adhesion,
migration, invasion, cytoskeleton, and experimental metastasis of
murine Bl6a melanoma cells.

Clinical application of BA and RA is

increasing despite limited knowledge on how these agents perturb
cellular migration and invasion.

I have discussed within in chapters

IV, V and VI some of the mechanisms behind the the affect of BA and RA
on tumor cells.

The mechanism of action of BA and RA at the molecular

level needs further study.
Phenotypic Drift and Metastasis
Phenotypic diversity and tumor cell progression are important
parts of the metastatic process.

Tumor cell progression is defined as

the evolution of tumor cells through a combination of genetic
instability and host selection.

Progression produces tumor cells with

enhanced autonomy, survival and growth characteristics.

The ultimate

success of chemotherapy depends on the ability to eliminate rare,
highly metastatic cell subpopulations.

Elimination of the majority of

tumor cells by cytotoxic drugs can create a new group of subclones that
are drug resistant and phenotypically unstable.

Long term cultures

with BA-treated cells have not shown typical signs of drug resistance
such as failure to inhibit proliferation.

In fact, these cultures have

shown further phenotypic changes including enhanced cell spreading.

A

substantial increase in the invasion or migration rates was noted if
the inhibition of proliferation induced by BA was factored into these
rates.

In addition, I have shown in the migration and invasion assays,

have shown that increasing the time of BA incubation further enhances
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migration and invasion.

This was not the case in the invasion assay

with RA-treated and RA-pretreated cells.

The limited effect of RA on

the invasion of Bl6a cells may be due to the low invasive capability of
Bl6a cells, since RA-pretreatment of K-1735 cells (a highly invasive
cell line) reduced invasion.

Radical changes in morphology, eg. cell

size were not observed with RA-treatment.

The amount of actin in

nonmigratory and invasive RA-pretreated cells was significantly less
than nonmigratory and invasive untreated cells, respectively.

How this

information may be related to the decrease in migration and invasion by
RA-pretreated cells is open to speculation.
operate to control movement in cells.

Two factors seem to

These are the F-actin to G-actin

ratio (an increase in F-actin is indictative of an increase in
migration) and the organization of F-actin (higher forms of
organization are indicative of a decrease in migration).
seem to operate with RA-pretreated cells.

Both factors

Nonmigratory RA pretreated

cells have more total F-actin and increased organization of F-actin
than migratory cells.

The questions that remain are whether there is a

decrease in total actin (globular and filamentous) or if there are
changes in actin binding proteins that regulate actin polymerization.
The genetic instability of metastatic tumor cells has been
reported

vitro and in vivo.

I have observed that the migration rate

of untreated Bl6a cells decreased with increasing passage of cells in
culture (McGarvey and Persky, 1989b).

I have also observed that no

extrapulmonary metastasis occurred with tail vein injection of a
mixture of lung nodule-derived and subcutaneously-derived Bl6a cells
(McGarvey et al., 1990).

In contrast, Honn et al. (1981) have reported
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liver and spleen metastases from tail vein injection of Bl6a cells.
There may a link between decreased migration in the Transwell system
and a decrease in extrapulmonary metastasis.

Decreased migration of

subcutaneously-derived cells compared to early passage cells may be
linked to decreased deformability of the cells through the lung
capillaries.

Subtle changes in genome probably account for these

changes.
Phenotypic drift of the Bl6 melanoma cell line has been observed
(Poste et al., 1981; Stackpole, 1983).

There was interlesional

heterogeneity in the early stages of growth in experimental metastatic
assays followed by intralesional heterogeneity (Poste et al., 1981).
Before 25 days, cells are homogeneous within lesions.

Progressive

growth of the nodules gave rise to clones with differing metastatic
capability (Poste et al., 1981).

Stackpole (1983) has reported that

the Bl6 melanoma cell line was not stable in culture or in serial
subcutaneous passage (over 30 monthly generations).

During this time,

metastatic activity of the original tumor, which was intially slight,
was lost by generation 10 and was restored by generation 18.
different phenotypes were observed.

Four

Some lines produced both

spontaneous and experimental metastases, some lines produced
spontaneous metastases only, some lines produced experimental colonies
only, while other lines produced neither spontaneous nor experimental
metastases.

Phenotypic drift is not exclusive to the Bl6 cell line

(for review see Welch and Tomasovic, 1985).

Other tumor cell lines

reported to drift with respect to metastatic rate are the murine Kl735
melanoma ~Talmadge et al., 1984) and clones of the 13762NF mamamary
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adenocarcinoma (Welch et al., 1984).

Schirrmacher (1980) has reported

that the ESb lymphoma cell line has extremely high rates of drift to
nonmetastatic behavior.

Therefore, care must be taken in evaluating

both in vitro and in vivo using metastatic tumor cells.

Because of

phenotypic drift, I performed tail vein and subcutaneous injections
before and after all in vitro studies in order to verify that the cells
were tumorigenic and metastatic.
Cellular Migration
The fundamental question in cellular migration is "what is the
driving force behind cellular motility?"
role, while myosin probably does not.

Clearly actin has a major

Certain forms of actin

especially actin 3, are indicative of nonmigratory untreated or drug
treated Bl6a cells.

The actin morphology of BA-pretreated cells appear

to be an example of a nonmigratory cell, but BA-pretreated cells are
highly migratory.

I have shown that BA modifies the organization of

diffuse actin and actin bundles.

This modification probably occurs

through controlling the expression of actin binding proteins such as
alpha actinin (Ryan and Higgins, 1987).

Answers to how BA affects

actin need to be solved at the molecular level.
Actin bundles can change cell shape and regulate cell movement.

I

have shown in Chapter VI that the process of migration and invasion can
change the morphology and amount of total F-actin, but only a
combination of factors (substrate interactions and drug treatment) can
account for the actin morphology observed in invasive and migratory
cells.

The interaction between drug treatment and the migratory

process is important.

For example, there was no significant difference
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in total F-actin between untreated and BA-treated nonmigratory cells,
but there was significantly more total F-actin in BA-treated cells than
untreated migratory cells.

However, the effect of drug interactions

with the migratory or invasive processes on the F-actin does not tell
the whole story.

There were differences in actin morphology and total

F-actin between untreated migratory and invasive cells.

In addition,

the affect of substrate interactions with drug treatment on F-actin
morphology was observed in comparing noninvasive untreated and drug
treated cells.

Transformed motile cells, transformed nonmotile cells,

and untransformed motile cells are interesting model systems to examine
the mechanisms behind cellular motility.
movement expand the model systems.

Drugs that affect cellular

The role of differentiating agents,

such as DMSO and DMF, on motility would be interesting to investigate
since they are known to change the morphology of tumor cells
(Lampugnani et al., 1987; Dexter et al., 1974).
The Transwell system allows for the isolation of unique
subpopulations of cells (nonmigratory/migratory and
noninvasive/invasive) for further analysis.

One question that was not

addressed in my experiments was whether there was a quantifiable change
in the nonactin cytoskeleton by BA or RA.

There is, apparently, a role

for microtubules as shown by TEM in the migration of untreated and drug
treated cells through the pores, but quantification was not posssible.
It is clear that the morphology of actin filaments is distinctive in
subpopulations of untreated Bl6a cells.

The actin morphology of

migratory and invasive untreated cells is different from nonmigratory
and noninvasive untreated cells and is not just a result of substrate
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interactions.
Substrate interactions do have an effect on morphology, motility
and metastasis of tumor cells (Nabi et al., 1990).

In my study, there

are differences in the actin morphology of nonmigratory and noninvasive
untreated cells.

The majority of F-actin filaments of noninvasive

cells is confined to diffuse actin.

In contrast, actin filaments (not

diffuse actin) dominate the cytoplasm of untreated cells grown on
uncoated polycarbonate membranes.

The noninvasive and nonmigratory

cells were similiar in that the majority of the cells grew in clusters.
Migration and cell shape are related to metastasis?

For example,

an increase in motility and lung colonization was found in Bl6Fl
melanoma cells that were grown as spheroids on a nonadhesive substrate
(Poly(HEMA)) (Raz and Ben-Ze'ev, 1983; Nabi et al., 1990).

Bl6Fl cells

that were grown on Poly(HEMA) and allowed to reattach to tissue culture
treated plastic were found to have increased spreading characteristics
compared to cells that were grown only on the tissue culture treated
plastic.

Increased spreading was correlated to increased motility

(Nabi et al., 1990).

This is interesting to note since I have noted

increased spreading and migratory capability of BA-treated Bl6a cells
(McGarvey and Persky, 1989).

The molecular events that increased

motility in Poly (HEMA) grown cells may be related to events that
increase the migration of BA-treated cells.

The actin morphology of

noninvasive BA-pretreated Bl6a cells does not appear to be different
from nonmigratory BA-pretreated cells.

However, I have found by image

analysis that there is an increase in actin 3, which represents·the
highest level of actin organization.

This information is further
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evidence that higher levels of organization of actin is correlated with
decreased migration.
The Matrigel Invasion Assay
The Matrigel assay can be modified to further understand the
invasion process.

In this dissertation, a chemoattractant from NIH

fibroblasts was added to the lower chamber of the Transwell chamber.
The advantage of this modification is that the time period for the
invasion assay was shortened and that an inhibition of proliferation
can be separated from an inhibition in invasion.

The addition of the

chemoattractant increased the invasion rate of untreated cells, but
likewise increased the invasion rate of BA-pretreated cells.
modifications of the Matrigel assay have been done.

Other

For example,

additional amounts of collagen type IV have been added to the Matrigel
(Wang and Stearns, 1988).

They found that invasion of tumor cells

decreased through the modified Matrigel as compared to the invasion
through Matrigel alone.
I have shown that cellular adhesion to Matrigel was enhanced by BA
pretreatment.

A major constituent of Matrigel is laminin.

The

interaction of tumor cells with laminin is important since BA has been
shown to reduce the number of laminin receptors in a human pancreatic
cell line (Bryant et al., 1986).

However, laminin has also been shown

to enhance the release of type IV collagenase (Turpeenniemi-Hujanen,
1986).

The Transwell system lends itself to manipulation to further

elucidate the factors involved in cellular migration and invasion.

The

bottom surfaces of polycarbonate membranes may be coated with ·various
basement membrane proteins for haptotactic assays or with chemotactic
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peptides.

Likewise, proteins may be added to the lower chamber to

increase migration and invasion.
A major concern about Matrigel for invasion assays is that it
forms at varying concentrations a consistent uniform barrier.

Scanning

microscopy, transmission electron microscopy, and fluorescent diffusion
studies have confirmed the integrity of the Matrigel barrier (Persky et
al., 1990).

Basement membrane products such as thrombospondin, which

is not present in Matrigel is important to the invasion process
(Roberts et al., 1987).

Thrombospondin induced chemotactic and

haptotactic responses in several human tumor cell lines (Roberts et
al., 1987).

A defined basement membrane product similiar to Matrigel,

that is functionally analogous to the human amnion, which contains a
basement membrane and a collagenous stroma, would be advantageous in
tumor invasion studies.
It is clear from this dissertation that
tell the whole story.

vitro assays may not

My in vitro experiments evaluated two agents.

Butyric acid increased the adhesion, migration and invasion of Bl6a
cells.

In contrast, the other agent, RA decreased migration and

invasion.

However, both agents inhibited experimental metastasis.

The

intricate nature of the metastatic cascade is not limited to tumor cell
invasion or migration, but includes other complex interactions with the
host.

Liotta (1970) observed that only 0.1% of the cells injected into

tail veins of mice produced metastatic foci.

The tail vein protocol

includes the steps of entrapment of cells in the lungs, extravasation,
and growth of the foci, yet only a small number of cells survive.
Since this time, the role of phenotypic selection of tumor cells in
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metastasis has gained exceptance.

Metastasis may be conceptually be

thought of as a series of limiting steps or gates.

These steps include

lung entrapment, extravasation (which includes adhesion, invasion and
migration), growth, and escape from the host defenses.

Administration

of BA may open the invasion gate, but close the proliferation gate
allowing host defences to eradicate the tumor.

Retinoic acid can have

affect any point in the experimental metastatic assay, closing still
tighter the various gates.

In addition, various cell types including

placental trophoblasts, which are neither tumorigenic nor metastatic,
can migrate and invade through Matrigel (Librach et al., 1989).
Although the Matrigel and migration assays are interesting reductionist
model systems to study tumor cells, the importance of the
metastasis assays (experimental and spontaneous) can not be
overemphasized.

vivo

CHAPTER VIII

SUMMARY
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The affect of two potential antiturnor agents, butyric acid (BA)
and all trans-retinoic acid (RA), on murine Bl6a melanoma cells was
investigated in vitro and in vivo.

Initial studies determined the

cytostatic/cytotoxic concentrations of BA and RA by hemacytometer
counts and by the trypan blue exclusion test.

Cytostasis was confirmed

by autoradiography and beta scintillation measurement of incorporation
3

of either

H-thymidine or

3

H-Iodo-deoxyuridine.

The in vitro studies included both migration and invasion assays.
For the migration assays, cells were plated onto 3 and 5 um diameter
pore polycarbonate membranes.

For the invasion assays, cells were

plated onto recombinant basment membrane coated 8 um pore polycarbonate
membranes.

Migration and invasion rates were quantified by scanning

electron microscopy.

Cells were treated with the cytostatic

concentrations of BA and RA or untreated for 72 hrs before the
migration and invasion assay.

Butyric acid or RA was again added at

the time of plating of cells onto the membranes.
The cytoskeleton of untreated and drug-treated migratory and
invasive cells was also investigated by transmission electron
microscopy and fluorescent microscopy.

Cytoskeletal changes were

quantified by image analysis of F-actin that had been stained by Bodipy
phallacidin.
The

vivo study used the experimental metastatic assay (tail

vein inoculation).

Butyric acid or RA containing pellets, as well as

placebo pellets, were administered subcutaneously.
The major findings were:
1.

The range of cytostatic/cytotoxic concentrations of RA were 1
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X 10-

7

- 1 X 10

-6

/ > 1 X 10

-5

Mand of BA were .5 mM - 1.5 mM / 2.0

mM.
3.

The chosen cytostatic concentration of BA (1.5 mM) decreased

by 80% the incoporation of
4.

3

H-thymidine.

The chosen cytostatic concentration of RA (1 X 10-

decreased by 72.3% the incorporation of
5.
3

3

7

M)

H-IdUR.

The cytostatic concentration of BA decreased incorporation of

1-dUR within 24 hrs.
7.

Butyric acid increased migration and invasion of Bl6a cells.

Pretreatment with BA further increased migration or invasion.
9.

Retinoic acid decreased migration and invasion of Bl6a cells.

10. Administration of BA and RA by subcutaneous pellet
significantly decreased the number of lung nodules.

In addition,

administration of BA by subcutaneous pellet also decreased the
incidence of lung nodule formation.
12. Both migratory and invasive cells formed pseudopods containing
networks of cortical actin and parallel microtubules.
13. Migratory untreated cells had significantly less filamentous
F-actin than migratory BA-pretreated cells and migratory RA-pretreated
cells.
14. Invasive cells with or without drug treatment had similiar
amounts of filamentous F-actin.
15. Untreated and drug-treated invasive and migratory cells were
capable in varying degrees of bundling actin.

This finding is

important since it has been reported that invasive cells contained only
diffuse actin.
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17. Untreated/drug treated noninvasive and nonmigratory cells have
more actin 3 (the highest level of actin organization) than
untreated/drug treated invasive and migratory cells.
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APPENDIX I

The appendix is titled "Discussion with Reviewers" and has been
published in the paper "The Effects of Butyric Acid and Retinoic Acid
on In Vitro Migration by Murine Bl6a Melanoma Cells: A Quantitative
Scanning Electron Microscopy Study." Scanning Microscopy, 3 (2): 591 604.

The appendix contains material pertinent to Chapter IV.
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DISCUSSION WITH REVIEWERS

R. Lotan:
Authors:

What is a diffusion chamber?
The diffusion chamber is a modification of the Membrane

Invasion Culture System (MIGS) chamber (Gehlsen et al., 1984; see
References).

Figure 13 is a 14 well MIGS chamber.

The diffusion

chamber is similar to the MIGS chamber except that the diffusion
chamber has 45 wells.

In the migration assays, complete medium with or

without a drug is added to the lower wells.

The polycarbonate membrane

is placed between an upper and lower chamber, creating 45 separate
upper and lower wells.

Cells are then added in complete medium, with

or without a drug, to the upper wells.
Figure 13:

MEMBRANE INVASION CULTURE SYSTEM
(MIGS; Pat Pending 84-027-1)

(A) Top Plate
(B) Bottom Plate
(C and E) Upper Wells
(D and F) Lower Wells
(G) Polycarbonate Membrane
(H) Washer
(I) Bolt
Redrawn with permission from
Hendrix et al. (1985).
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M.J.C. Hendrix:

It is very difficult to derive significant statistical

information from Table 4 when less than seven cells are presented?
Authors:

As a purely statistical question, this is a valid criticism.

Table 4 presents data obtained from 50 fields at 1700X.

Data could

have been presented at lower magnifications, e.g., 500X.

At 500X, the

exact same quantitated surface area would have provided 15 fields
(1,700 divided by 500 = 3.4; 50 divided by 3.4 = 15).

The mean number

of cells for Table 4 would therefore be 3.4X greater.

I chose to

present the data at l,700X because we could positively distinguish
individual cells at higher magnification.
R.Lotan:

It would have been interesting if a low metastatic variant

had been used in the migration assay.
Authors:

This is true, but the objectives of this project are to

evaluate the effect of two drugs on a highly metastatic cell line.
This project is part of an overall investigation that will evaluate the
effect of RA and BA on viability, proliferation, migration, invasion,
and metastasis.

Since the human amnionic basement membrane (HABM)

assay of Liotta et al. (New method for preparing large surfaces of
intact human basement membrane for tumor invasion studies.
Letters,

Cancer

·141-152, 1980) is being used as one of the invasion assays,

and since the HABM assay is only valid for highly invasive cells
(Welch, DR. 1986 Discussion of the suitability, availability and
requirements for in

and in vitro models of metastasis.

In: Cancer

Metastasis, Experimental and Clinical Strategies. (eds). DR. Welch, BK.
Bhuyan, and LA. Liotta. Alan R. Liss, Inc., N.Y., p. 135).
metastatic cells were not used.

Low
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M.J.C. Hendrix:

Is the rapid rate of biological degradation of

retinoic acid by tumor cells similar for butyric acid?

If not, what

bearing would this information have on the data generated in this
study?
Authors:

To our knowledge the rate of biological degradation of BA by

tumor cells has not been reported.

The incorporation of tritiated RA

by murine S91 melanoma cells has been reported to be rapid during the
first 15 min.

Tritiated RA is incorporated much more slowly after this

initial 15 min time period (Lotan et al., Characterization of retinoic
acid-induced alterations in the proliferation and differentiation of a
murine and a human melanoma cell line in culture.
359: 150-170, 1981).
grown in 10

-5

Ann N.Y. Acad Sci

In addition, S91 and Bl6 melanoma cells, when

M RA for six days and then refed in RA-free medium,

continued to proliferate at a reduced rate for 24-48 h.

However, after

3 days of incubation in RA-free medium, the growth rate of previously
RA-treated cells returned to that of the control cells (Lotan et al.,
Characterization of the inhibitory effects of retinoids on the vitro
growth of two malignant murine melanomas. JNGI 60: 1035 1041, 1980).
This reversible inhibition of growth of various tumor cell lines has
been reported by others using BA (Prasad and Sinha, Effect of sodium
butyrate on mammalian cells in culture: a review.
1976).

In Vitro 12:125-135,

I have observed reversible changes in morphology of RA and

BA-treated Bl6a cells after removal of the drug from the medium.
Therefore, despite a rapid incorporation and rapid degradation of RA
(and possibly BA) these drugs remain effective in changing morphology
and inhibiting growth beyond the 72 h experimental time period.
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M.J.C. Hendrix:

Was scanning electron microscopy the only technique

used to quantitate the tumor cells on the polycarbonate membranes?

If

so, what precautions were taken to insure that the entire filter was
examined with SEM?

Weren't the samples quite large to handle?

Our intial attempts to quantitate cells by light microscopy
were unsuccessful because we were not able to distinguish cells above,
in, and below the membrane.

Radioisotope labelling of cells was also

attempted, but difficulties were encountered in removing BA-treated
cells from the polycarbonate membranes.

Even a 20 min trypsin/EDTA

incubation failed to completely remove the BA-treated cells from the
membrane.

The entire membrane was observed by SEM.

select SO random fields to quanitate migration.
large to handle.

Care was taken to

Samples were not too

On the contrary the small size of the membranes

permitted three complete Transwell membranes to be loaded at one time
into the scanning scope.
M.J.C. Hendrix:

Do the authors propose that SEM offers a universal

quantitation approach for tumor cell invasion that supersedes currently
available technology?
Authors:

Scanning electron microscopy is an accurate and reproducible

method for quantifying migration and invasion.

SEM allows

visualization of top and bottom membrane surfaces and permits
observation of individual cells.

SEM does not have the depth of field

resolution problem that is associated with light microscopy.

SEM is

but one method to quantitate cell invasion and migration.
Why is it probable that increasing the pore size from 3 um
to 5 um allows "flattened" cells to migrate?
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Authors:

I have shown that the migration of early passage untreated

Bl6a cells through 5 um diameter pore membranes is 66% greater than the
migration through 3 um diameter pore membranes (Trials 1 and 3, Table
4).

I have observed that cells on the top surface of the 3 um diameter

pore membrane are heterogeneous in shape and contain flattened cells.
In contrast, the heterogeneous population of cells on top of 5 um
diameter pore membranes have few flattened cells.

It appears that the

majority of cells on the bottom surface of the 5 um pore membrane are
flat in shape.
R. Lotan:

It is possible to dehydrate tissues for SEM with alcohol

instead of acetone that would have allowed you to critical point dry
the specimens instead of air drying them.

Also, the membranes can be

cut out of the plastic well and processed separately.
Authors:

Despite the cracking produced by air drying, problems were

not encountered in quantitating cells.

The cracking produced by air

drying the filters can be reduced by using hexamethyldisilazane (Nation
et al.

A new method using hexamethyldisilazane for preparation of soft

insect tissues for scanning electron microscopy.
~:347-351,

1983).

Stain Tech.

It is possible to dehydrate with alcohol instead of

acetone before critical point drying.

Our electron microscopy facility

does not have a suitable drying agent, such as Freon 113, for critical
point drying alcohol dehydrated specimens.

The membranes were

processed in Transwell chambers to facilitate ease of handling.
Cutting out the membranes prior to alcohol dehydration causes the
membranes to roll up.
Reviewer #4:

Is the rate of proliferation the same between cells grown
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on polycarbonate membranes as cells grown on tissue culture treated
plastic?
Authors:

Yes.

I have previously determined that there is no

significant difference between Bl6a cell proliferation rates for cells
grown on plastic dishes versus polycarbonate membranes.

I quantified

proliferation by plating cells into Transwell chambers (50,000
cells/well) and into a 24 well plate (Corning) (50,000 cells/well).
Each experiment was done in triplicate and the number of cells
determined after 72 h by hemacytometer count.
Reviewer #4: Why did the authors use two different radioisotopes to
determine proliferation rates?
Authors:

After completing the BA experiments with

changed radioisotopes to

3

tt-IdUR.

3

tt-thymidine, we

The irreversible binding property of

3
3
tt-IdUR makes it a better radiolabel than H-thymidine (Fidler, I.
Metastasis: quantitative analysis of distribution and fate of tumor
emboli labelled with
1971).

125

I-5-Iodo-2'-deoxyuridine. JNCI, 45:773-782,

Since BA had already been shown to produce a significant

inhibition of

3
H-thymidine incorporation, we thought it would not be

necessary to repeat the BA experiments using

3

tt-IdUR.

Since the publication of this manuscript, the BA experiments were
performed using

3
HidUR.

Butyric acid inhibited the incorporation of

3
HidUR by 76% after 18 h incubation (54 h preincubation with BA) and
84% after 48 h incubation (24 h preincubation with BA).
Reviewer #4:

The methodology of choice for determining

cytotoxic/cytotstatic effects of drugs is the double-label growth
assay.

Why did the authors not use this technique?
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I agree that the double label growth assay is a preferred
method to quantitate viablity and proliferation in drug studies.
Although the trypan blue exclusion method is less sensitive, it did
provide cytotoxic/cytostatic data that was statistically significant.

APPENDIX II

This appendix is titled "Transmission Electron Microscopy of the
Cytoskeleton of Migratory and Invasive Cells" and has been published
under the same name in the Journal of Electron Microscopy Technique,
13(3): 272 - 273.

This appendix describes the methodology used to

evaluate the cytoskeleton of migratory and invasive cells by
transmission electron microscopy.

This methodology is pertinent to

Chapter VI.
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INTRODUCTION.

The recent development of the Transwell cell culture

chamber insert (Costar Co., Cambridge, MA) permits analysis of cellular
migration and invasion.

Transwell inserts contain a porous

polycarbonate membrane and fit into 6 and 24 well cluster plates.
Although cellular migration and invasion through polycarbonate
membranes have been quantitated by routine LM, SEM and radiolabel
techniques, few reports have focused on the cytoskeleton of cells in
the process of moving through pores.

This communication reports a

simple methodology to evaluate the cytoskeleton of both migratory and
invasive tumor cells within 5 um and 8 um diameter pore Transwell
polycarbonate membranes.

MATERIALS AND METHODS.

Murine Bl6a melanoma cells were cultured in

Eagle's medium (MEM) (Gibco, Grand Island, NY) containing Hank's salts
and 1-glutamine supplemented with sodium pyruvate (Sigma, St. Louis,
MO), 10% heat inactivated fetal calf serum (FCS) (Gibco), 1% penicillin
G-streptomycin sulfate-amphotericin B (Fungizone) (Gibco), MEM non
essential amino acids (Gibco), sodium bicarbonate (Sigma), and Hepes
(Sigma).

Cells were treated with sodium butyrate acid (BA) (JT Baker,

Phillipsburg, NJ) for 3 days before plating onto the Transwell
membranes.

Transwell membranes were uncoated for migration assays

(McGarvey and Persky, 1989) and coated with Matrigel (Collaborative
Research, Cambridge, MA) for invasion assays (Repesh, 1989).
Transmission electron microscopy (TEM) followed the method of
McDonald (1984) in order to preserve microfilaments.

Membranes were

fixed for 30 min at 37°C with 2% glutaraldehyde in 50 mM cacodylate
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buffer (pH 7.4) containing 5 mM Cacl , rinsed in buffer (3X) for 5 min
2
at 37°C and incubated for 30 min in buffer containing 0.8% K Fe(CN) .
3
6
Membranes were then incubated for 30 min in buffer containing 0.5% Oso

4

and 0.8% K Fe(CN) , rinsed in buffer, rinsed in distilled water (3X),
3
6
stained en bloc with 2% uranyl acetate (distilled water) for 60 to 120
min, rinsed in distilled water (3X) and dehydrated in ethanol.
Membranes were infiltrated into resin (Epon-Araldite), cut out of the
Transwell inset, and polymerized in blocks at 60°C for 3 days.

Thin

sections were cut, stained in 1% uranyl acetate (in 70% methanol) and
lead citrate, and viewed with an Hitachi H-600 microscope at 75 kV.

RESULTS AND DISCUSSION.

This investigation reports a simple method to

prepare and analyze by TEM the cytoskeleton of migratory and invasive
cells within a polycarbonate membrane.

Figure 1 demonstrates a

migratroy cell be seen extending two large pseudopods into two S um
pores.

Anchoring of the cell to the polycarbonate membrane appears to

take place both within the pores as well as above and below the
membrane (arrows).

Higher magnification (Fig. 2) reveals an extensive

parallel arrangement of the cytoskeleton within one of the large
pseudopods.

The cell border displays bundles of cortical actin.

Cortical actin has been reported to have a major role in cell motility
and migration (Hay, 1985).

It is obvious that the actin preservation

is excellent.
Butyric acid (BA) was used in this study at a concentration of 1.5

mM.

This concentration has been shown to be noncytotoxic, to-

significantly increase cellular migration, and to induce changes in the
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cytoskeleton of Bl6a cells (McGarvey and Persky, 1989).

The

arrangement of the cytoskeleton in the large pseudopod (Fig 2) may not
only be indicitive of a migrating cell but also of BA treatment.
The Transwell insert is an important new tool to analyze cellular
migration and invasion.

The polycarbonate membrane of the Transwell

insert was uncoated for migration and coated with a reconstituted
basement membrane, Matrigel, for invasion.
BA-treated cell on top of the Matrigel.

Figure 3 depicts a

A portion of this cell and

possibly another cell have extended into an 8 um pore by digesting the
Matrigel (arrow).

Higher magnification of this area (Fig. 4) reveals a

cytoplasm without the extensive cortical actin and other cytoskeletal
filaments seen in the migratory cell.

Areas of contact with the

Matrigel appear to contain actin (arrows).

Kramer et al. (1989) have

reported fibrosarcoma cells, which invaded Matrigel, to have (1) formed
pseudopodia which contained organized microfilaments and (2) have
cleared the matrix adjacent to the pseudopodia.

While we did not

observe bundles of microfilaments, matrix clearing (me) was evident
around the pseudopodia.
The ease of handling the Transwell insert is a major advantage for
microscopy.

Membranes can be processed for TEM in the Transwell

inserts until embedding in the plastic.

Together, the Transwell insert

and Matrigel lend themselves to techiques such as immunogold to locate
and identify cytoskeletal proteins and proteolytic enzymes in cells
that are within the pores of the polycarbonate membrane.
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FIGURE 1.

A migrating BA-treated Bl6a cell cultured on a 5 um diameter pore
polycarbonate membrane (pc).

A large pseudopod extends the length of a

pore with a smaller projection within a second pore (arrows).

Bar= 2

um.

FIGURE 2.

Higher magnification of the large pseudopod of Fig 1.

Note the

extensive actin (a) , intermediate filament () , and microtubule ()
system.

Bar

=

1 um.

FIGURE 3.

An invasive BA-treated Bl6a cell cultured on a Matrigel coated (m) 8 um
diameter pore polycarbonate membrane (pc).

A projection of this cell

or possibly another cell (arrow) is found below the Matrigel barrier.
Bar

= 2 um.

FIGURE 4.

A higher magnification of the projection of Fig 3 with some cortical
actin (a) as well as a clear Matrigel clear zone (me).

Bar= 0.5 um.
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